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ABBREVATIONS 
 
ACS  Acute coronary syndromes 
AH  Avoidable hospitalisations 
AMI  Acute myocardial infarction 
CABG  Coronary artery bypass surgery 
CHOP  Swiss operation procedure code 
CPR  Cardiopulmonary resuscitation 
CVD  Cardiovascular disease 
DRG  Diagnosis Related Groups 
EMS  Emergency medical services 
EOLC  End of life care 
HSA  Hospital service area or health service area  
HSR  Health services research 
ICD  International Classification of Diseases 
MedStat Geographical region defined for the hospital discharge and hospital statistics 
NCDs  Non-communicable diseases 
NSTEMI Non-ST-segment elevation myocardial infarction 
OECD  Organisation for Economic Co-operation and Development 
PCI  Percutaneous coronary intervention 
SEP  Swiss neighbourhood socioeconomic position index 
SFSO  Swiss Federal Statistical Office 
SNC  Swiss National Cohort 
SNSF  Swiss National Science Foundation 
STEMI  ST-segment elevation myocardial infarction 
WHO  World Health Organization 
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SUMMARY 
Switzerland is facing an aging population and a growing amount of patients with chronic diseases. It 
is crucial to display health care processes and pathways, to identify inequalities and obstacles, and to 
point out possibilities for improvements of the Swiss health care system (e.g. increase efficiency). 
The introductory part of the thesis presents a brief description of the Swiss health care system, 
health services research and regional variation as well as an introduction of CVD and its 
epidemiological key figures, aetiology and treatments. This is followed by the description of the 
utilized methods and data, and the objectives of this thesis.  
The subsequent sections present the four articles included in this thesis. The first article focuses on a 
small area analysis on regional variation of avoidable hospitalisations in Switzerland including density 
of primary care physicians and specialists, rurality and hospital supply factors as explanatory 
variables in the analysis. Lower rates of avoidable hospitalisations were found in areas with very high 
supply of primary care physicians, increased avoidable hospitalisation rates in areas with more 
specialists and in areas with higher proportion of rural residents. 
The second article aims to examine whether emergency patients with acute ST-segment elevation 
myocardial infarction were adequately treated, i.e. according to the treatment guidelines, in 
Switzerland. Results show that older and female patients were less likely to receive revascularization 
which suggests that the treatment guidelines may not be uniformly applied in Switzerland. 
Similar to the first article, also in the third article a small area analysis was performed but this time 
investigating regional variation in costs at the end of life. Strongest associations of cost was found 
with cause of death, age and language region of the decedents. The strong spatial variation of costs 
could only partly be explained by the included covariates. 
Article four aims to examine the relationship of distance to different hospital types and mortality 
from AMI or stroke. We found that AMI mortality in the Swiss population 30 and older and stroke 
mortality in those 65 and above increased with distance to central and university hospitals, while 
adjusting for sociodemographic and economic characteristics of the population. 
The presentation of the four articles is followed by a discussion, which summarizes the main findings 
and the strengths and limitations of the presented articles. The thesis concludes with a discussion 
about the challenges for policy, practice and future research.   
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1 Introduction 
This thesis is a contribution to the field of cardiovascular disease (CVD) epidemiology and health 
services research (HSR) in Switzerland. The four articles presented in this thesis address different 
research questions and utilize a wide variety of methods and data, reflecting the multidisciplinary 
field of health services research. 
This thesis first addresses the determinants of regional variations in avoidable hospitalisations in 
article 1. Avoidable hospitalisations are also called ambulatory-care sensitive conditions, indicating 
that appropriate ambulatory care can contribute to the prevention of avoidable hospitalisations. The 
thesis presents a study investigating avoidable hospitalisations including diabetes, hypertension and 
congestive heart failure. These conditions are risk factors for, or precursors or sequelae of, severe 
cardiovascular diseases such as acute myocardial infarction or stroke. 
In article 2, the application of treatment guidelines in emergency patients with acute ST-segment 
elevation myocardial infarction (STEMI) is examined throughout Switzerland. The analysis included 
several characteristics of the patients and hospitals as possible factors to induce the treatment of 
STEMI patients.  
At the end of life, health care costs often increase sharply. CVD is the number one cause of death in 
Switzerland and also plays a major role in the generated costs at the end of life. However, it remains 
unclear why health care costs differ between regions. An investigation of possible reasons for these 
differences is presented in the third article in this thesis.  
A major research focus of HSR is access to health care. Time to treatment is an important factor to 
prevent severe health outcomes of life-threatening diseases such as acute myocardial infarction 
(AMI) and stroke. The fourth article of this thesis explores geographical access to Swiss hospitals and 
its influence on mortality due to AMI and stroke.  
The following sections provide background information about the Swiss health care system, 
cardiovascular diseases, health services research, regional variations, the study designs and data 
used, and the objectives of this thesis. 
1.1 Swiss health care system 
The Swiss health care system is considered to be among the best health care systems worldwide, 
based on indicators including life expectancy, the number of health professionals and patient 
satisfaction. However, it also ranks as one of the most expensive health care systems among OECD 
(Organization for Economic Co-operation and Development) countries with 11.4% of its gross 
domestic product being spent on health care in 2009. Like other high-income countries, Switzerland 
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is facing a massive demographic change in the form of a rapidly aging population. The consequence 
of this is a growing burden for the health care system and a resulting increase in costs. The OECD and  
WHO (World Health Organization) stated in their review of the Swiss health system in 2011 that a 
major challenge for Switzerland will be maintaining and improving the care of people suffering from 
chronic conditions (OECD/WHO, 2011).  
Switzerland is a federal country with a decentralized structure, both governmentally and for health 
care. The 26 cantons each take on the responsibility for the planning and supply of health care 
services, subsidies of insurance premiums and financing of hospitals in their jurisdiction. The central 
government determines federal health legislation and regulates the health insurance market 
(including payment procedures and defining the health services to be covered by compulsory health 
insurance packages).  
Basic health insurance is compulsory for all Swiss residents. Residents can choose from around 60 
insurance companies. The insured can also choose the annual excess they will pay in the event of 
making a claim or claims. This excess is in the range of 300 to 2,500 Swiss Francs, with the monthly 
premium (ranging from 230 to 650 CHF) being lowered when a higher excess is selected. In addition 
to the excess, 10% of the yearly health expenditures are payable by the insured to a maximum of 700 
Swiss Francs. In contrast to other countries, Swiss residents have the free choice of their physicians, 
hospital and other health care providers. However, individuals can choose insurance plans with 
managed care networks or GPs as gatekeepers where premiums are reduced.  
Approximately 37% of all Swiss residents receive subsidies from their cantons for their health 
insurance to prevent premiums exceeding 8 – 10% of their household’s income. Around half of 
inpatient health care costs are also paid by the cantons, with the goal of providing equal access to 
high-quality health care. 
The insurance providers are prevented by law from making a profit from compulsory insurance 
packages, but they can profit from additional private insurance packages e.g. covering dental care, 
single bed rooms in hospitals or complementary medicine (Biller-Andorno and Zeltner, 2015; 
Reinhardt, 2004).  
Demographic changes and constantly rising health-care costs have created challenges for the Swiss 
health care system in the provision of sufficient health care professionals to deliver services for an 
elderly population and in preventing supply-induced overconsumption (Biller-Andorno and Zeltner, 
2015). The fragmented health care system and the sheer number of health-care- and insurance-
providers makes it challenging to collate data to provide insights into opportunities for improvement 
in Swiss health care. Nevertheless, the awareness of this great need for more information is 
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increasing. The Swiss National Sciences Foundation just released a call for proposals to promote 
innovative health services research, examine the challenges of caring for chronically ill and improving 
the usability of health data (SNSF, 2015). 
1.2 Health services research 
The U.S. National Library of Medicine lists on their website HSR definitions of five American 
institutions from 1980 to 2000 and summarizes: “…, health services researchers investigate three 
major aspects of health care: access to care, the quality of care, and its cost. Health services 
researchers attempt to evaluate the effects and outcomes of the health care ‘system’ on people’s 
health.” (NIH, 2014)  
In August 2015, the Swiss Federal Office of Public Health released a factsheet about HSR, stating that 
there is a backlog in Switzerland in HSR and results of HSR studies of other countries are not easily 
transferable to Switzerland. They define the aim of HSR in Switzerland as follows: to gain knowledge 
about how to optimize the structure of health care, how to increase the health care quality and 
efficiency, how to reduce over-, under- and wrong utilization of health-care services, and how 
patients’ safety and navigation through the system can be improved (BAG, 2015).   
1.3 Regional variation  
A major research focus of HSR is the identification of regional variation in health care. The Dartmouth 
Institute for Health Policy & Clinical Practice in New Hampshire are pioneers in exploring regional 
variation using small area analysis in the US health-care system. For more than 20 years, they have 
explored efficiency and effectiveness of the US health care system in their Dartmouth atlases or 
reports of health care presenting maps and analyses of regional variation in costs, surgical 
procedures, end of life care or supply-sensitive care (The Dartmouth institute, 2016). The National 
Health Service England have published atlases of variation in health care for topics like diabetes, 
respiratory disease or diagnostic services since 2010 (NHS Right Care, 2016). 
In Switzerland and elsewhere, considerable geographical and temporal variation in cardiovascular 
health care and mortality has been shown (David E.Wennberg and John D. Birkmeyer, 1999; Insam et 
al., 2014, 2013; Maeder et al., 2010; Marques-Vidal and Paccaud, 2012; Radovanovic et al., 2012). 
Variations can be shown in costs, treatment pattern, intensity of care, health outcome (e.g. 
mortality), re-hospitalisations as a measure of quality of care and health care expenditures, as well as 
utilization of health care providers (Agarwal et al., 2015; Busato et al., 2012; Panczak et al., 2012; 
Roussot et al., 2016). Several factors cause regional variation: differences in the prevalence of the 
underlying diseases, patient’s medical conditions, demographic and socioeconomic characteristics, 
regional differences in capacity, quality and accessibility of supply, financial incentives related to 
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different reimbursement systems, as well as patient or provider driven deviations from evidence-
based practice. High variation can point to unnecessary care or underutilization of necessary care.  
1.4 CVD – epidemiology, aetiology and treatment 
Cardiovascular diseases belong to the non-communicable diseases (NCDs), also known as chronic 
diseases, with long duration and slow progression. The four main types of NCDs are CVD, cancers, 
chronic respiratory diseases and diabetes. Common potentially modifiable risk factors for dying from 
non-communicable diseases are physical inactivity, tobacco use, harmful use of alcohol and 
unhealthy diets. Globally, 17.5 million people die from CVD every year, making it the leading cause of 
death in the world (WHO, 2015a, 2008). CVD also causes the largest economic burden of disease 
worldwide. In 2004, the British National Health Service spent 21% of their health expenditures on 
CVD treatment alone (Luengo-Fernández et al., 2006).  
Although over three quarters of CVD deaths take place in low- and middle-income countries and 
deaths from CVD decreased in high-income countries over the last decade, CVD is still the main cause 
of death in Switzerland (Bundesamt für Statistik, 2014; WHO, 2015b). In total, 21,674 persons died of 
CVD in 2013 (9,745 men and 11,929 women). 13,864 cases have been hospitalized because of AMI 
(65.5% men, 34.5% women) and 14,192 cases because of stroke (51.2% men, 48.8% women) (SFSO, 
2015a).   
Due to the huge burden of disease from CVD, various studies (Framingham Heart study, MONICA - 
Multinational Monitoring of trends and determinants in cardiovascular disease) were started to 
examine the determinants and risk factors, changes in prevalence and incidence of CVD, preventive 
factors and medication, the development of a risk score or the evaluation of different treatment 
procedures, which resulted in evidence based treatment guidelines (D’Agostino et al., 2013; Eriksson 
et al., 2012; Hense, 2000; Mendis; O’Gara et al., 2013; Peltonen et al., 1998; Steg et al., 2012; 
Windecker et al., 2014).  
1.4.1 Aetiology of CVD 
Cardiovascular disease comprises a group of disorders of the heart, blood vessels and vascular 
diseases of the brain. CVD due to atherosclerosis comprises ischemic heart disease or coronary artery 
disease (e.g. angina pectoris, heart attack), cerebrovascular disease (e.g. stroke) and diseases of the 
aorta and arteries, including hypertension and peripheral vascular disease. Other diseases belonging 
to CVD are rheumatic heart disease, congenital heart disease (malformations of heart structures), 
cardiomyopathies (disorders of the heart muscle) and cardiac arrhythmias (WHO, 2015b, 2011).   
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Atherosclerosis is a slow progressing pathological process in the walls of blood vessels, often 
beginning in childhood and adolescence. Several risk factors are known: tobacco use, physical 
inactivity, obesity, diabetes, unhealthy diet, harmful use of alcohol, hypertension, raised blood lipids, 
male gender, advancing age or genetic disposition. Atherosclerosis is an inflammatory process 
affecting medium- and large-sized blood vessels. Fatty material and cholesterol are deposited inside 
the lumen of the arteries. The continuing deposition of these plaques cause the lumen to become 
narrow and the blood flow is limited. Finally, the plaque can rupture and result in the formation of a 
thrombus. If the thrombus is large enough to block a coronary or a cerebral blood vessel than this 
results in a heart attack or ischemic stroke.  
Another cause of stroke, although it is less frequent, is bleeding (haemorrhage) triggered by a 
rupture of a blood vessel due to an aneurysm or due to damage from high blood pressure. Also 
travelling blood clots can cause a stroke (Davis, 2005; WHO, 2011). Ischemic strokes are by far more 
frequent than haemorrhagic strokes, but this ratio differs by regions. Ischemic strokes account for 
approximately 80-90 % of all strokes (Andersen et al., 2009; Khaw and Kessler, 2006).  
There are two different types of acute myocardial infarctions: non-ST-segment elevation myocardial 
infarction (NSTEMI or non-STEMI) and ST-segment elevation myocardial infarction (STEMI) referring 
to the different directions of ST-segment of an electrocardiogram. The ST elevation is due to the 
entire thickness of the myocardium having undergone necrosis, usually triggered by a total occlusion 
of the infarct-related artery. A non-occlusive thrombus causes NSTEMI (Kumar and Cannon, 2009a, 
2009b), which is more frequent than STEMI. It’s estimated that each year worldwide more than 4 
million people have a NSTEMI compared to more than 3 million having an acute STEMI (White and 
Chew, 2008). The change of the STEMI to NSTEMI ratio (declining STEMI and increasing NSTEMI 
diagnoses) in the past decades is most likely attributed to the changes in the diagnosis of AMI as well 
as the amelioration of troponin assays which lead to more diagnoses of NSTEMI instead of unstable 
angina (McManus et al., 2011; Tisminetzky et al., 2014). Together with unstable angina, STEMI and 
NSTEMI form the group of acute coronary syndromes (ACS).  
1.4.2 Treatment of CVD 
Emergency treatment depends on the type of AMI and stroke, the condition of the patient and the 
time from symptom onset and start of treatment. The earlier the treatment is initiated the more 
deaths and disability from heart attack and stroke can be prevented (Moser et al., 2006). AMI 
patients will have the greatest benefit from reperfusion therapy when it is performed within 2-3 
hours from symptoms onset (Windecker et al., 2014). Stroke patients treated within 3 hours of stroke 
onset will have less disability after 3 months than patients with delayed care (Hacke et al., 2004). One 
component influencing the time to treatment is the travel distance to hospitals. The relationship of 
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mortality from AMI or stroke with the distance to different types of hospital will be investigated in 
article 4. 
In both AMI and stroke emergency treatment, it is of great importance to immediately reduce pain, 
remove the clot or blockage and prevent further heart attacks or strokes. The European Guidelines 
for management of acute STEMI patients recommend immediate angiography with primary 
percutaneous coronary intervention (PCI) if it can be performed in a timely manner (first medical 
contact to reperfusion therapy ≤ 90 min). Another option is pharmacological reperfusion with 
fibrinolytic therapy. Although primary PCI should be the primary choice of treatment, according to 
guidelines, performance of primary PCI is more difficult to implement than fibrinolysis as treatment 
in PCI-capable hospitals must be available in timely manner. If primary PCI is not possible to perform 
in time then fibrinolysis should be performed within 30 min of the first medical contact. Another 
treatment is coronary artery bypass surgery (CABG), which is an open heart surgery and much more 
invasive than the other two procedures. This procedure is not often performed in the acute phase of 
STEMI (Steg et al., 2012). In article 2 of the thesis the adherence to the treatment guidelines for 
STEMI is examined. 
The treatment of NSTEMI is dependent on the risk profile of the patient. For low risk patients a 
conservative strategy (medical management, catheterization, revascularization if necessary) should 
be chosen, for high risk patients an early invasive strategy (cardiac catheterization, revascularization 
with PCI or CABG) is the treatment of choice (Hamm et al., 2011).  
Ideally, stroke patients should be treated by stroke units, as they provide a reduction in mortality and 
improve the outcome of stroke in general (European Stroke Organisation Executive Committee, 
2008; Steiner et al., 2006). Again, the treatment of ischemic or haemorrhagic stroke patients 
depends on the condition of the patient. The usual treatment for ischemic stroke is Aspirin given 
intravenously to prevent blood clots from forming and to prevent future strokes. The gold standard is 
an intravenous tissue plasminogen activator to break down the clots. Other treatments are 
mechanical clot removal, angioplasty and stents (European Stroke Organisation Executive 
Committee, 2008). 
In the treatment of haemorrhagic stroke it is extremely important to lower the blood pressure in the 
brain, which is achieved through the administration of medications. Common treatments for 
ruptured intracranial aneurysms, a type of haemorrhagic stroke, are neurosurgical clipping and 
endovascular embolization (coiling) (Molyneux et al., 2002). 
As stated previously, AMI and stroke, once they have occurred, are severe diseases and need 
immediate treatment. However, prevention of these conditions should be the major goal, as the 
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majority of cases are due to modifiable risk factors. Appropriate treatment of known risk factors for 
AMI and stroke (e.g. hypertension or diabetes) by health care services are necessary for disease 
prevention, in addition to other interventions such as lifestyle changes.  
1.5 Methods and data  
In the following paragraphs I will present the study designs and the data sets that were used in this 
thesis.  
1.5.1 Study designs  
All study designs presented in this thesis are observational studies. In contrast to experimental 
studies, the investigator simply observes and does not intervene in observational studies.  
Cross-sectional study 
Cross-sectional studies measure exposures and outcomes simultaneously, i.e. it is a snapshot of the 
population’s health status at a certain point in time. It is possible to identify prevalent cases, but not 
incident (new) cases. Therefore, this study design is also called a prevalence study. Cross-sectional 
studies are relatively easy and cheap to conduct and are often used for health services planning or to 
determine current health practices. Repeated cross-sectional studies are used to discover changes or 
trends in the outcome(s) or exposure(s) over time, which makes them ideal for monitoring purposes. 
Since information on both the exposures and outcomes are collected simultaneously, it is normally 
not possible to know whether the exposure preceded the outcome. Having no information about the 
temporal relationship of the exposure and outcome diminishes the possibility to infer causality quite 
substantially. Nevertheless, cross-sectional studies are used to generate research hypotheses, which 
then can then be applied to cohort or case-control studies to establish etiologic relationships 
(Carneiro and Howard, 2011; Gordis, 2009).   
Cohort study 
The word “cohort” is derived from the Latin word “cohors”. One Roman legion consisted of 10 
cohorts with a specific number of soldiers who would be traced during the battle (Song and Chung, 
2010). The word “cohort” was first introduced into the epidemiology arena in a 1935 publication by 
Wade Hampton Frost (Doll, 2001; Song and Chung, 2010). The current definition of cohort in 
epidemiology is a “group of people with defined characteristics who are followed up to determine 
incidence of, or mortality from, some specific disease, all causes of death, or some other outcome.” 
(Morabia, 2004) 
A common characteristic of the study subjects can be their place of work or residence, their age or 
lifestyle choices (e.g. smoking habits), for example. Cohort studies are normally used to examine one 
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or several common outcomes of interest. It is also possible to use a cohort design to study rare 
exposures, since the study population is selected by their exposure status. Investigator(s) select an 
exposed and an unexposed group of individuals who have not yet experienced the outcome of 
interest to form the study population. Participants are followed over time until the outcome occurs. 
The incidence of an outcome in the exposed group is then compared with the incidence of the 
outcome in the unexposed group in order to measure the effect of the exposure on the outcome of 
interest. The cohort study might include more than two groups (e.g. there may be groups 
representing no, little, moderate and high exposure). Cohort studies belong to longitudinal study 
designs which implies conducting several observations of the same subject over a period of time. The 
advantage is that the investigators can detect the developments or changes in characteristics of the 
study subjects (Carneiro and Howard, 2011; Gordis, 2009). Due to cohort studies identifying the 
exposure before the outcome, cohort studies meet the temporality criterion for causality and can 
therefore provide stronger scientific evidence of causality than cross-sectional studies (Song and 
Chung, 2010).  
Cohort studies can be prospective or retrospective. Prospective cohort studies start, as described 
above, with the selection of the study population and finishes with the experience of the outcome or 
the predefined time frame. The disadvantages of this design are that they may be expensive to 
conduct, due to the large number of people followed over time, and that they often required long 
durations of follow-up. Furthermore, maintaining follow-up is difficult and loss to follow-up is a 
serious issue.  
For retrospective cohort studies the investigator(s) identifies a historical cohort (e.g. all students of a 
school at January 1st, 2000) that don’t have the outcome at the start date. Historical data is used to 
obtain the outcome and exposure (e.g. past records of yearly health examinations at school). The 
advantage of this study design is the reduction of the time required for the study, especially when 
studying diseases which take decades to develop. Often, routinely collected data are used in a 
retrospective cohort study and typically these data were not collected for the purpose of the study, 
and consequently important information about risk factors or confounders are not available (e.g. 
student was not present at all health examinations) or are of poor quality (e.g. incomplete health 
examination sheets) which can result in a biased cohort due to selection bias (Carneiro and Howard, 
2011; Gordis, 2009; Song and Chung, 2010). 
Article 4 of this thesis is presenting the investigation of a possible relationship of the distance to 
hospital and AMI or stroke mortality using the data of the Swiss National Cohort (SNC). 
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1.5.2 Data sources  
In the following I give an overview of the data sets that were used to conduct the studies described in 
this thesis. Unlike Scandinavian countries, Switzerland does not have a universal personal identifier 
that can be used to link different data sets. Nevertheless, by using probabilistic and deterministic 
linkage techniques, various data sets without unique personal identifiers can be linked e.g. census 
data and death notifications (see the description of the Swiss National Cohort).  
Hospital discharge statistics (medizinische Statistik der Krankenhäuser) 
The Swiss Federal Statistical Office (SFSO) started the mandatory collection of hospital discharge 
statistics from all Swiss hospitals in 1998. This data is used to monitor the incidence and prevalence 
of the most important diseases, to provide basic medical data to investigate inter-cantonal care 
structures and to provide a data set for researchers and the public. Every record in the data set 
represents a hospitalisation and contains around 50 variables to describe the patient’s characteristics 
(e.g. age, gender, and residential region called MedStat, see section 1.6.3) as well as information on 
where the patient was before admission (home, another hospital, nursing home, etc.), whether it 
was an emergency admission, how many hours the patient spent in an intensive care unit as well as 
the main diagnoses and comorbidities using ICD-10 codes (International Classification of Diseases, 
Injuries and Causes of Death, version 10), and the description of the treatment using CHOP codes 
(Swiss operation procedure code). Updated coding guidelines are published regularly, describing the 
procedure of the diagnosis and treatment coding. Before releasing the data to researchers, the 
hospital creates an encrypted and anonymous patient id using the patient’s first name, surname, 
gender and date of birth. The hospitals send the data to the cantons, which are responsible for 
cleaning and checking the data. The cantons then transfer the data to the SFSO. The encrypted id 
enables the SFSO to identify the patient in different hospitals and over the years. Patients cannot be 
identified as a specific individual in the population (e.g. by name) through data in the SFSO.  
Hospital statistics (Krankenhausstatistik) 
Since 1997, all hospitals are obligated to send information about their technical infrastructure, staff 
and their ambulant and inpatient activities to the SFSO. For instance, they have to provide 
information about the type of hospital, number of CT scanners, MRI and angiography devices, 
number of beds, number of employees, their training and level of employment, number of 
discharges, finances and costs.  
The hospital discharge and hospital statistics are used by the cantons for their health care planning 
and delivery of health services. The SFSO uses the data to inform the public about the health status 
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of the population or trends in disease incidence. Research institutes also have access to the data, 
although not in the same detail as, for example, the cantons.   
Hospital list of the Federal Office for Health (FOH) 
The Federal Office for Health publishes key figures of all Swiss hospitals every year including their 
structure, staff, services, patients’ characteristics and financial situation. This key figures data set is 
based on the hospital discharge statistics and the hospital statistics, but presents only a limited 
number of variables. Additionally, the addresses of the hospitals are provided in the dataset. 
Unfortunately, this list of addresses is not complete as companies that have several hospital locations 
report cumulated data for all their locations and only the address of the headquarters is stated. 
Therefore, I used data from the Federal Office of Topography (swisstopo) and TomTom to add the 
missing hospital locations.  
The Swiss National Cohort (SNC) 
The Swiss National Cohort, established in 2005, is an ongoing longitudinal study, based on census 
data from 1990 and 2000 on the resident population of Switzerland.  Data from 6.87 million 
individuals from the 1990 census and 7.29 million individuals from the 2000 census are included. 
These data were linked to mortality and emigration records up to 2008 resulting in 1,052,527 linked 
deaths (see figure 1) (Spoerri et al., 2010).  
Since 1850 censuses were conducted every ten years using questionnaires delivered to all residents 
of Switzerland. The census consists of three questionnaires to survey several variables: one for each 
person (for instance: date of birth, gender, marital status, citizenship, education, religious affiliation, 
number of children, languages, current employment situation, means of transport), one for each 
household (for instance: number of rooms, number of persons in the household) and for each 
building filled in by the owner of the building (for instance: type of building, number of floors, 
heating system, price of rent). The building questionnaires could then be linked to the federal 
registry of buildings which provided the geographical coordinates of each building. The dataset of the 
2000 census includes 172 variables for each individual, 204 variables on household and 48 on 
building level (Spoerri et al., 2010).  
The cause of death statistics have been collected in Switzerland since 1876 (Bundesamt für Statistik, 
1996). The cause of death is coded according to the ICD (ICD-8 until 1994, ICD-10 since 1995). Aside 
from the cause of death, death certifications also record information on date of birth, gender, marital 
status, the place of residence and religion. The aim of the SNC is to examine all-cause and cause-
specific mortality according to socioeconomic determinants.  
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Due to the lack of a unique person identifier and the anonymous death registration in Switzerland, 
the linkage used a combination of deterministic and probabilistic methods based on sex, gender, 
date of birth, marital status, nationality, religion and place of residence. For the linkage procedure 
the Generalized Record Linkage System package developed by Statistics Canada was used (Fair, 
2004). Results of a pilot study in the canton of Zurich indicated that the linkage can be improved by 
including emigration records as well (Bopp and Gutzwiller, 2000).   
Of the 1,122,376 deaths recorded in the mortality statistics, 93.8% could be linked to a census record 
from 1990 or 2000. The main characteristics of the unlinked deaths were: young (10-29 years), no 
Swiss nationality, female and single. Furthermore, 6.9% of the persons registered in the 1990 census 
couldn’t be linked to a mortality, emigration or 2000 census record. The majority of these unlinked 
records are related to young individuals (10-29 years), which most likely refers to their higher 
mobility and residence in large cities (Spoerri et al., 2010) (see figure 1).   
 
Figure 1: Structure of the Swiss National Cohort from Spoerri et al 2010. 
The accuracy of the official mortality records differ according to the cause of death. Well-defined 
diagnoses are better reported than less well-defined diagnoses. The quality should be satisfactory for 
malignant neoplasms, cerebrovascular disease, ischemic heart disease and accidents, whereas for 
diseases of the nervous system, chronic respiratory diseases and other forms of heart disease the 
accuracy of the death certificates are less reliable (Bopp et al., 2009).  
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Another limitation is the lack of information about the income, capital or other assets of the 
individuals (Spoerri et al., 2010). Nevertheless, Panczak et al. were able to develop the Swiss 
neighborhood socioeconomic position index (SEP) based on the census data using the variables 
median rent, education and occupation of household heads and household crowding (Panczak et al., 
2012). The development of the SEP broadened the possibility for subsequent studies to include the 
socioeconomic position of the neighborhood of the individual.  
Similar to other countries, the census procedure has changed in Switzerland. Since 2010 the census is 
conducted every year using the data from registries (county and cantonal resident registries, federal 
registry of buildings) instead of sending questionnaires to the entire population. Just 5% of the 
residents have been interviewed in written or oral form each year to add information that is not 
recorded in the registries (e.g. work, mobility, education, language etc.). The registry data, the micro 
survey as well as the death and emigration records will be linked with each other and added to the 
current SNC data (BFS 2011).   
The study design of the SNC is described in detail by Bopp et al and Spoerri et al (Bopp et al., 2009; 
Spoerri et al., 2010). Further information (e.g. the census questionnaires) can also find here: 
www.swissnationalcohort.ch. In article 4 of this thesis I used the SNC from 2000 to 2008 to examine 
the effect of distance to hospital on mortality due to AMI and stroke.  
Additional data  
In addition to the major data sets presented above, additional data that were used in this thesis 
were:  
- SFSO census data from 2010, number of persons per community stratified by age and gender 
(SHAPE project)  
- Community classification data set from the SFSO (Raumgliederung) 
- A list of physicians and their specialisation, sector of employment (ambulatory, stationary, 
other), and postcode, from the Swiss Medical association 
- Billing records of dead persons insured 12 months before their death from 6 major Swiss 
health insurances 
1.6 Geographical units and their spatial congruence  
Having several data sets with different geographical reference units (e.g. administrative areas, 
postcodes) is challenging, especially when they are not congruent with each other or change over 
time. In the following I give an overview and description of all used geographical units and how they 
relate to each other. 
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Communities 
Communities are the smallest administrative units in Switzerland and are the basis of higher-level 
administrative units (districts, canton), regional planning regions and analytic regions (e.g. language 
regions, commuter regions, urban or rural classification). Community borders and numbers change as 
communities frequently merge, separate or otherwise restructure (reference date 31.12.2010: 2584 
communities; reference date 31.12.2015: 2324 communities) (SFSO, 2016a).  
Postcodes 
A Swiss postcode is a series of four digits used in the address for the purpose of sorting mail. 
Normally, they are referring to a specific geographical area. There are also postcodes assigned to 
individual addresses or institutions. Postcodes are assigned by the Swiss Post and are subject to 
changes (implementation of new or abolition of old postcodes) due to population decrease or 
increase. Since postcodes are assigned independently of the community administrative units, they 
may not map perfectly to one another. As of 1st August 2015, there were 3,199 postcodes in 
Switzerland and 2,324 communities. Around 60% of these 3,199 postcodes mapped to one 
community or part of one community only. The remaining postcodes areas belonged to more than 
one community (see figure 2) (SFSO, 2015b; Swisstopo, 2016).  
MedStat 
The 705 Swiss MedStat regions are used in the hospital discharge and hospital statistics to determine 
the geographical region of the patients’ place of residence and the location of the hospital. They 
were developed to prevent the identification of persons with rare diseases. MedStat regions consist 
of aggregated postcode areas resulting in more or less the same number of inhabitants per MedStat. 
Because postcodes are changing, the SFSO publishes a new table each year determining which 
postcode belongs to which MedStat region. The hospitals have to incorporate this updated list into 
their hospital information system to assign the patient to the correct MedStat region (SFSO, 2016b). 
In the article about avoidable hospitalisations we used the term aggregated zip-code areas instead of 
MedStat regions (see article 1). 
In 2008, the SFSO changed the formation of the MedStat regions, i.e. different postcodes to before 
were aggregated to new MedStat regions. Old names were used for new regions at new locations. 
The new MedStat regions are not compatible with MedStat regions before 2008. Unfortunately, my 
investigations showed that not all hospitals updated the postcode-MedStat list instantly but one or 
two years later. Consequently, we found huge variation in the number of hospitalisations per 
MedStat region in the hospital discharge statistics from 2008 to 2010 due to the wrong assignment of 
the MedStat region (Berlin et al., 2014b). Therefore, we decided to exclude 6 cantons from the 
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analysis of the study of avoidable hospitalisations (see article 1) (Berlin et al., 2014a), changed the 
focus from small area analysis in the treatment article to the difference between the volume of cases 
of hospitals (see article 2) and limited our analysis in the end of life and treatment articles to the data 
from 2010 and/or 2011 (see article 2 and 3).  
 
 
Figure 2: Communities, postcodes and MedStat regions and their spatial congruence. The four maps 
presenting the same geographical extent of the area around the city Winterthur.   
 
Hospital service areas 
Hospital service areas (HSAs) are created on the basis of the hospital discharge statistics and 
represent utilisation-based areas. HSAs were constructed by cross-tabulating the sum of the 
discharges of every MedStat region of the patients to the MedStat region of all possible hospitals. 
The hospital MedStat region with the highest number of discharges from a specific residential 
MedStat region was the main hospital provider region for the population of that particular residential 
MedStat region. Some assignments had to be adjusted manually e.g. when the patients went to two 
or more hospital regions equally often, i.e. the number of discharges was almost similar.  
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In summary, one HSA consists of one or more MedStat regions and can also be seen as the major 
catchment area of the hospitals. In areas with a low hospital density the HSAs can be geographically 
large. It is also possible to construct disease-specific HSAs by only using the discharges with this 
specific disease. More details about the construction of HSAs is described elsewhere (Klauss et al., 
2005; Wennberg and Gittelsohn, 1973). Hospital service areas may also be called health service 
areas, as we did in article 1.  
Geographical coordinates 
The Swiss building and flat register (www.housing-stat.ch) provides, besides other variables, the 
geographical coordinates of all buildings used for living. The data of the registry were linked to the 
census data of 2000 and are therefore also included in the SNC data set.  
1.7 Objective of this thesis 
The overall aim of this thesis is to make a substantial contribution to the investigation of the 
determinants of regional variation in CVD health care and mortality in Switzerland.  
Specific objectives included: 
1) To examine regional variation in avoidable hospitalisations and to identify factors that affect 
them, such as medical resources, reimbursement systems or rurality (Article 1). 
2) To analyze differences in evidence-based treatment of STEMI cases by hospital volume 
(Article 2). 
3) To investigate the variation in costs for end-of-life care and detect the factors influencing the 
variation across regions (Article 3). 
4) To explore the influence of distance from place of residence to different hospital types on 
AMI and stroke mortality (Article 4). 
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http://www.biomedcentral.com/1472-6963/14/289RESEARCH ARTICLE Open AccessAvoidable hospitalizations in Switzerland: a small
area analysis on regional variation, density of
physicians, hospital supply and rurality
Claudia Berlin1, André Busato1,2ˆ, Thomas Rosemann2, Sima Djalali2 and Maud Maessen1*Abstract
Background: Avoidable hospitalizations (AH) are hospital admissions for diseases and conditions that could have
been prevented by appropriate ambulatory care. We examine regional variation of AH in Switzerland and the
factors that determine AH.
Methods: We used hospital service areas, and data from 2008–2010 hospital discharges in Switzerland to examine
regional variation in AH. Age and sex standardized AH were the outcome variable, and year of admission, primary
care physician density, medical specialist density, rurality, hospital bed density and type of hospital reimbursement
system were explanatory variables in our multilevel poisson regression.
Results: Regional differences in AH were as high as 12-fold. Poisson regression showed significant increase of all
AH over time. There was a significantly lower rate of all AH in areas with more primary care physicians. Rates
increased in areas with more specialists. Rates of all AH also increased where the proportion of residences in rural
communities increased. Regional hospital capacity and type of hospital reimbursement did not have significant
associations. Inconsistent patterns of significant determinants were found for disease specific analyses.
Conclusion: The identification of regions with high and low AH rates is a starting point for future studies on
unwarranted medical procedures, and may help to reduce their incidence. AH have complex multifactorial origins
and this study demonstrates that rurality and physician density are relevant determinants. The results are helpful
to improve the performance of the outpatient sector with emphasis on local context. Rural and urban differences
in health care delivery remain a cause of concern in Switzerland.
Keywords: Ambulatory care, Health services, Small area variation analysis, HospitalizationBackground
Increasing utilization and rising health care costs threaten
the financial sustainability of many western health care
systems. Governments and researchers have a growing
interest in identifying ineffective and unnecessary health
care. Avoidable hospitalizations (AH), also referred to as
hospitalizations for ambulatory care sensitive conditions
(ACSC) are hospital admissions for diseases and condi-
tions that might have been avoided if better ambulatory
care were available [1]. AH are indicators of access and
quality of ambulatory care and have been used to monitor* Correspondence: mmaessen@ispm.unibe.ch
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37health system performance in several countries, including
the United States, Canada, Brazil, several European
countries, New Zealand and Australia [2-11]. Comparisons
between countries that show AH rates for different health
care systems may point out strengths and weaknesses of
each system.
Structural deficits of care provision such as inequitable
access across different societal groups, e.g. urban rural
differences, racial and ethnic minorities or different levels
of health insurance coverage were identified mainly in the
US literature as important predictors of AH’s [12,13]; but
AH can also be seen as an indicator of process quality
resulting in medical procedures not warranted by effective
needs [14]. We are in favor of this process based view as it
seems to be more relevant for the Swiss health systemtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
Berlin et al. BMC Health Services Research 2014, 14:289 Page 2 of 10
http://www.biomedcentral.com/1472-6963/14/289which is characterized by high density of supply and
generally unlimited access to care [15].
For Switzerland, comprehensive data on AH in different
regions and its causal factors are currently unavailable
[11]. Switzerland is an interesting country to study AH,
because it spends more on health care per capita (5270
USD) than any other country except the United States
(8233 USD) and Norway (5388 USD) [16]. Switzerland is
also an OECD country with among the highest per capita
availability of physicians and nurses and it has one of the
world’s highest life expectancies [17].
Health care services in Switzerland are reimbursed by
private insurances with compulsory basic health plans that
cover a comprehensive catalogue of goods and services for
all Swiss inhabitants. There are practically no uninsured
patients and limited access to health care is rarely a factor
in AH. However, Swiss health care is also characterized by
considerable fragmentation due to cantonal autonomy
[18] and heterogeneity regarding the distribution of physi-
cians, hospitals and medical facilities, so regional variation
of AH rates is to be expected. This project was initiated
by the Swiss Federal Office of Public Health (SFOPH)
with the goal of documenting regional variation in AH,
and identifying relevant determinants of AH rates in
Switzerland.
Methods
Design of the study
The study is designed as a retrospective analysis of all
hospitalizations in Switzerland for the years 2008–2010.
In 2002, the OECD initiated the Health Care Quality
Indicator Project to measure and compare the quality of
health care provision across countries and to develop a
set of health care quality indicators [15,19,20]. Within
this framework, the OECD uses AH as a measure of
quality for prevention and management of chronic dis-
eases in primary care. For comparability reasons, these
indicators, including hospitalizations with a principal
ICD10 code of asthma, chronic obstructive pulmonary
disease (COPD), diabetes complications, congestive heart
failure (CHF), and hypertension [19], are used to define
AH for this study. Based on OECD eligibility criteria, we
included only patients aged 15 and up (15+) and patients
not transferred from other hospitals. Detailed ICD codes
and additional information on inclusion and exclusion cri-
teria of these conditions as defined by the OECD are given
in the Additional file 1.
Data
We used data from multiple sources. Inpatient care data,
including patient demographics, regional data of patient
residency, characteristics of hospitalizations (length of
stay, type of discharge, referral pathways, health insur-
ance status) and diagnostic and treatment data (ICD10,38procedure codes and All Patient Diagnosis Related
Groups (APDRG’s)) were extracted from the “Medizinische
Statistik der Krankenhäuser”, housed at the Swiss Federal
Statistical Office (SFSO) [21]. These data cover all hospitali-
zations of acute care hospitals in Switzerland. One patient
can be hospitalised multiple times (multiple cases). Anon-
ymized unique patient identifiers allow tracking patients
across hospitals in case of multiple hospitalizations. Data
on structural attributes of acute care hospitals (localization,
type, size and specialization of hospitals) are also available
from the SFSO (Krankenhausstatistik).
Demographic data at the community level, including
age and gender distribution, were available from the SFSO
(census data) [22]. In 2010, a new federal population cen-
sus was introduced by the SFSO (SHAPE project) and the
population aged 15+ was used to build the denominator
to calculate regional rates of AH for 2010. SHAPE data
were also used to directly standardize rates by sex and age
groups.
Geographic unit
Utilization-based health service areas (HSA) of acute
care hospitals were the unit of geographic analyses.
HSA’s were constructed by analysing discharge data of
all acute care hospitals in Switzerland for the period of
2008–2010 [23,24]. We used HSA’s and aggregated zip-
code areas of patient residence as the smallest geographic
unit (MedStat areas). HSA’s were constructed by cross-
tabulating the sum of discharges of every zip-code cluster
with all possible hospital regions, and then these regions
were merged into an HSA by assigning to the hospital re-
gion in which the highest number of patients were treated
[25]. Using HSA’s has the advantage of describing where
patients actually receive care, without regard to cantonal
or other administrative borders [21,23,24,26,27]. This ap-
proach is well established and has become an indispens-
able source of information for current US healthcare
reformers [28].
In 2008, the SFSO modified the concept of MedStat
areas to make them compatible with other geographic
classification systems. However, these changes were not
equally implemented in the data collection procedures
of all Swiss cantons during the course of the study. In
consequence, geographic classification of hospitals and
of patient residence was inconsistent in some cantons.
Data from cantons Appenzell Innerrhoden, Appenzell
Ausserrhoden, Schaffhausen, St. Gallen, Thurgau and
Zurich were therefore discarded from the small area
analysis.
Statistical procedures
All hospitalizations corresponding to the list of AH pub-
lished by the OECD were included [15]. Statistical analysis
of the data was performed in two steps. The first included
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step identified determinants of regional differences of
AH-rates in cantons with eligible data. Descriptive proce-
dures documented overall rates, demographic characteris-
tics, comorbid conditions of patients (Charlson index
[29]), length of stay, APDRG cost-weights, and inpatient
mortality of all AH in Switzerland. APDRG cost weights
that accounted for outliers of length of stay were calcu-
lated according to version 6.0 of the specifications of
APDRG-Suisse [30].
Regional rates of AH were calculated at the level of
zip-code clusters; the number of AH admittances in the
numerator and the total regional population aged 15+
were the denominator. Direct standardization of rates by
sex and age was performed at the level of zip-code clusters
and used the total 15+ Swiss population of 2010 as the
reference.
For geographic analyses we summarized the data at
two levels (utilization-based health service areas [n = 59]
and aggregated zip-code clusters [n = 436]) and developed
statistical models to explore the relationship between rates
of AH and characteristics of regional supply of medical
care. For each zip code cluster, we determined the density
of primary care physicians and of specialists in own prac-
tice (physicians per 10000 population). Physician groups
were defined based on definitions established by the Swiss
Medical association [31]. We also calculated the propor-
tion of the population living in rural communities [32]. At
the level of HSA’s we calculated the number of acute care
hospital beds per 10000 people as a measure of regional
hospital supply.
We used a multilevel poisson regression model with
the natural logarithm of the age and sex standardized
number of AH as the outcome. We used the log number
of the population of zip-code clusters as a fixed offset
term in the regression equation. We added information
on regional supply of ambulatory care and of population
characteristics at the level of zip-code clusters, and added
predictors at the level of HSA to estimate effects related
to hospital supply. The final set of explanatory variables
was obtained after a series of preliminary analyses that
explored bivariate associations between the outcome and
various measures of physician’s supply, including full time
equivalents, and other methods to classify patient resi-
dency geographically. We eventually included explanatory
variables which explained the largest variability of AH
admissions.
These are the explanatory variables included in the
final model:
Level 1 (436 zip code areas)
– Year (2008, 2009, 2010)
– Number of primary care physicians per 10000
population39– Number of specialists per 10000 population
(all medical specialists with office based practice)
– Proportion of the population living in rural areas
– Type of hospital reimbursement system
(APDRG vs. other systems)
Level 2 (59 utilization based health service areas)
– Number of hospital beds per 10000 population
We added random intercepts at the level of HSA’s and
zip-code clusters to allow for unexplained variation
around the respective means. We used the same model
to analyse effects associated with the overall rate, and
for condition specific rates of AH’s. In order to explore
linear relationships between continuous explanatory var-
iables and AH, we additionally defined a second model
and replaced the continuous data with quintiles of the re-
spective variables. Differences to the first quintile were doc-
umented as incidence risk ratios. SAS 9.3 (proc GLIMMIX)
was used for multilevel modeling and ArcGis 10 to create
maps, the level of significance was set to p < 0.05 through-
out the study.
Results
Characteristics of avoidable hospitalizations
For 2008–2010, 3470812 hospitalizations of patients were
documented in the discharge data of the “Medizinische
Statistik der Krankenhäuser”. Of these, 92804 hospitali-
zations fulfilled the OECD inclusion criteria and had an
ICD10 diagnose that corresponded with a AH. The overall
rate of AH for the 15+ population during this period was
467 hospitalizations per 100000. The respective rates were
455 for women and 483 for men. From 2008 to 2010, we
observed an increase of 2.7%. Annual rates for 2008–2010
were 463, 467 and 476 per 100000. In 2010, AH accounted
for 3.1% of all hospital stays (n = 31805) and generated
180–200 Mio CHF of direct hospital costs (depending on
annual cantonal APDRG base rates). The proportion of
patients with additional health insurance in the study
population was 15.2% — slightly below the Swiss average
of 16.6% of all hospitalized patients. 74.3% of the AH were
classified as emergencies, i.e. with a need for treatment
within 12 hours, and 11.8% of patients were re-hospital-
ized within 3 months. On average, patients with a rehospi-
talization had 2.7 hospitalizations during the study period
(2.3 for hypertension, 2.6 for Asthma, CHF and Diabetes
and 3.0 for COPD). Inpatient mortality of AH was 5.1%.
Characteristics of disease specific AH are given in Table 1.
Hospital characteristics
We used the specification of the SFSO to categorize hos-
pitals into five hospital groups based on annual number of
all hospitalizations. Characteristics of AH across these
groups are given in Table 2. It is important to note the
differences between low-volume clinics, usually located in
Table 1 Major characteristics of avoidable hospitalizations across ICD10 groups in Switzerland 2008-2010
ICD10 Group Rate* Avg. age of
patients
Avg. length of
stay (days)
Emergency
admissions
In-hospital
deaths
3-month
Rehospitalization§
Asthma 18.6 54.1 6.8 84.0% 0.5% 5.6%
CHF† 211.0 78.8 12.2 78.1% 9.0% 11.5%
COPD‡ 110.0 71.3 11.3 73.7% 3.6% 14.9%
Diabetes 70.7 62.6 12.2 63.7% 1.0% 7.5%
Hypertension 58.3 70.1 6.3 71.4% 0.4% 3.5%
All Avoidable hospitalizations 468.6 72.5 11.0 74.3% 5.1% 10.4%
*Rate per 100000 total population.
†Congestive heart failure.
‡Chronic obstructive pulmonary disease.
§Percentage of patient rehospitalized within 3 months after the initial hospitalization.
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areas. There was almost twice the proportion of AH in
low-volume clinics (4% vs. 2%); average length of stay
was six days longer; patients were older; and, in-hospital
mortality was higher. In high volume clinics, APDRG
cost-weights per case were almost double those of low
volume clinics.
Regional differences
The 59 HSA’s included in the study covered 87.0% of the
area of Switzerland and 69.2% of the Swiss population in
2010. Key characteristics of these areas are given in
Table 3. Depending on year, we observed up to 12-fold
regional differences of age and sex standardized rates of
AH across HSA’s. As an example, geographic patterns
are documented for 2010 in Figure 1. The three year
averages of AH rates of HSA’s showed only a 3.6-fold
regional variation (range: 274–982 admittances per 100000
population). Rate ratios to the mean of the three year aver-
ages were used to document the regional variation of AH
across disease groups (Figure 2). This data implies particu-
larly high levels of variation for asthma and hypertension
and less variation for congestive heart failure, COPD and
diabetes.
The results of multilevel modelling are summarized in
Table 4. The data show a significant increase in all AHTable 2 Characteristics of avoidable hospitalizations across d
% avoidable
hospitalizations†
(%)
Patient
age
(mean)
Hospital group*
Centrally provided treatments 1
(>30′000 admittances/year)
2.1 68.2
Centrally provided treatments 2
(9′000-30′000 admittances/year)
2.9 73.0
Basic care 1 (6′000-9′000 admittances/year) 3.0 70.8
Basic care 2 (3′000-6′000 admittances/year) 2.2 70.4
Basic care 3 (<3000 admittances/year) 4.0 74.0
*Based on definitions of the Swiss Federal Statistical office.
†Proportion of avoidable hospitalizations among all hospitalizations.
‡Average APDRG cost weights per avoidable hospitalization.
40over time, and significantly lower rates for all AH areas
with more primary care physicians. Rates were increased
in areas with more specialists, and also increased rates
in areas with a higher proportion of rural residents.
There was an insignificant association of all AH for re-
gional hospital capacity (hospital beds per 10000 popula-
tion) and for type of hospital reimbursement (APDRG
vs. other). Quintiles of supply and population data show
a 0.91 times lower incidence of AH in areas with more
than 8.1 primary care physicians per 10000 compared to
areas with less than 3.8 physicians (p < 0.05); there was a
1.15 times higher incidence in areas with more than 4.2
specialists in comparison to areas with zero specialists
(p < 0.05) and a 1.12 times greater incidence in areas
where more than 42% of the population lived in rural
communities (reference: areas with zero rural residents,
p < 0.05) (Table 4).
Inconsistent patterns of significant incidence ratios
across different disease groups were observed for regional
care supply. For asthma, a higher number of primary care
physicians was partially associated with fewer AH, but
increased rates of AH were observed for diabetic patients
in areas with more primary care physicians. We observed
more consistent significant associations of AH with re-
gional specialist supply; higher supply was associated with
higher rates irrespective of disease group. Inconsistent andifferent acute care hospital groups
Length
of stay
(days)
Charlson
index
(mean)
Cost
weights‡
(mean)
3-month
Rehospitalization
(%)
In-hospital
Mortality
(%)
10.5 0.23 2.33 9.8% 4.1%
10.6 0.29 1.12 9.8% 5.5%
10.0 0.31 1.14 9.4% 5.1%
10.8 0.21 1.29 10.0% 4.2%
16.8 0.20 1.26 13.2% 6.3%
Table 3 Regional variation, characteristics of 59 health
service areas (averages of 2008–2010)
Characteristic Average Min Max HILO ratio‡
Population size 94301 1614 507789 314.6
Population density* 303.4 26.4 1863.0 70.6
Number of hospitals 2.4 1 12 12.0
Hospital beds per 10000 41.1 13.5 414.0 30.7
Primary care physicians
per 10000
6.5 1.9 10.9 5.7
Specialists per 10000 2.1 0.0 6.2 ?
-Rate of avoidable
hospitalizations†
- Asthma 21.5 2.2 79.5 36.1
- congestive heart failure 236.2 146.0 569.2 3.9
- COPD 122.0 55.4 252.9 4.6
- Diabetes 74.1 30.4 136.3 4.5
- Hypertension 59.9 18.4 207.0 11.3
- all ICD10 groups 495.2 274.5 982.4 3.6
*Population per km2 surface below 2000 meters altitude.
†Age and sex standardized rate per 100000 population.
‡Ratio of highest vs. lowest values.
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were also seen for significant associations of AH with more
rural populations (Table 4).
Discussion
Our study highlights up to 12-fold regional differences
of AH over a period of three years. Research on medicalFigure 1 Age and sex standardized rates per 100000 inhabitants of a
41practice variation shows that regional differences of this
extent are mainly associated with the medical care system
including provider factors and less to regional variation in
the incidence of the underlying disease categories [8,9,33].
Comparative data across countries for avoidable hospitali-
zations are available from the OECD for Asthma, COPD
and uncontrolled diabetes [17]. These data show low over-
all rates of avoidable hospitalizations for all three condi-
tions in Switzerland implying a high quality of primary
care. However, patterns of variation observed in our data
point to difficulties of the Swiss health system to provide
effective and equitable medical care to all societal groups.
Theoretically, hospital admissions for ACSC can be
prevented by effective ambulatory care, irrespective of
disease prevalence. However in practice, even the best
ambulatory care may not be able to prevent these hospi-
talizations. Some factors are beyond the scope of ambu-
latory care providers, for example: different propensity
of patients to seek care; advanced stage and complexity
of some conditions; lack of compliance with preventive
measures; financial constraints; and, poor access to trans-
portation. To some degree, regional differences of AH
rates will continue to reflect differences in prevalence of
the underlying disease. However, studies which took re-
gional variation of health status into account still found an
independent association between AH and care supply
[34,35]. It is therefore unlikely that adjacent geographical
areas have a high enough difference in prevalence to pro-
duce up to 12-fold regional differences of AH. Our results
also showed that, irrespective of condition, the majority ofvoidable hospitalizations for 2010 of 436 zip-code clusters.
Figure 2 Regional variation (59 HSA’s) of disease specific avoidable hospitalization rates*. *Each dot represents a HSA, rates are plotted as
a ratio to the mean on a log scale. black dots denote HSA’s with at least on high volume clinic.
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raise questions about how avoidable these hospitalizations
are, but they may also suggest inappropriate use of costly
emergency services and indicate non-optimal quality and
efficacy of outpatient care in Switzerland. Our data allow
no further analysis of potential causes of emergency ad-
missions as the data obtained from the Federal Statistical
Office contain no variables on type of physicians referring
patients to a hospital.
Characteristics of supply
Regional variation in the data suggest distinct differences
between the decisions of primary care physicians and
specialists to admit patients to hospitals, even demo-
graphic characteristics of patients and higher rates of
AH in predominantly rural populations are both ac-
counted for. An explanation of the patterns would require
further comparison of physician practice styles. Risk ratios
show that patients living in areas with a high density of
primary care physicians are less likely to be admitted to
hospitals for conditions that can be treated in ambulatory
care. But it is important to note that we observed mostly
non-linear relationships between AH and primary care
supply. Our results show that AH can only be reduced in
areas with very high density of primary care physicians.
We also found differences across major disease groups in-
dicating that primary care physicians may have varying42ability to treat health problems and to prevent exacerba-
tions, depending on the conditions they treat.
Our general findings are consistent with multiple stud-
ies performed in many countries, with a variety of health
care delivery systems [35-37]. The data highlight the
importance of primary care as an effective first-contact
access to health care irrespective of the characteristics of
the health system in which care takes place.
In contrast to the data on primary care physicians, we
observed a consistent pattern of higher risks of AH in
areas with a high density of specialists who work in own
practices. Specialist practices in Switzerland are almost
exclusively located near hospitals (not shown). We can-
not confirm other research that established an associ-
ation between AH and regional hospital beds supply
[38]. Our findings suggest that primary care physicians
and specialists have different priorities when they refer
patients to hospitals, irrespective of regional hospital
capacity.
It may be that specialists are treating more patients
with more severe conditions which are more likely to re-
quire hospitalization. Our analyses, however, used age
and sex standardized population-based rates on a small
area scale as an outcome, and it is unlikely that popula-
tions in areas with high specialist density are character-
ized by a higher burden of disease. Specialists working
in own practice are often affiliated with local hospitals
Table 4 Incidence rate ratios of health system characteristics associated with avoidable hospitalizations
Characteristic All avoidable hospitalizations Asthma CHF COPD Diabetes Hypertension
Intercept 0.005* 0.000* 0.002* 0.001* 0.001* 0.001*
Year 2008† - - - - - -
Year 2009 1.155* 0.979 0.923* 1.011 0.954 1.066*
Year 2010 1.168* 1.105* 0.940* 1.042* 0.904* 1.016
Primary care physicians per 10000 0.986* 0.989 0.998 1.006 1.015* 1.003
Q1‡ - - - - - -
Q2 1.033 0.827* 1.060 1.043 1.174* 1.064
Q3 1.028 0.819* 0.996 1.049 1.152* 1.043
Q4 1.043 0.769* 1.021 1.046 1.132* 1.065
Q5 0.905* 0.883 1.002 1.029 1.189* 1.020
Specialists per 10000 1.017* 1.048* 1.017* 1.017* 1.019* 1.013
Q1‡ - - - - - -
Q2 1.019 1.162 0.961 0.996 1.073 1.018
Q3 1.066* 1.044 1.008 1.031 1.126* 0.985
Q4 1.067* 1.262* 1.040 1.101* 1.063 1.005
Q5 1.152* 1.330* 1.132* 1.125* 1.162* 1.131
Proportion of residents in rural communities 1.113* 0.799 1.207* 1.061 0.981 0.888
Q1‡ - - - - - -
Q2 0.987 0.918 1.023 0.895* 0.999 0.887
Q3 1.038 0.842 1.044 1.148* 0.990 0.967
Q4 1.037 0.771* 1.047 1.006 1.055 0.972
Q5 1.115* 0.859 1.171* 1.022 1.009 0.897
Hospital beds per 10000 1.000 1.001 0.999 1.001 1.000 0.998
Q1‡ - - - - - -
Q2 1.008 1.144 1.040 0.959 1.134 0.918
Q3 1.023 1.076 1.027 1.069 1.141 0.804*
Q4 1.026 1.023 1.032 1.073 1.141 0.838*
Q5 1.024 1.062 1.001 1.069 1.070 0.877
Type of hospital reimbursement 0.949 1.414* 1.005 0.909 0.932 0.662*
*Significant incidence risk ratio, p < 0.05.
†Year 2008 as the reference.
‡Incidence risk ratio from a model with annual quintiles of continuous explanatory variables with the first quintile as the reference, quintiles are varying across
years therefore no threshold levels are given in the table.
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by financial incentives [39].
We observed distinct differences between patient char-
acteristics and outcome indicators for high- and low vol-
ume clinics. AH in low-volume clinics were characterized
by older patients with fewer comorbid conditions, higher
3-month rehospitalization rates, and higher in-patient
mortality. These results appear contradictory and raise
questions about the validity of diagnostic data; it is un-
likely that older patients have lower burden of disease and
fewer comorbid conditions. We speculate that this may be
explained by different procedures for coding diagnoses
across hospitals. Larger hospitals usually have dedicated43staff for his task, while coding in smaller hospitals is
normally done by clinicians.
Hospital data also show higher proportions of AH
and considerable longer hospital stays in low volume
clinics. Consistent with our geographic analysis of
rurality, and with other research [40], these results
suggest potential effects scarcity of outpatient re-
sources in proximity to low-volume clinics. However,
we cannot exclude in this setting that supply sensitive
effects of such hospitals are also promoting AH in
order to legitimate the viability of low-volume hospitals.
Due to lack of data, we cannot discriminate between the
two mechanisms.
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Our data showed more AH in men and confirmed gen-
der associated differences documented in other research
[20,41]. Our evidence on the socio-economic status of
patients was in conflict with other research [37,42].
Some characteristics of Swiss health care are therefore
important to note. All Swiss residents are required to
purchase compulsory health insurance, covering a com-
prehensive catalogue of goods and services. Residents
may also have supplementary health insurance contracts
that typically provide superior levels of accommodation,
give more choice of in-hospital physicians in hospitals
and may provide cash benefits for sickness absence [18].
Data from the 2007 Swiss health survey shows that
supplementary health insurance is typically purchased by
those with high income [43]. Type of insurance coverage
is thus a good proxy for the socio-economic status of
patients. Our data on health insurance status of patients
hospitalized for ACSC show 1.4% less patients with sup-
plementary coverage compared to the overall Swiss aver-
age of 16.6% of patients with supplementary coverage.
The results do not support the evidence that AH is
influenced by a socioeconomic gradient in the setting of
Swiss health care.
As in previous research [40,44], regional variation in our
data indicates positive associations between AH and rural-
ity of patient residence. Appropriate allocation of resources
in rural areas is of concern to health care planners. How-
ever, we cannot distinguish between the effects of limited
access to care and patient level factors that have been ob-
served among rural residents in previous research, such as
lower propensity to seek care [7]. More data is required to
explain this regional variation within Swiss health care, and
until it is collected and analyzed, specific policy recom-
mendations cannot be made.
Strengths and limitations
Although we used hierarchical mixed models with ran-
dom effects at the level of HSA’s and zip-code clusters,
which should address some concerns about unmeasured
variables, it is important to recognize that health care
delivery in the out-patient sector is highly complex. Stat-
istical modelling is difficult because factors like physician
behaviour, perceptions of quality of the interaction be-
tween patients and physicians, social status of patients
and cultural norms including differential propensity
among subpopulations to seek care are not fully under-
stood [45]. The search for determinants is further com-
plicated by a scarcity of data that measures the impact
of different forms of care delivery on patient health at
the health system level.
We were also limited by the lack of ambulatory
care sensitive conditions specifically validated as indi-
cators of quality of care for Switzerland. When using44administrative data it is not always possible to directly
discriminate between AH and necessary hospitalizations.
A major limitation is that we have no knowledge about
the patient’s history of disease before the admission to the
hospital: We don’t know whether the patient’s disease or
symptoms of the disease were diagnosed, appropriate
treated and monitored by ambulatory care before [1]. So
we cannot determine with certainty that the hospitali-
zation was clinically preventable or necessary. Although
this misclassification on clinical level is unfortunate, we
believe that the AH selection of the OECD can still
be useful as a health indicator from a health service
perspective.
The concept of avoidable hospitalizations is based on
specific diagnoses that should not be treated in hospitals.
Database information allows therefore only indirect
identification of avoidable hospitalizations. We used the
criteria of the OECD initiated Health Care Quality Indi-
cator Project as the case definition of AH, but clinical
criteria and appropriateness of hospitalization remains
subject of constant debate. It will continue to be, as long
as the concept of AH is not validated by patient-level
outcomes. The concept of AH does not take into account
the potential benefits for patients of a theoretically avoid-
able hospital stay. But as long as valid data regarding the
outcome of hospitalizations on patient health remain un-
available, AH is currently the best approach for estimating
the appropriateness of care.
We used administrative hospital data not specifically
designed for this type of research, which caused a num-
ber of problems. Our results indicate that completeness
and accuracy of coding diagnoses may differ between
hospitals and that accuracy of geographic data of hospital
location and patient residence were compromised in some
cantons. This forced us to exclude data from six cantons
for small area analysis. These difficulties directly reflect
effects of federalism and cantonal autonomy in Swiss
health care and point to an urgent need to improve the
quality of nationwide health data collection.
Finally, we used age and sex standardized rates of AH
for the whole population as the outcome in this study.
This outcome may underestimate the overall burden of
ACSC, and rates adjusted to the underlying disease
prevalence should be used instead [46]. Unfortunately,
small area data for disease prevalence are not available,
and an expensive data collection processes would be re-
quired to obtain such data. However regional differences
of rates of AH can also be interpreted as differential ability
of a health system to meet region-specific burdens of
ACSC; a prevalence adjusted analysis would obliterate
such differences.
The major strength of this study is its nationwide
approach; it gives insight into AH rates that transcend
cantonal administrative boundaries. It proves that small
Berlin et al. BMC Health Services Research 2014, 14:289 Page 9 of 10
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opened the door to further monitoring of regional
variations of health interventions, which will support
evidence-based policy making in Swiss health care.
Another strength is our use of OECD definitions for AH
and reported disease specific characteristics. This well
established approach improves the generalizability of our
data and allows comparative analyses across multiple
health systems [15].
Conclusions
We identified significant determinants of AH in the
Swiss health system that are important for health care
planning. We uncovered disease specific characteristics
of AH, indicating that disease specific health policy may
be effective. However, we are limited by the quality of
the data we used; more valid data must be collected by
hospitals and ambulatory care providers. Our results
may be used to improve the performance of the outpatient
sector, particularly in local regional contexts. Rural and
urban differences remain a cause of concern. Future
research should assess specific physician characteristics
that contribute to AH, with the goal of reducing the num-
ber of unnecessary procedures.
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Additional file  
 
These tables represent the in- and exclusion criteria for avoidable hospitalizations based of 
on the criteria from the OECD Health Care Quality Indicator Project. 
 
Asthma admission rate 
Numerator: All non-maternal hospital discharges (age 15+) with a principal diagnosis code of asthma in a 
specified year. 
 Asthma diagnosis codes: 
ICD-9-CM ICD-10-WHO 
49300 Ext Asthma W/O Stat Ash   J450 Predominantly allergic asthma 
49301 Ext Asthma W Status Ash   J451 Nonallergic   asthma 
49302 Ext Asthma W Acute Exac Oct00-   J458 Mixed asthma 
49310 Int Asthma W/O Stat Asth   J459 Asthma, unspecified 
49311 Int Asthma W Status Asth   J46 Status asthmaticus 
49312 Int Asthma W Acute Exac Oct00-     
49320 Ch Ob Asth W/O Stat Asth     
49321 Ch Ob Asthma W Stat Asth   
49322 Ch Obs Asth W Acute Exac Oct00-   
49381 Exercse Ind Bronchospasm Oct03-   
49382 Cough Variant Asthma Oct03-   
49390 Asthma W/O Status Asthm   
49391 Asthma W Status Asthmat   
49392 Asthma W Acute Exacerbtn Oct00-   
Exclude cases: 
- transferring from another institution 
- pregnancy, childbirth, and puerperium  
- newborn and other neonates  
- with any diagnosis code of cystic fibrosis and anomalies of the respiratory system 
- same day/day only admissions (admissions with a length of stay less than 24 hours. In those countries 
where a timestamp of admission or discharge is not available cases with a length of stay of 0 days shall be 
excluded. 
 Exclude diagnostic codes cystic fibrosis and anomalies of the respiratory system: 
  ICD-9-CM ICD-10-WHO 
27700 Cystic Fibros W/O Ileus  E840 Cystic fibrosis with pulmonary manifestations 
27701 Cystic Fibros W Ileus   E841 Cystic fibrosis with intestinal manifestations 
27702 Cystic Fibros W Pul Man   E848 Cystic fibrosis with other manifestations 
27703 Cystic Fibrosis W Gi Man   E849 Cystic fibrosis, unspecified 
27709 Cystic Fibrosis Nec   P27.0 Wilson-Mikity syndrome 
74721 Anomalies Of Aortic Arch   P27.1 Bronchopulmonary dysplasia originating in 
the perinatal period 
7483 Laryngotrach Anomaly Nec   P27.8 Other chronic respiratory diseases originating 
in the perinatal period 
7484 Congenital Cystic Lung   P27.9 Unspecified chronic resp disease originating 
in the perinatal period 
7485 Agenesis Of Lung Q25.4 Other congenital malformations of aorta 
74860 Lung Anomaly Nos Q31.1 Congenital subglottic stenosis 
74861 Congen Bronchiectasis Q31.2 Laryngeal hypoplasia 
47
74869 Lung Anomaly Nec Q31.3 Laryngocele  
7488 Respiratory Anomaly Nec Q31.5 Congenital laryngomalacia 
7489 Respiratory Anomaly Nos Q31.8 Other congenital malformations of larynx 
7503 Cong Esoph Fistula/Atres Q31.9 Congenital malformation of larynx, 
unspecified 
7593 Situs Inversus Q32.0 Congenital tracheomalacia 
7707 Perinatal Chr Resp Dis Q32.1 Other congenital malformations of trachea 
  Q32.2 Congenital bronchomalacia 
  Q32.3 Congenital stenosis of bronchus 
  Q32.4 Other congenital malformations of bronchus 
  Q33.0 Congenital cystic lung 
  Q33.1 Accessory lobe of lung 
  Q33.2 Sequestration of lung 
  Q33.3 Agenesis of lung 
  Q33.4 Congenital bronchiectasis 
  Q33.5 Ectopic tissue in lung 
  Q33.6 Hypoplasia and dysplasia of lung 
  Q33.8 Other congenital malformations of lung 
  Q33.9 Congenital malformation of lung, unspecified 
  Q34.0 Anomaly of pleura 
  Q34.1 Congenital cyst of mediastinum 
  Q34.8 Other specified congenital malformations of 
respiratory system 
  Q34.9 Congenital malformation of respiratory 
system, unspecified 
  Q39.0 Atresia of oesophagus without fistula 
  Q39.1 Atresia of oesophagus with tracheo-
oesophageal fistula 
  Q39.2 Congenital tracheo-oesophageal fistula 
without atresia 
  Q39.3 Congenital stenosis and stricture of 
oesophagus 
  Q39.4 Oesophageal web 
  Q39.8 Other congenital malformations of 
oesophagus 
  Q89.3 Situs inversus 
  
 Denominator: 100,000 Population (age 15+ years). 
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COPD  admission rate  
 
Numerator: All non-maternal hospital discharges (age 15+) with a principal diagnosis code for Chronic 
Obstructive Pulmonary Disease (COPD) in a specified year. 
 COPD diagnosis codes: 
  
ICD-9-CM ICD-10-WHO 
490 BRONCHITIS NOS*   J40   Bronchitis* 
4660 AC BRONCHITIS*   J410 Simple chronic bronchitis 
4910 Simple Chr Bronchitis   J411 Mucopurulent chronic bronchitis 
4911 Mucopurul Chr Bronchitis   J418 Mixed simple and mucopurulent chronic 
bronchitis 
49120 Obs Chr Brnc W/O Act Exa   J42 Unspecified chronic bronchitis 
49121 Obs Chr Brnc W Act Exa   J430 MacLeod's syndrome 
4918 Chronic Bronchitis Nec   J431 Panlobular emphysema 
4919 Chronic Bronchitis Nos J432 Centrilobular emphysema 
4920 Emphysematous Bleb J438 Other emphysema 
4928 Emphysema Nec J439 Emphysema, unspecified 
494 Bronchiectasis Oct00- J440 COPD with acute lower respiratory infection 
4940 Bronchiectas W/O Ac Exac Oct00- J441 COPD with acute exacerbation, unspecified 
4941 Bronchiectasis W Ac Exac Oct00- J448 Other specified chronic obstructive pulmonary 
disease 
496 Chr Airway Obstruct Nec J449 Chronic obstructive pulmonary disease, 
unspecified 
  J47   Bronchiectasis 
*Qualifies only if accompanied by secondary 
diagnosis of 491.xx, 492.x, 494.x or 496 (i.e., any 
other code on this list). 
 *Qualifies only if accompanied by secondary 
diagnosis of J41, J43, J44, J47 
  
 
 Exclude cases: 
- transferring from another institution 
- pregnancy, childbirth, and puerperium  
- newborn and other neonates)  
- same day/day only admissions (admissions with a length of stay less than 24 hours. In those countries 
where a timestamp of admission or discharge is not available cases with a length of stay of 0 days shall be 
excluded. 
 Denominator: 100,000 Population (age 15+ years). 
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Diabetes lower extremity amputation rate  
 
Numerator: All non-maternal discharges (age 15+) with procedure code for lower extremity amputation in any field and 
diagnosis code of diabetes in any field in a specified year. 
 Diabetes lower extremity amputation diagnostic codes: 
ICD-9-CM ICD-10-WHO 
Procedure codes for lower-extremity amputation Procedure codes for lower-extremity amputation 
    
8410 Lower Limb Amputat Nos   Not specified 
8411 Toe Amputation     
8412 Amputation Through Foot     
8413 Disarticulation Of Ankle     
8414 Amputat Through Malleoli     
8415 Below Knee Amputat Nec   
8416 Disarticulation Of Knee   
8417 Above Knee Amputation   
8418 Disarticulation Of Hip   
8419 Hindquarter Amputation   
    
Diagnosis Codes For Diabetes: Diagnosis codes for diabetes: 
    
25000 Dmii Wo Cmp Nt St Uncntr   E10.0 Insulin-dependent diabetes mellitus with coma 
25001 Dmi Wo Cmp Nt St Uncntrl   E10.1 Insulin-dependent diabetes mellitus with 
ketoacidosis 
25002 Dmii Wo Cmp Uncntrld   E10.2 Insulin-dependent diabetes mellitus with renal 
complications 
25003 Dmi Wo Cmp Uncntrld   E10.3 Insulin-dependent diabetes mellitus with ophthalmic 
complications 
25010 Dmii Keto Nt St Uncntrld   E10.4 Insulin-dependent diabetes mellitus with 
neurological complications 
25011 Dmi Keto Nt St Uncntrld   E10.5 Insulin-dependent DM with peripheral circulatory 
complications 
25012 Dmii Ketoacd Uncontrold   E10.6 Insulin-dependent DM with other specified 
complications 
25013 Dmi Ketoacd Uncontrold   E10.7 Insulin-dependent diabetes mellitus with multiple 
complications 
25020 Dmii Hprsm Nt St Uncntrl   E10.8 Insulin-dependent diabetes mellitus with unspecified 
complications 
25021 Dmi Hprsm Nt St Uncntrld   E10.9 Insulin-dependent diabetes mellitus without 
complications 
25022 Dmii Hprosmlr Uncontrold   E11.0 Non-insulin-dependent diabetes mellitus with coma 
25023 Dmi Hprosmlr Uncontrold   E11.1 Non-insulin-dependent diabetes mellitus with 
ketoacidosis 
25030 Dmii O Cm Nt St Uncntrld   E11.2 Non-insulin-dependent diabetes mellitus with renal 
complications 
25031 Dmi O Cm Nt St Uncntrl   E11.3 Non-insulin-dependent DMwith ophthalmic 
complications 
25032 Dmii Oth Coma Uncontrold   E11.4 Non-insulin-dependent DM with neurological 
complications 
25033 Dmi Oth Coma Uncontrold   E11.5 Non-insulin-dependent DM with peripheral 
circulatory complications 
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25040 Dmii Renl Nt St Uncntrld   E11.6 Non-insulin-dependent DM with other specified 
complications 
25041 Dmi Renl Nt St Uncntrld   E11.7 Non-insulin-dependent diabetes mellitus with 
multiple complications 
25042 Dmii Renal Uncntrld   E11.8 Non-insulin-dependent DM with unspecified 
complications 
25043 Dmi Renal Uncntrld   E11.9 Non-insulin-dependent diabetes mellitus without 
complications 
25050 Dmii Ophth Nt St Uncntrl E13.0 Other specified diabetes mellitus with coma 
25051 Dmi Ophth Nt St Uncntrld E13.1 Other specified diabetes mellitus with ketoacidosis 
25052 Dmii Ophth Uncntrld E13.2 Other specified diabetes mellitus with renal 
complications 
25053 Dmi Ophth Uncntrld E13.3 Other specified diabetes mellitus with ophthalmic 
complications 
25060 Dmii Neuro Nt St Uncntrl E13.4 Other specified diabetes mellitus with neurological 
complications 
25061 Dmi Neuro Nt St Uncntrld E13.5 Other specified DM with peripheral circulatory 
complications 
25062 Dmii Neuro Uncntrld E13.6 Other specified diabetes mellitus with other 
specified complications 
25063 Dmi Neuro Uncntrld E13.7 Other specified diabetes mellitus with multiple 
complications 
25070 Dmii Circ Nt St Uncntrld E13.8 Other specified diabetes mellitus with unspecified 
complications 
25071 Dmi Circ Nt St Uncntrld E13.9 Other specified diabetes mellitus without 
complications 
25072 Dmii Circ Uncntrld   
25073 Dmi Circ Uncntrld   
25080 Dmii Oth Nt St Uncntrld   
25081 Dmi Oth Nt St Uncntrld   
25082 Dmii Oth Uncntrld   
25083 Dmi Oth Uncntrld   
25090 Dmii Unspf Nt St Uncntrl   
25091 Dmi Unspf Nt St Uncntrld   
25092 Dmii Unspf Uncntrld   
25093 Dmi Unspf Uncntrld   
    
  Diagnosis codes for diabetes (continued): 
    
  E14.0 Unspecified diabetes mellitus with coma 
  E14.1 Unspecified diabetes mellitus with ketoacidosis 
  E14.2 Unspecified diabetes mellitus with renal 
complications 
  E14.3 Unspecified diabetes mellitus with ophthalmic 
complications 
  E14.4 Unspecified diabetes mellitus with neurological 
complications 
  E14.5 Unspecified DM with peripheral circulatory 
complications 
  E14.6 Unspecified diabetes mellitus with other specified 
complications 
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  E14.7 Unspecified diabetes mellitus with multiple 
complications 
  E14.8 Unspecified diabetes mellitus with unspecified 
complications 
  E14.9 Unspecified diabetes mellitus without complications 
    
 Exclude cases: 
- transferring from another institution 
- pregnancy, childbirth, and puerperium)  
- newborn and other neonates)  
- with trauma diagnosis code in any field 
- same day/day only admissions (admissions with a length of stay less than 24 hours. In those countries where a 
timestamp of admission or discharge is not available cases with a length of stay of 0 days shall be excluded. 
 Exclude trauma diagnosis codes:  
  
ICD-9-CM ICD-10-WHO 
8950 Amputation Toe   S78.0 Traumatic amputation at hip joint 
8951 Amputation Toe-Complicat   S78.1 Traumatic amputation at level between hip and 
knee 
8960 Amputation Foot, Unilat   S78.9 Traumatic amputation of hip and thigh, level 
unspecified 
8961 Amput Foot, Unilat-Compl   S88.0 Traumatic amputation at knee level 
8962 Amputation Foot, Bilat   S88.1 Traumatic amputation at level between knee and 
ankle 
8963 Amputat Foot, Bilat-Comp   S88.9 Traumatic amputation of lower leg, level unspecified 
8970 Amput Below Knee, Unilat   S98.0 Traumatic amputation of foot at ankle level 
8971 Amputat Bk, Unilat-Compl S98.1 Traumatic amputation of one toe 
8972 Amput Above Knee, Unilat S98.2 Traumatic amputation of two or more toes 
8973 Amput Abv Kn, Unil-Compl S98.3 Traumatic amputation of other parts of foot 
8974 Amputat Leg, Unilat Nos S98.4 Traumatic amputation of foot, level unspecified 
8975 Amput Leg, Unil Nos-Comp T05.3 Traumatic amputation of both feet 
8976 Amputation Leg, Bilat T05.4 Traumatic amputation of 1 foot and other leg [any 
level, except foot] 
8977 Amputat Leg, Bilat-Compl T05.5 Traumatic amputation of both legs [any level] 
  T13.6 Traumatic amputation of lower limb, level 
unspecified 
  
Denominator: 100,000 Population (age 15+ years). 
 
 
Diabetes Short-term Complications Admission Rate  
 Numerator: All non-maternal/non-neonatal hospital discharges (age 15+) with a principal diagnosis code for Diabetes 
short-term complications (i.e. ketoacidosis, hyperosmolarity, coma) in a specified year. 
 Diabetes short-term diagnostic codes: 
ICD-9-CM ICD-10-WHO 
25010 Dm Keto T2, Dm Cont   E100 Insulin-dependent diabetes mellitus with coma 
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25011 Dm Keto T1, Dm Cont   E101 Insulin-dependent diabetes mellitus with 
ketoacidosis 
25012 Dm Keto T2, Dm Uncont   E110 Non-insulin-dependent diabetes mellitus with coma 
25013 Dm Keto T1, Dm Uncont   E111 Non-insulin-dependent diabetes mellitus with 
ketoacidosis 
25020 Dm W/ Hyprosm T2, Dm Cont   E130 Other specified diabetes mellitus with coma 
25021 Dm W/ Hyprosm T1, Dm Cont   E131 Other specified diabetes mellitus with ketoacidosis 
25022 Dm W/ Hyprosm T2, Dm Uncnt E140 Unspecified diabetes mellitus with coma  
25023 Dm W/ Hyprosm T1, Dm Uncnt E141 Unspecified diabetes mellitus with ketoacidosis 
25030 Dm Coma Nec Typ Ii, Dm Cnt   
25031 Dm Coma Nec T1, Dm Cont   
25032 Dm Coma Nec T2, Dm Uncont   
25033 Dm Coma Nec T1, Dm Uncont   
    
  
Exclude cases: 
- transferring from another institution 
- pregnancy, childbirth, and puerperium)  
- newborn and other neonates)  
- with trauma diagnosis code in any field 
- same day/day only admissions (admissions with a length of stay less than 24 hours. In those countries where a 
timestamp of admission or discharge is not available cases with a length of stay of 0 days shall be excluded. 
 
Denominator: 100,000 Population (age 15+ years). 
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CHF admission rate  
 
Numerator: All non-maternal/non-neonatal hospital discharges (age 15+) with principal diagnosis code for 
Congestive Heart Failure (CHF) in a specified year. 
CHF diagnostic codes: 
ICD-9-CM ICD-10-WHO 
39891 Rheumatic Heart Failure   I11.0 Hypertensive heart disease with (congestive) heart 
failure 
40201 Mal Hypert Hrt Dis W Chf   I13.0 Hypertensive heart and renal disease with 
(congestive) heart failure 
40211 Benign Hyp Hrt Dis W Chf   I13.2 Hypertensive heart and renal disease with both 
(congestive) heart failure and renal failure 
40291 Hyperten Heart Dis W Chf   I50.0 Congestive heart failure 
40401 Mal Hyper Hrt/Ren W Chf   I50.1 Left ventricular failure 
40403 Mal Hyp Hrt/Ren W Chf/Rf   I50.9 Heart failure, unspecified 
40411 Ben Hyper Hrt/Ren W Chf     
40413 Ben Hyp Hrt/Ren W Chf/Rf     
40491 Hyper Hrt/Ren Nos W Chf     
40493 Hyp Ht/Ren Nos W Chf/Rf     
4280 Congestive Heart Failure     
4281 Left Heart Failure     
42820 Systolic Hrt Failure Nos Oct02-   
42821 Ac Systolic Hrt Failure Oct02-   
42822 Chr Systolic Hrt Failure Oct02-   
42823 Ac On Chr Syst Hrt Fail Oct02-   
42830 Diastolc Hrt Failure Nos Oct02-   
42831 Ac Diastolic Hrt Failure Oct02-   
42832 Chr Diastolic Hrt Fail Oct02-   
42833 Ac On Chr Diast Hrt Fail Oct02-   
42840 Syst/Diast Hrt Fail Nos Oct02-   
42841 Ac Syst/Diastol Hrt Fail Oct02-   
42842 Chr Syst/Diastl Hrt Fail Oct02-   
42843 Ac/Chr Syst/Dia Hrt Fail Oct02-   
4289 Heart Failure Nos   
  Exclude cases: 
- transferring from another institution 
- pregnancy, childbirth, and puerperium)  
- newborn and other neonates)  
- with cardiac procedure codes in any field 
- with trauma diagnosis code in any field 
- same day/day only admissions (admissions with a length of stay less than 24 hours. In those countries where a 
timestamp of admission or discharge is not available cases with a length of stay of 0 days shall be excluded. 
 
 Denominator: 100,000 Population (age 15+ years). 
 
 
 
 
 
 
 
Hypertension Admission Rate  
Numerator: All non-maternal hospital discharges (age 15+) with principal diagnosis code for Hypertension in a 
specified year. 
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Hypertension diagnostic codes: 
  
ICD-9-CM ICD-10-WHO 
4010 Malignant Hypertension   I10   Essential (primary) hypertension 
4019 Hypertension Nos   I119 Hypertensive heart disease without (congestive) heart failure 
40200 Mal Hyperten Hrt Dis Nos   I129 Hypertensive renal disease without renal failure 
40210 Ben Hyperten Hrt Dis Nos   I139 Hypertensive heart and renal disease, unspecified 
40290 Hypertensive Hrt Dis Nos     
40300 Mal Hyp Ren W/O Ren Fail   
40310 Ben Hyp Ren W/O Ren Fail   
40390 Hyp Ren Nos W/O Ren Fail   
40400 Mal Hy Ht/Ren W/O Chf/Rf   
40410 Ben Hy Ht/Ren W/O Chf/Rf   
40490 Hy Ht/Ren Nos W/O Chf/Rf   
  
Exclude cases: 
- transferring from another institution 
- pregnancy, childbirth, and puerperium)  
- newborn and other neonates)  
- with cardiac procedure codes in any field 
- with cardiac procedure codes in any field 
- same day/day only admissions (admissions with a length of stay less than 24 hours. In those countries where a 
timestamp of admission or discharge is not available cases with a length of stay of 0 days shall be excluded. 
 
 
 Denominator: 100,000 Population (age 15+ years). 
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Abstract
Background
Cardiovascular diseases are the leading cause of death worldwide and in Switzerland.
When applied, treatment guidelines for patients with acute ST-segment elevation myocar-
dial infarction (STEMI) improve the clinical outcome and should eliminate treatment differ-
ences by sex and age for patients whose clinical situations are identical. In Switzerland, the
rate at which STEMI patients receive revascularization may vary by patient and hospital
characteristics.
Aims
To examine all hospitalizations in Switzerland from 2010–2011 to determine if patient or
hospital characteristics affected the rate of revascularization (receiving either a percutane-
ous coronary intervention or a coronary artery bypass grafting) in acute STEMI patients.
Data and Methods
We used national data sets on hospital stays, and on hospital infrastructure and operating
characteristics, for the years 2010 and 2011, to identify all emergency patients admitted
with the main diagnosis of acute STEMI. We then calculated the proportion of patients who
were treated with revascularization. We used multivariable multilevel Poisson regression to
determine if receipt of revascularization varied by patient and hospital characteristics.
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a11111
OPEN ACCESS
Citation: Berlin C, Jüni P, Endrich O, Zwahlen M
(2016) Revascularization Treatment of Emergency
Patients with Acute ST-Segment Elevation
Myocardial Infarction in Switzerland: Results from a
Nationwide, Cross-Sectional Study in Switzerland for
2010-2011. PLoS ONE 11(4): e0153326. doi:10.1371/
journal.pone.0153326
Editor: Ingo Ahrens, University Hospital Medical
Centre, GERMANY
Received: July 20, 2015
Accepted: March 28, 2016
Published: April 14, 2016
Copyright: © 2016 Berlin et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: Individual data from
different data sets were used for this study. All these
data are the property of the Swiss Federal Statistical
Office (SFSO) (www.bfs.admin.ch) and can only be
made available to other researchers by legal
agreements with the SFSO.
Funding: This study was funded by the Swiss
National Science Foundation (SNSF), grant number
32473B_138056 (www.snf.ch). Grant holder was MZ.
The funders had no role in study design, data
59
Results
Of the 9,696 cases we identified, 71.6% received revascularization. Patients were less likely
to receive revascularization if they were female, and 80 years or older. In the multivariable
multilevel Poisson regression analysis, there was a trend for small-volume hospitals per-
forming fewer revascularizations but this was not statistically significant while being female
(Relative Proportion = 0.91, 95% CI: 0.86 to 0.97) and being older than 80 years was still
associated with less frequent revascularization.
Conclusion
Female and older patients were less likely to receive revascularization. Further research
needs to clarify whether this reflects differential application of treatment guidelines or limita-
tions in this kind of routine data.
Introduction
Mortality for cardiovascular diseases (CVDs) has continually decreased in developed countries,
but CVDs are still the leading cause of death in Switzerland for both sexes [1]. More rapid and
improved treatment of acute myocardial infarction (AMI) has substantially reduced CVDmor-
tality [2]. International guidelines recommend, for optimal treatment, that AMI patients
receive evidence-based therapies [3–5]. Treatment guidelines differ by type of AMI: ST-eleva-
tion myocardial infarction (STEMI) is differentiated from non-ST-elevation myocardial infarc-
tion (NSTEMI). If treatment guidelines are consistently followed, they should reduce or
eliminate sex- or age-based treatment differences for patients whose clinical situations are
identical.
In Switzerland, however, there is evidence that AMI patients are treated inconsistently, and
that guidelines are more likely to be followed for men than for women. Radovanovic et al ana-
lyzed patients of the Swiss AMI registry (AMIS) between 1997–2011 and saw that percutaneous
coronary interventions (PCI) had increased in STEMI patients overall. But, since 2006, they
found that over 80% of male patients received PCI, while only 70% of women were treated with
PCI [6]. Women were less likely to receive primary reperfusion (thrombolysis and PCI) and
medications according to evidence-based guidelines [6,7]. Other studies documented that AMI
treatment in Switzerland varied by region, hospital characteristics (presence or absence of 24
hour/7day cardiac catheterization facility), age, and number of comorbidities [7–9].
We used nation-wide hospital data of patients admitted to all Swiss hospitals in 2010 and
2011, with the goal of including all patients with acute STEMI as their main diagnosis because
well-established treatment guidelines exist for these patients [3]. Our goal was to investigate
the effect of patient and hospital characteristics on receipt of revascularization in acute STEMI
patients accounting for hospital transfers and use of treatment information over the whole
course of treatment.
Data and Methods
Ethics
Ethical approval was not required for this analysis of data, which are available to research insti-
tutions according to the ordinance on federal statistical monitoring activities and surveys.
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collection and analysis, decision to publish, or
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Data sets
We used two national data sets from the Swiss Federal Statistical Office (SFSO) that provided
information about inpatient care and hospital infrastructure in 2010 and 2011. The first data
set,Medizinische Statistik der Krankenhäuser, focuses on hospital stays (HS) and includes man-
datory information on all patients hospitalized for at least a day, recording age, sex, place of
residence, date of admission and discharge (month) of the patient, as well as main and con-
comitant diagnoses, and treatment provided. The second data set, Krankenhausstatistik,
focuses on hospital characteristics (HC) and contains information on hospital infrastructure
for all hospitals in Switzerland, including type of hospital, number of beds, number of physi-
cians and nurses, number of angiography devices, CT or MRI machines, presence of an emer-
gency room. The information in these data sets can be cross-referenced by hospital-ID. To
ensure data is protected, the patient residence and the geographical location of the hospital are
aggregated into zip code areas consolidated into 705 medical statistics (Medstat) regions.
Ethical approval was not required for this analysis of data, which are available to research
institutions according to the ordinance on federal statistical monitoring activities and surveys.
We used the community classification data set (Raumgliederung) from the SFSO (reference
date December 31st, 2010) to determine the level of urbanization of Medstat regions. The vari-
able urban/rural region in the community classification data set included four categories: (1)
main city of an agglomeration; (2) other agglomeration community; (3) isolated city; and, (4)
rural community. One Medstat region usually contains more than one community. If at least
one community in the Medstat region was classified as 1, 2 or 3, we coded the whole Medstat
region as urban. Otherwise we coded it as rural.
Construction of course of treatment
The years 2010–2011 included a total of 2,708,942 hospital stays (2010: 1.345.245; 2011:
1,363,697; Fig 1). We excluded 44,338 records for which date of entry, date of exit, hospital-ID
or patient-ID were missing. Of that, the majority (99.7%) had no date of exit because these
patients were hospitalized over New Year. So they had an incomplete record the year they
entered the hospital and a complete record the year they were discharged. So we excluded them
to eliminate duplicates and just use complete records. To protect patient anonymity, the treat-
ing hospital uses a Hash code (derived from the patient’s name, gender and date of birth) to
create a patient ID, which can be used to track patients with multiple hospital stays, either in
the same, or in another hospital.
Patients with several hospital stays recorded close together may have been referred between
hospitals to treat the same condition. For example, STEMI patients would be recorded twice in
the HS data if they were treated in one hospital for a day, and then transferred to spend several
days in another hospital for further treatment. To avoid double counting of patients, we recon-
structed each of these short courses of treatment, searching for sequential hospitalizations in
the HS record by patient-ID, sequence number, days to next hospitalization (< = 1), and
month of entry. A case may thus contain several hospital stays. For the years 2010 and 2011,
we constructed 2,418,502 full cases.
Selection of STEMI patients
The International Classification of Diseases, Injuries and Causes of Death (ICD) 10 codes were
used to code main and secondary diagnoses in the HS data set. The ICD 10 code that starts
with I21 is for acute transmural myocardial infarctions. To select AMI patients with STEMI
specifically, we excluded cases with acute subendocardial myocardial infarction (I21.4) and
unspecified acute myocardial infarction (I21.9). Cases with acute transmural myocardial
Revascularization Treatment of STEMI Patients in Swiss Hospitals
PLOS ONE | DOI:10.1371/journal.pone.0153326 April 14, 2016 3 / 14
61
infarction of anterior wall (I21.0), acute transmural myocardial infarction of inferior wall
(I21.1), acute transmural myocardial infarction of other sites (I21.2) or acute transmural myo-
cardial infarction of unspecified site (I21.3) were included. These four main diagnoses (I21.0,
I21.1, I21.2, and I21.3) had to appear at the first or second hospitalization record. If mentioned
on the second record we restricted the selection to cases matching predefined main diagnoses
at the first record (see S1 Table). We chose these predefined diagnoses as they have similar
symptoms like AMI and we wanted to identify just patients being hospitalized as an emergency
with AMI. We only included cases if the first record was an emergency admission. This way we
excluded patients with planned hospital stays, who were unlikely to have an acute STEMI.
After applying these restrictions, we included 9,696 full treatment cases in our analysis.
Information on treatment received
To describe the treatments that STEMI patients received, we considered all records of treat-
ment for each case. We coded information on treatment procedures in the HS data according
to the Swiss operation classification system (CHOP), which was derived and modified from the
American International Classification of Diseases, Ninth Revision, Clinical Modification: ICD-
9-CM, volume 3, 1994. We also coded it according to classification in All Patient Diagnosis
Related Groups (APDRG). We classified the 9,696 AMI cases into four groups, based on avail-
able treatment information: (1) codes that indicated a PCI; (2) codes that indicated a coronary
artery bypass grafting (CABG); (3) codes that indicated treatments other than PCI or CABG;
and, (4) patients with no available treatment codes (see S2 and S3 Tables for the exact CHOP
Fig 1. Flow chart of the selection process.
doi:10.1371/journal.pone.0153326.g001
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and APDRG codes we used). We then created a variable that described if patients were treated
with revascularization (PCI, CABG, or both) or not.
Patient characteristics
We assessed the following socio-demographic variables: sex, age (grouped 18–44, 45–49, 50–
54, 55–59, 60–64, 65–69, 70–74, 75–79, 80–84, 85+ years), and nationality (Swiss, foreign). As
a proxy for the patient’s socio-economic position, we used the patients insurance status (public,
semi-private, or private), which indicates the type of insurance used for billing. Public insur-
ance is mandatory, semi-private and private insurance are optional and paid for by patients in
addition to paying public insurance. Semi private insurance is associated with a hospital stay in
a two-bed room, private insurance with a stay in a single-bed room. We also used information
on who referred the patient to the hospital (the patient or relatives, rescue service or a physi-
cian). To characterize the comorbidities of the patient, we used the maximum number of sec-
ondary diagnoses recorded either in the first or, if the patient was referred, the second record
in the HS data (grouped into no, 1 to 2, 3 to 4, 5 to 6, and 7 or more secondary diagnoses).
Hospital characteristics
We used the following hospital level information: presence of an angiography device; full-time
equivalent (FTE) of the physicians by 1,000 cases (grouped into tertiles); type of hospital region
(urban or rural); language region of the hospital (German, French or Italian); and the number
of hospital stays per year. As has been done previously [10], we divided hospitals into three
groups: small-volume (<15,001 cases/year), medium-volume (15,001–30,000 cases/year) or
high-volume (> 30,000 cases/year) volume.
Except for treatment information and comorbidities, we derived both patient and hospital
characteristics from the first hospital stay of the short course of treatment. Coding guidelines
for HS data imply that the referring hospital coded the treatment when it referred a patient to
another hospital for ambulatory treatment, e.g., an ambulatory PCI. This explains why we
focused on the first hospital, which also took the lead in providing treatment and made the
decision to refer a patient to another hospital.
Statistical analysis
We calculated the number and percentage of patients who received revascularization and com-
puted crude relative proportions with 95% confidence intervals (95% CI) when comparing
groups of patients. We used Pearson Chi-square-test with a two-sided significance level
p<0.05 to test for differences by patient or hospital characteristics. We then estimated relative
proportions using multivariable multilevel Poisson regression to adjust for confounders and to
identify characteristics independently associated with receiving revascularization [11]. We
included patient characteristics (sex, age, nationality, bed category, maximum number of sec-
ondary diagnoses at first or second hospital, entry decision) and hospital characteristics (angi-
ography device, fulltime equivalent of physicians per 1,000 cases, type of hospital region,
language region, and hospital groups). We used multilevel Poisson regression as implemented
in Stata, with the xtpoisson command, to account for the multilevel structure of the data (clus-
tering of patients within the first contact hospital), and used Wald tests to examine the signifi-
cance of association. In the analyses of variables with ordered levels we used the lowest level as
the reference group and for dichotomous variables the level without the corresponding charac-
teristic. We performed a sensitivity analysis by analyzing treatment with PCI alone, excluding
CABG and found no major differences between the model with PCI alone and the model with
Revascularization Treatment of STEMI Patients in Swiss Hospitals
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PCI/CABG, hence we used PCI/CABG in all further analyses. All analyses were performed
using Stata version 13 (StataCorp, College Station, TX, USA).
Results
In Switzerland, in 2010 and 2011, 300 hospitals provided inpatient care, including specialized
services for acute care, psychiatry, rehabilitation/geriatrics, or delivery/obstetrics. More than
half these hospitals had an acute care division (2010: 179, 2011: 180). Of these 300 hospitals, 98
were the site of first contact in 2010, and 96 in 2011, for the 9,696 STEMI cases we included. In
both years, 77 of the hospitals were located in an urban area. Of the first contact hospitals, 54
in 2010, and 56 in 2011, had at least one angiography device. Over both years, 35.4% of the
included STEMI patients were initially treated in a small-volume hospital, 31.9% in a medium-
volume hospital, and 32.6% in a high-volume hospital.
Study population
The 9,696 STEMI cases (total: 9,598 different persons) were, on average, 65.8 years old (range:
18–102 years); 70.8% were male, and the mean length of stay was 11.7 days. In the group
treated with revascularization (6,946 of the 9,696, or 71.6% of all), mean age was 63.3 years,
75.6% were men, and average length of stay was 11.4 days. The 2,750 patients who did not
receive revascularization were, on average, 72 years old; 58.7% were male, and mean length of
stay was 12.5 days.
The proportion of cases who received revascularization was highest in the 50–54 age group
(83.5%), and lowest in the 85+ years age group (29.6%). The proportion was highest in the pri-
vate (76.8%), and lowest in the public insurance category (70.9%). It was highest in the high-
volume hospital group (81.3%), and lowest in the small-volume hospital group (55.3%). In the
Italian hospital language region, 80.6% of all hospitalized STEMI cases received revasculariza-
tion, while in the French language region, 70.9% received the treatment (see Table 1).
Factors associated with receiving a revascularization
The results of the univariable Poisson regression analyses showed revascularization was less
common in female patients, those older than 69 and those who were Swiss (see Table 1).
Patients were more likely to receive revascularization if they were referred to the hospital by
their physician, had any secondary diagnoses, were in the private insurance category, were first
treated in a medium- or high-volume hospital, or were hospitalized in the Italian language
region. The relative proportion of revascularization treatments increased with the number of
FTE of physicians per 1,000 cases. Patients treated in an urban hospital, and in hospitals with
an angiography device were more likely to receive revascularization.
In the multivariable multilevel Poisson regression analysis most of these associations disap-
peared, while following associations persisted: A negative association of revascularization with
being female (RP = 0.91, 95% CI: 0.86 to 0.97) and with being 80 years and older (age group
80–84 years: RP = 0.80, 95% CI: 0.70 to 0.91; age group 85+ years: RP = 0.42, 95% CI: 0.36 to
0.49). Having more comorbidities did not reduce the likelihood for revascularization (see Fig 2
and S4 Table).
Furthermore, we present (Figs 3 and 4; S5 and S6 Tables) separate multilevel Poisson regres-
sion analyses for men and women, stratified by age (younger age group: 18–64 years, older age
group: 65+ years).
Having comorbidities wasn’t a limiting factor to receive revascularization for young or old
men and old women. In the adjusted analyses, revascularization was lower for men and women
over 80. Women in the older age group had more often revascularization (RP = 1.18, 95% CI:
Revascularization Treatment of STEMI Patients in Swiss Hospitals
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Table 1. Socio-demographic, socioeconomic and healthcare-related factors of the study population and crude rates of receiving a revasculariza-
tion, Switzerland 2010–2011.
N (%) PCI/CABG (%) Unadjusted model crude
relative proportions (95% CI)
Total 9,696 (100.00%) 6,946 (71.64%)
Sex p<0.0000 p<0.0000
Male 6,869 (70.84%) 5,254 (76.49%) 1.0
Female 2,827 (29.16%) 1,692 (59.85%) 0.78 (0.76,0.81)
Age groups p<0.0000 p<0.0000
18 to 44 years 567 (5.85%) 454 (80.07%) 1.0
45 to 49 years 727 (7.50%) 594 (81.71%) 1.02 (0.97,1.08)
50 to 54 years 988 (10.19%) 825 (83.50%) 1.04 (0.99,1.10)
55 to 59 years 1,113 (11.48%) 888 (79.78%) 1.00 (0.95,1.05)
60 to 64 years 1,189 (12.26%) 946 (79.56%) 0.99 (0.94,1.04)
65 to 69 years 1,174 (12.11%) 952 (81.09%) 1.01 (0.96,1.06)
70 to 74 years 1,003 (10.34%) 756 (75.37%) 0.94 (0.89,0.99)
75 to 79 years 1,063 (10.96%) 727 (68.39%) 0.85 (0.81,0.91)
80 to 84 years 916 (9.45%) 521 (56.88%) 0.71 (0.66,0.76)
85+ years 956 (9.86%) 283 (29.60%) 0.37 (0.33,0.41)
Citizenship p<0.0000 p<0.0000
Foreign 1,731 (17.85%) 1,331 (76.89%) 1.0
Swiss 7,965 (82.15%) 5,615 (70.50%) 0.92 (0.89,0.94)
Entry decision p<0.0386 p<0.0382
Herself/Himself, relatives 2,415 (24.91%) 1,693 (70.10%) 1.0
Rescue services 3,730 (38.47%) 2,659 (71.29%) 1.02 (0.98,1.05)
Physician 3,551 (36.62%) 2,594 (73.05%) 1.04 (1.01,1.08)
Comorbidities p<0.0000 p<0.0000
No 276 (2.85%) 91 (32.97%) 1.0
1–2 2,298 (23.70%) 1,757 (76.46%) 2.32 (1.96,2.75)
3–4 3,072 (31.68%) 2,384 (77.60%) 2.35 (1.99,2.79)
5–6 1,908 (19.68%) 1,415 (74.16%) 2.25 (1.90,2.67)
7+ 2,142 (22.09%) 1,299 (60.64%) 1.84 (1.55,2.18)
Insurance status p<0.0030 p<0.0013
Public 7,700 (79.41%) 5,462 (70.94%) 1.0
Half Private 1,401 (14.45%) 1,027 (73.30%) 1.03 (1.00,1.07)
Private 595 (6.14%) 457 (76.81%) 1.08 (1.03,1.13)
Hospital groups p<0.0000 p<0.0000
Small (<15001 cases) 3,435 (35.43%) 1,900 (55.31%) 1.0
Medium (15001–30000 cases) 3,097 (31.94%) 2,475 (79.92%) 1.44 (1.40,1.50)
High (>30000 cases) 3,164 (32.63%) 2,571 (81.26%) 1.47 (1.42,1.52)
Language region p<0.0000 p<0.0000
German 7,140 (73.64%) 5,085 (71.22%) 1.0
French 2,052 (21.16%) 1,455 (70.91%) 1.00 (0.96,1.03)
Italian 504 (5.20%) 406 (80.56%) 1.13 (1.08,1.18)
FTE physicians/1000 cases p<0.0000 p<0.0000
1. tertile (<11.86) 3,236 (33.37%) 1,932 (59.70%) 1.0
2. tertile (11.86-<17.46) 3,300 (34.03%) 2,454 (74.36%) 1.25 (1.20,1.29)
3. tertile (17.46+) 3,151 (32.50%) 2,556 (81.12%) 1.36 (1.31,1.40)
n/a 9 (0.09%) 4 (44.44%)
(Continued)
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Table 1. (Continued)
N (%) PCI/CABG (%) Unadjusted model crude
relative proportions (95% CI)
Hospital region p<0.0000 p<0.0000
Rural 504 (5.20%) 230 (45.63%) 1.0
Urban 9,192 (94.80%) 6,716 (73.06%) 1.60 (1.45,1.76)
Angiography device p<0.0000 p<0.0000
No 1,290 (13.30%) 666 (51.63%) 1.0
Yes 8,406 (86.70%) 6,280 (74.71%) 1.45 (1.37,1.53)
doi:10.1371/journal.pone.0153326.t001
Fig 2. Results of multilevel Poisson regression for revascularization.
doi:10.1371/journal.pone.0153326.g002
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1.01 to 1.38) if their insurance status was semi-private. Young and old men as well as young
women were more often treated with revascularization when admitted first to a medium size
hospital (young men: RP = 1.29, 95% CI: 1.03 to 1.60; old men: RP = 1.32, 95% CI: 1.10 to 1.58;
young women: RP = 1.38, 95% CI: 1.05 to 1.81).
In a sensitivity analysis we excluded cases which died the same day of admission, were 85
+ years old or were admitted to hospitals with less than 3000 cases/year. This left 8,188 cases
for the analysis. The stratified models showed that being hospitalized first in a small hospital
led to less revascularization than an admission to a medium or high-volume hospital. The full
model showed no significant association.
Fig 3. Results of multilevel Poisson regression for revascularization for male and female patients
younger than 65 years.
doi:10.1371/journal.pone.0153326.g003
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Discussion
Main findings
In patients with acute ST-segment elevation myocardial infarction admitted as emergencies to
Swiss hospitals in 2010 and 2011, close to three-quarters (71.6%) received revascularization.
Women were less likely than men to be treated with PCI or CABG. Independent of other
patient and hospital characteristics, patients 80 years and older underwent revascularization
less frequently. In younger women, we observed no incremental association with number of
comorbidities. Compared to patients with no comorbidities, having comorbidities was not a
barrier to receive revascularization for old male and female patients as well as for young men.
Patients admitted to a medium-sized (15001–30000 hospitalizations per year) hospital were
more likely to receive a PCI or CABG. In a sensitivity analysis excluding patients died the day
Fig 4. Results of multilevel Poisson regression for revascularization for male and female patients 65
years and older.
doi:10.1371/journal.pone.0153326.g004
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of admission, patients being 85 years and older or admitted to hospitals with less than 3000
cases/year we found a positive trend for revascularization when admitted to a medium or high-
volume hospital compared to cases first hospitalized in a small hospital.
Limitations and strengths
Our study had some limitations. We used secondary data that was not collected for our study
purpose, so we did not know why patients received no revascularization, or what kind of medi-
cation they received. For patients treated in more than one hospital, coding guidelines limit our
ability to clearly determine which hospital provided which treatment [12]. We addressed this
in two ways. First, for our analysis, we used the characteristics of the first hospital a patient
went to. Second, we used treatment information across all hospitals in which a patient stayed
during the course of treatment.
We chose the ICD-10 codes I21.0, I21.1, I21.2 and I21.3 to identify STEMI cases after con-
sulting cardiologists and a coding expert from the Bern University hospital. ICD-10 codes do
not distinguish between STEMI or NSTEMI cases [13,14]. Although they found difficulties in
identifying the correct proportion of STEMI and NSTEMI on the bases of ICD-10 Alexan-
drescu et al. suggest to use I22.0, I22.1 and I22.8 additional to our chosen codes (I21.0-I21.3) to
identify STEMI cases. When we included these ICD-10 codes, additional 44 cases were identi-
fied with almost identical results when included in the regression analyses.
We lacked specific information about the capability of a hospital to offer revascularization,
and used the presence of an angiography device as a proxy without information about service
hours of catheter labs (e.g. 24/7). Since treatments are coded, and diagnoses are made at the
hospital where the patient is treated, coding practices may differ between hospitals e.g. due to
variation in adherence to coding guidelines; this could introduce differential misclassification.
The official coding guidelines are changed almost yearly. To limit the impact of changes, we
restricted our analysis to 2010 and 2011. Although we used multilevel multivariable regression
analyses, we cannot exclude residual confounding, bias due to variation of data collection pro-
cedures across hospitals, especially in information on prognostic factors of patients.
We examined the referral pattern per hospital group and the length of stay to consider dif-
ference in comorbidity coding. Of the 3,771 cases being transferred, 773 had no comorbidities
coded in the first hospital. Considering the length of stay of these cases 88.4% (683) left the
first hospital to another hospital the same day they were admitted. Therefore we believe that
due to the short length of stay the registration of the comorbidities of the patient was poor in
the first hospital. To overcome these differences in comorbidity coding we decided to use the
maximum number of comorbidities at the first or second hospital. In a first analysis we used
the number of comorbidities coded just by the first hospital. We found that having more than
six comorbidities leads to less revascularization. We are convinced that the new variable of the
maximum number of comorbidities is a better proxy for the real number of comorbidities of
the patients. Nevertheless, this improvement is just referring to cases which were transferred.
Our study has several strengths. We analyzed standardized data of all hospitalized patients
in all hospitals in Switzerland, so our results are valid for the whole country. The data set not
only included patient characteristics and treatment provided, but also, via linkage to hospital
characteristics data of the SFSO, it contained information on the personnel and technical infra-
structure of Swiss hospitals. By constructing the course of treatment of emergency STEMI
patients, we accounted for referrals and used the treatment information from all hospitals the
patient visited during treatment. To our knowledge, previous Swiss studies did not take into
account the treatments the patients received at all hospitals in case of hospital transfers [6–
9,14]. The studies reporting on patients monitored in the AMIS registry restricted their analysis
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to patients exclusively treated at hospitals collaborating in the AMIS registry [6,7,9]. As 39% of
all cases in our study were transferred at least once, it was important to consider all treatment
information available over the whole course of treatment.
Comparison with other studies
Like other studies of AMI patients, the receipt of optimal revascularization varied by age and
gender when we adjusted for age and other patient and hospital characteristics [6,15–18]. Stud-
ies in the US and UK observed higher rates of invasive cardiac procedures in hospitals with on-
site revascularization facilities [19,20]. In our univariable analysis, patients in hospitals with an
angiography device more often received revascularization, but in the multivariable analysis,
this association was no longer statistically significant.
Tung, et al, showed more PCI use among physicians who had high overall case volume [21].
Although the total number of annual hospitalizations does not directly reflect the frequency
with which a hospital performs PCI and CABG we found a trend for less revascularization
when admitted first to a small-volume hospital but the association was not significant. Just in
the stratified (by age and gender) sensitivity analysis (exclusion of cases admitted to hospitals
with less than 3000 cases/year, 85 years and more of age or patients which died the day of
admission) this trend was significant.
Insam and colleagues analyzed hospitalizations for AMI in Switzerland before 2009 to
determine if clinical management of AMI varied across seven major regions. They observed
significant geographical differences and explained that Swiss hospitals are largely autonomous
in defining their standards of care [8,14], but did not account for urbanization. Like studies
from Canada [22,23], we found no regional differences, either between the language regions or
between urban and rural hospitals.
Conclusions
Older patients and women were less likely to receive revascularization. Further research needs
to clarify whether this reflects differential application of treatment guidelines or limitations in
this kind of routine data.
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Supporting Information 
S1: Predefined main diagnosis at first hospitalization record if second hospitalization record is 
STEMI 
ICD 10 code Diagnosis 
I20.0 Unstable angina 
I20.1 Angina pectoris with documented spasm 
I20.8 Other forms of angina pectoris 
I20.9 Angina pectoris, unspecified 
I24.8 Other forms of acute ischaemic heart disease 
I24.9 Acute ischaemic heart disease, unspecified 
I25.1 Atherosclerotic heart disease 
I46.0 Cardiac arrest with successful resuscitation 
I49.0 Other cardiac arrhythmias 
R06.0 Dyspnoea 
R07.1 Chest pain on breathing 
R07.2 Precordial pain 
R07.3 Other chest pain 
R07.4 Chest pain, unspecified 
R57.0 Cardiogenic shock 
R57.9 Shock, unspecified 
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S2: CHOP and APDRG codes used to identify PCI treatment 
CHOP code 
indicating PCI Explanation 
Z00.45 One stent inserted 
Z00.46 Two stents inserted 
Z00.47 Three stents inserted 
Z00.48 Four or more stents inserted 
Z00.66 Percutaneous transluminal coronary angioplasty [PTCA] or coronary atherectomy 
Z36.0 Removal of coronary artery obstruction and insertion of stent(s) 
Z36.06 Insertion of non-drug-eluting coronary artery stent(s) 
Z36.07 Insertion of drug-eluting coronary artery stent(s) 
APDRG code 
indicating PCI Explanation 
112 Percutaneous cardiovascular intervention without acute myocardial infarction, 
cardiac insufficiency/heart failure or shock 
1112 Percutaneous cardiovascular intervention without acute myocardial infarction, 
cardiac insufficiency/heart failure or shock, with multiple interventions  
808 Percutaneous cardiovascular intervention with acute myocardial infarction, 
cardiac insufficiency/heart failure or shock 
1808 Percutaneous cardiovascular intervention with acute myocardial infarction, 
cardiac insufficiency/heart failure or shock, with multiple interventions 
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S3: CHOP and APDRG codes used to identify CABG treatment 
CHOP code 
indicating 
CABG Explanation 
Z36.1 Bypass anastomosis for heart revascularization 
Z36.10 Aortocoronary bypass for heart revascularization, not otherwise specified 
Z36.11 (Aorto)coronary bypass of one coronary artery 
Z36.12 (Aorto)coronary bypass of two coronary arteries 
Z36.13 (Aorto)coronary bypass of three coronary arteries 
Z36.14 (Aorto)coronary bypass of four or more coronary arteries 
Z36.15 Single internal mammary-coronary artery bypass 
Z36.16 Double internal mammary-coronary artery bypass 
Z36.19 Other bypass anastomosis for heart revascularization 
APDRG code 
indicating 
CABG Explanation 
106 Coronary bypass, with intracardiac catheter 
107 Coronary bypass, without intracardiac catheter 
546 Coronary bypass, with severe complications 
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S4: Results of the multilevel Poisson regression for revascularization 
  All patients 
  (95% CI) 
Sex p<0.0023 
Male 1.0  
Female 0.91 (0.86,0.97) 
Age groups p<0.0000 
18 to 44 years 1.0  
45 to 49 years 1.02 (0.90,1.15) 
50 to 54 years 1.04 (0.93,1.16) 
55 to 59 years 1.01 (0.90,1.13) 
60 to 64 years 0.99 (0.88,1.10) 
65 to 69 years 1.01 (0.90,1.13) 
70 to 74 years 0.97 (0.86,1.10) 
75 to 79 years 0.91 (0.81,1.03) 
80 to 84 years 0.80 (0.70,0.91) 
85+ years 0.42 (0.36,0.49) 
Citizenship p<0.9026 
Foreign 1.0  
Swiss 1.00 (0.93,1.06) 
Entry decision p<0.3483 
Herself/Himself, relatives 1.0  
Rescue services 0.96 (0.89,1.02) 
Physician 0.96 (0.89,1.02) 
Comorbidities p<0.0000 
No 1.0  
1 - 2 1.87 (1.51,2.32) 
3 - 4 1.92 (1.56,2.38) 
5 - 6 1.88 (1.51,2.33) 
7+ 1.60 (1.29,1.99) 
Insurance status p<0.2585 
Public 1.0  
Half Private 1.05 (0.98,1.13) 
Private 1.06 (0.96,1.17) 
Hospital groups p<0.2157 
Small (<15001 cases) 1.0  
Medium (15001-30000 cases) 1.17 (0.94,1.47) 
High (>30000 cases) 1.27 (0.89,1.82) 
Language region p<0.2404 
German 1.0  
French 1.20 (0.94,1.54) 
Italian 1.30 (0.77,2.19) 
FTE physicians/1000 cases p<0.8691 
1. tertile (<11.86) 1.0  
2. tertile (11.86-<17.46) 1.02 (0.88,1.18) 
3. tertile (17.46+) 1.06 (0.85,1.31) 
Hospital region p<0.8227 
Rural 1.0  
Urban 1.03 (0.78,1.37) 
Angiography device p<0.2886 
No 1.0  
Yes 1.13 (0.90,1.41) 
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S5: Results of the multilevel Poisson regression for revascularization for male and female patients 
younger than 65 years 
  Men Women 
  (95% CI) (95% CI) 
Age groups p<0.8529 p<0.9728 
18 to 44 years 1.0  1.0  
45 to 49 years 1.02 (0.90,1.17) 0.97 (0.69,1.38) 
50 to 54 years 1.04 (0.92,1.17) 1.06 (0.77,1.46) 
55 to 59 years 1.00 (0.88,1.14) 1.02 (0.76,1.39) 
60 to 64 years 0.98 (0.87,1.11) 1.06 (0.79,1.44) 
Citizenship p<0.9426 p<0.7214 
Foreign 1.0  1.0  
Swiss 1.00 (0.92,1.09) 0.96 (0.77,1.20) 
Entry decision p<0.9014 p<0.6067 
Herself/Himself, relatives 1.0  1.0  
Rescue services 0.98 (0.90,1.08) 1.05 (0.84,1.31) 
Physician 0.98 (0.89,1.08) 1.12 (0.89,1.40) 
Comorbidities p<0.0000 p<0.3332 
No 1.0  1.0  
1 - 2 2.06 (1.52,2.79) 1.68 (0.82,3.45) 
3 - 4 2.06 (1.52,2.79) 1.80 (0.88,3.68) 
5 - 6 2.02 (1.48,2.75) 1.91 (0.93,3.94) 
7+ 1.72 (1.25,2.36) 1.59 (0.77,3.29) 
Insurance status p<0.7019 p<0.7939 
Public 1.0  1.0  
Half Private 1.04 (0.93,1.17) 1.08 (0.84,1.38) 
Private 1.04 (0.89,1.22) 0.94 (0.61,1.44) 
Hospital groups p<0.0655 p<0.0703 
Small (<15001 cases) 1.0  1.0  
Medium (15001-30000 cases) 1.29 (1.03,1.60) 1.38 (1.05,1.81) 
High (>30000 cases) 1.20 (0.91,1.60) 1.29 (0.95,1.75) 
Language region p<0.4001 p<0.7709 
German 1.0  1.0  
French 1.09 (0.88,1.34) 1.06 (0.86,1.31) 
Italian 1.28 (0.84,1.95) 1.13 (0.70,1.84) 
FTE physicians/1000 cases p<0.5446 p<0.8723 
1. tertile (<11.86) 1.0  1.0  
2. tertile (11.86-<17.46) 1.00 (0.85,1.19) 1.03 (0.81,1.31) 
3. tertile (17.46+) 1.14 (0.90,1.44) 1.08 (0.81,1.43) 
Hospital region p<0.4421 p<0.7278 
Rural 1.0  1.0  
Urban 1.12 (0.84,1.48) 1.09 (0.67,1.76) 
Angiography device p<0.9030 p<0.6044 
No 1.0  1.0  
Yes 1.01 (0.82,1.26) 1.10 (0.77,1.57) 
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S6: Results of the multilevel Poisson regression for revascularization for male and female patients 
65 years and older 
  Men Women 
  (95% CI) (95% CI) 
Age groups p<0.0000 p<0.0000 
65 to 69 years 1.0  1.0  
70 to 74 years 0.96 (0.86,1.07) 0.95 (0.79,1.14) 
75 to 79 years 0.91 (0.81,1.03) 0.83 (0.69,1.00) 
80 to 84 years 0.79 (0.68,0.91) 0.74 (0.62,0.89) 
85+ years 0.46 (0.38,0.55) 0.35 (0.28,0.44) 
Citizenship p<0.8817 p<0.7658 
Foreign 1.0  1.0  
Swiss 1.01 (0.89,1.15) 1.03 (0.83,1.29) 
Entry decision p<0.4203 p<0.6750 
Herself/Himself, relatives 1.0  1.0  
Rescue services 0.96 (0.85,1.09) 0.93 (0.77,1.11) 
Physician 1.04 (0.91,1.18) 0.97 (0.81,1.17) 
Comorbidities p<0.0001 p<0.0135 
No 1.0  1.0  
1 - 2 1.83 (1.24,2.71) 2.35 (1.24,4.44) 
3 - 4 1.90 (1.29,2.79) 2.52 (1.33,4.74) 
5 - 6 1.85 (1.25,2.74) 2.34 (1.24,4.43) 
7+ 1.54 (1.04,2.27) 2.09 (1.11,3.94) 
Insurance status p<0.6274 p<0.0359 
Public 1.0  1.0  
Half Private 1.00 (0.89,1.12) 1.18 (1.01,1.38) 
Private 1.08 (0.92,1.26) 1.25 (0.98,1.59) 
Hospital groups p<0.0102 p<0.0873 
Small (<15001 cases) 1.0  1.0  
Medium (15001-30000 cases) 1.32 (1.10,1.58) 1.27 (1.00,1.60) 
High (>30000 cases) 1.19 (0.95,1.48) 1.26 (0.95,1.67) 
Language region p<0.3227 p<0.1167 
German 1.0  1.0  
French 1.04 (0.88,1.24) 1.12 (0.90,1.40) 
Italian 1.26 (0.93,1.73) 1.50 (0.99,2.28) 
FTE physicians/1000 cases p<0.1582 p<0.2855 
1. tertile (<11.86) 1.0  1.0  
2. tertile (11.86-<17.46) 1.02 (0.88,1.19) 0.98 (0.80,1.20) 
3. tertile (17.46+) 1.21 (0.99,1.48) 1.21 (0.93,1.57) 
Hospital region p<0.2783 p<0.4489 
Rural 1.0  1.0  
Urban 1.17 (0.88,1.55) 1.15 (0.80,1.66) 
Angiography device p<0.2043 p<0.3051 
No 1.0  1.0  
Yes 1.14 (0.93,1.41) 1.15 (0.88,1.49) 
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Abstract (250 words) 
Background 
Healthcare spending increases sharply at end of life (EOL). As the population ages, this places more and 
more pressure on the healthcare system. However, we know little about variation of EOL care between 
regions, or determinants of that care in Switzerland.  
Methods 
We used basic health insurance (BHI) claims of individuals who died between 2008 and 2010 to derive EOL 
care costs. We linked to the mortality database for information on cause of death and individual 
characteristics. We described characteristics of regions of residence, including healthcare supply measures. 
We used multilevel regression models to estimate differences in costs across regions and characteristics.  
Results 
Study population consisted of 111,275 individuals. Reimbursement by BHI was, on average, 33.1k 
(thousand) Swiss Francs (standard deviation 33.2k) during last year of life. Variance was reduced by 62-85% 
when we added individual and regional characteristics, with strong effect of language region. The highest 
cost ratios were observed for cause of death, particularly for cancer. These were followed by age and 
language region. Civil status and area-based socioeconomic position had smaller effects. Nationality, 
urbanicity and healthcare supply measures had little effect. We found spatial pattern in cost across 
regions: higher values clustered in the Eastern (French-speaking) part of the country, and around the cities 
of Bern, Basel and Zurich.  
Conclusions 
BHI data show that in Switzerland, EOL care cost depends mainly on the cause of death and age at death. 
Variation might indicate that that EOL care process seems to be organized differently between linguistic 
regions. 
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Introduction 
Two factors characterize the Swiss healthcare system: high performance and high cost. An aging 
population and advances in medicine raise healthcare costs even higher. 1 Treatment patterns, intensity, 
and resulting costs depend both on medical condition, and on demographic and socioeconomic patient 
characteristics. 2 Since HCE are unevenly distributed across the life span 3, and end of life (EOL) is often 
associated with sharp increases in spending on health, the imbalance in spending may be attributable to 
rising costs and demands for resources placed on healthcare systems by EOL patients. 4–6 
A growing body of literature suggests that regional provider factors, such as financial incentives, and 
physicians’ beliefs or practice norms result in different patterns of healthcare use and expense. 7–9 For 
instance, several Swiss studies found that in regions where density of physicians was higher, the cost of 
care also increased 10–14 suggesting supply-induced demand. Others pointed out that different 
reimbursement schemes affect cost-efficiency among hospitals that provide inpatient care. 15,16 These 
patterns do not necessarily match the preferences of patients and their families 17,18, it is not clear that 
more or more expensive services increase patient satisfaction or improve outcomes. 19,20  
Unfortunately, tracking variation in healthcare and identifying its causes, is non-trivial exercise. 21 It is 
particularly difficult in Switzerland, where strong federalism and regulated competition within the 
healthcare system, and a very culturally diverse population, can interact in various ways to cause myriad 
differences in healthcare utilization and costs among and across regions. 2,4,11,14,22 This may explain why 
only a handful of studies attempted to examine the importance of EOL care (EOLC) in the Swiss health 
system. Reich et al. 18 examined differences in healthcare utilization across place of death; Matter-Walstra 
et al. 2,23 looked at the delivery of care to cancer patients, and, von Wyl et al. 24 developed typology of cost 
trajectories in EOLC. All these studies had limited power to investigate small-area patterns across the 
country despite importance of such research for informing policy makers and clinicians. 6,11,25 In addition, 
some of these studies are limited because they used heterogeneous areas such as Swiss cantons that may 
not be best suited for regional analyses. 26,27 
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We set out to study regional variation in cost of EOLC in Switzerland. We first constructed a nationally 
representative dataset of EOLC, allowing us to perform studies across small-areas. We then identified 
contextual factors and described how, and to what degree, context shaped variation in cost across regions.  
Methods 
Study setting 
Switzerland is a small European federal republic of 26 cantons, stretched between the Alps, the Swiss 
Plateau and the Jura Mountains. Its consumer-driven healthcare system is chiefly financed by compulsory 
basic health insurance (BHI) and out-of-pocket payments. The package covers all essential benefits related 
to medical illness and pregnancy and deemed medically- and cost-appropriate. [see Text 1, SDC for more 
details]. 
Data sources 
We harmonized and combined anonymized BHI claims of six large companies and used them as the 
primary data source for our study (Table 1, SDC). We included all individuals with BHI who died between 
1.1.2008 and 31.12.2010. Information on sex, age, date of birth and death, and place of residence were 
available for each insuree. We aggregated all BHI claims within the last 12 months of life, and used the 
total amount reimbursed to derive overall EOLC cost. 
The Swiss Federal Statistical Office’s (SFSO) database of causes of death was probabilistically linked to 
insurance records using date of birth, date of death, sex, and community of residence to derive 
information on cause of death, nationality, civil status and religion. Based on SFSO data, we also assessed 
representativeness of the data. Characteristics of communities, supply of ambulatory, inpatient and non-
acute care together with population denominator were derived from available sources (Table 1, SDC). 
Analytical regions 
We used 705 MedStat regions - basic unit of delivery of SFSO’s health statistics, and aggregated them into 
564 custom regions (hereinafter referred to as MedStat) that best approximated boundaries of Swiss 
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communities. We then used SFSO’s classification of communities (the lowest level of administrative 
division) to derive urbanicity and language region of MedStat. Swiss-SEP (area-based socioeconomic 
position) index 28 was derived as a median value of all neighbourhoods that overlapped MedStat and 
divided into quintiles. Utilization-based HSAs were created using methodology described in details 
elsewhere 26. In short, we used individual-level discharges of all Swiss hospitals in 2010 to create matrix of 
patient flows and then aggregated them to form 71 units, where majority of residents were hospitalized 
[Figure 1, SDC].  
Study population & measures 
We excluded individuals below age 19, those who lived abroad, and those whose address was not known. 
We also excluded individuals who were not linked to mortality records, and those with no claims 
reimbursed by BHI during their last 12 months of life.  
We aggregated age into 5-year bands. Civil status was categorized into ‘single’, ‘married’, ‘widowed’ and 
‘divorced’; nationality into ‘Swiss’ and ‘foreigner’ (including missing values); religion into ‘Protestant’, 
‘Catholic’, ‘No affiliation’ and ‘Other/Unknown’. Primary causes of death were simplified to eight 
categories, based on the main groupings of the 10th revision of the International Statistical Classification of 
Diseases and Related Health Problems (ICD-10) classification (see Table 1 for detailed codes).  
Characteristics of regions of residence included urbanicity (‘urban’, ‘peri-urban’, ‘rural’) and language 
(‘German’, ‘French’, ‘Italian’). Ambulatory care supply was measured by density of physicians per 10,000 
inhabitants, acute care as number of utilized hospital beds per 10,000 inhabitants, and non-acute care as 
number of nursing home beds per 10,000 inhabitants 65 year old and older (all in quintiles).  
Analyses 
We calculated frequencies and described overall cost (mean, standard deviation [SD]) across 
characteristics. We used individual level data to fit multilevel regression models; MedStat regions were 
nested within HSAs. Main outcome was the log transformed overall EOLC cost. 29,30 In sensitivity analyses 
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we used alternative measures of cost correcting for ambulatory care billed under the tariff system 
(TARMED): we used tariff points instead of CHF, and costs of inpatient care that included cantonal 
subsidies (based on first available data from 2012). 
We assessed interaction of sex, and, within sex strata, also a binary age indicator (divided into 19-65 year-
olds and those >66) with remaining variables. We considered four models, gradually increasing complexity 
by adjusting for more characteristics. Models were assessed according to the reduction of variance 
compared to unadjusted model. 31 For each region we calculated deviation from the national mean using 
the random part of the models. 
Data management and analyses were done with Stata 14 (StataCorp LP, College Station, Texas, USA) and 
we used The Generalized Record Linkage System for record linkage. 32 
Ethics 
Ethical approval was obtained from the Ethics Committee of the Canton of Bern.  
Results 
Study population 
The initial dataset consisted of 119,613 individuals. We excluded 620 (0.5%) individuals younger than 19, 
172 (0.1%) individuals who lived abroad, and 364 (0.3%) whose address was missing [Figure 2, SDC]. 
Remaining population was probabilistically linked to 2008-2010 mortality data with 95.6% success rate; 
5,180 unlinked individuals were similar to the linked ones [Table 2, SDC] and were excluded. We also 
excluded 2,002 individuals who had no reimbursed claims [Table 3, SDC].The study population covered 
61% of deaths in Switzerland between 2008-2010 [Table 4, SDC]. The sex, age nationality, civil status 
urbanicity, language region, Swiss-SEP and, most importantly, cause of death distributions were almost 
identical to overall mortality in that time period. 
Final study population consisted of 111,275 individuals (Table 1). Of these, 85% were 66 years or older; 
women were older at the time of death. Main causes of death were CVD (36%) and cancer (26%). Cancer 
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was more frequent among younger people and CVD more frequent among older. Relatively, older women 
more often died from mental and behavioural disorders, and older men more often from respiratory 
diseases. Young men were most likely to die of external causes. Study participants were almost all Swiss 
(92%), and either married (39%) or widowed (40%) at time of death. There were more foreigners and 
single individuals among younger age groups and older women were widows. There were few differences 
by religious affiliation, urbanicity and SEP.  
EOL healthcare costs 
Reimbursement by BHI was, on average, 33.1k (thousand) Swiss Francs (CHF; SD 33.2k) during last year of 
life [Table 5, SDC]. Average spending was higher among younger individuals, particularly women. For both 
sexes spending tended to first increase with age, and then decrease among the oldest age groups. Cancer 
deaths, especially among younger individuals, were the most expensive (range 40.4k to 66.4k CHF, 
depending on age). The next most expensive were diseases of the nervous system (particularly among 
younger individuals) and respiratory diseases (particularly for young women) - range of cost 30.4k – 46.0k 
CHF. CVD, external causes and, among younger individuals, mental and behavioural diseases, were on 
average, less expensive (range 13.5k - 26.3k CHF). Average EOL cost tended to be higher among foreigners, 
married persons, and those resident in French-speaking parts of Switzerland, and areas where SEP was 
higher but lower in areas with a higher density of nursing home beds. 
Determinants of EOL healthcare costs 
We found evidence of interaction of sex and age with other variables [Table 6, SDC]. We thus used 
separate models for younger (aged 19-65) and older (66 and above) men and women. Extending models by 
including more variables gradually reduced variance (Table 2). Model 2, which was adjusted for 
characteristics of individuals and their place of residence, reduced HSA level variance by 39% for younger 
men and 12% for older men, with smaller reductions for women (9% and 3%). When we also considered 
healthcare supply measures (Model 3) variance was 18% to 46% less than in the unadjusted model. Large 
effects appeared when we considered language region (Model 4): HSA level variance was less than half for 
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all age and sex groups, when compared only to Model 3. Different variance patterns were observed on the 
MedStat level with slight reductions of variance for older individuals, drop for younger women and slight 
increase for younger men after first adjustment (model 2).  
There was little change in the estimates of the covariates between Models 2 and 4 [Tables 7-10, SDC]. The 
fully adjusted model (4) showed wide variation of cost ratio across variables (Table 5). Cause of death had 
the strongest influence; cancer deaths were associated with the highest cost ratio, particularly for younger 
males and women. Costs were lower for cancer deaths among older men and older women. Death from 
diseases of the nervous system generated the second highest costs. The third costliest group varied based 
on age of death. For younger people, respiratory diseases were most expensive. For older people, mental 
and behavioural disorders were most expensive. Unsurprisingly, the cost was lowest for people who died 
from external causes. Age effect was weaker than cause of death and varied slightly between sexes. Young 
persons, and particularly men accumulated less costs. Costs increased among middle-aged individuals and 
then decrease again around age 70. We found moderate effects of increased cost among individuals from 
French- and Italian-speaking parts of Switzerland. We found small effects of decreased cost for people who 
were single, divorced, had no religious affiliation, and lived in areas of lowest SEP. Healthcare supply 
measures had little effect.  
Geographical variation in EOL healthcare costs 
There was considerable variation in spatial distribution of random effects (Figure 1). The highest cost was 
in the Western (French-speaking) parts of the country (regions around cities of Lausanne and Geneva), in 
canton Ticino (Italian-speaking) and near large German-speaking cities (Basel, Bern, Zurich). Costs 
associated with death among older people were higher in parts of canton Graubünden and Valais. The Alps 
and central and north-west regions had lower costs. Adjusting for individual, regional and supply care 
covariates (models 2 and 3) only slightly changed the random effects [Figure 3 and 4, SDC]. Adjusting for 
language region, however, had significant impact (Figure 2) and diminished the contrast between West, 
the South and rest of the country. The range of estimates significantly decreased: fewer regions fell into 
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extreme classes of maps. Higher costs, mainly among older individuals, were still present around large 
cities (Bern, Zurich, Basel) and in parts of Canton Vaud. Among older women, pockets of increased cost 
were found in Eastern Valais and parts of Graubünden. The belt of lower costs stretched, in the north, 
between cantons Neuchatel and Thurgau (with the exception of Basel), and the western part of Valais 
(particularly for older women). 
Discussion 
Main findings 
We studied geographical variation in EOLC cost in Switzerland and assessed possible determinants of cost 
across individual, regional and healthcare supply factors. We found strong associations of cost with cause 
of death and age of the decedent. When we included language region, variance was greatly reduced, and 
supply factors played virtually no role. The strong spatial patterning of cost between regions could be only 
explained by covariates. 
Strengths 
The biggest strength of the study is its sample size. This was the largest and most comprehensive dataset 
of EOLC ever assembled in Switzerland. Coverage and representativeness of the data allowed us to analyse, 
for the first time, small-area variation. Earlier Swiss studies used language regions 18,33 or 
cantons 10,11,14,23,34 to track variation in intensity and cost of care. But, as this study demonstrated, cantons 
are heterogeneous. Unlike other insurance-based EOLC studies from Switzerland 2,18,24, we included 
reliable cause of death information and socio-demographic characteristics recorded on the death 
certificate. By using BHI claims data, we were able to cover the full range of care providers and include cost 
from ambulatory, inpatient and non-acute settings. Finally, ancillary databases allowed us to describe 
communities and capture supply of healthcare. Supply measures, have been described using utilization-
based areas which are better suited for this purpose than administrative units. 26,27 
Limitations 
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The study has some limitations. First, studies based on health insurance claims contain limited patient-level 
information. Quality or appropriateness of care are also difficult to measure from administrative data. We 
supplemented this data by linking to other sources, but important aspects of EOLC cost determinants may 
not be included; for instance, we could not include non-claims based measures of illness severity 35, patient 
and family preferences 36,37, functional impairment, or presence of relative nearby. 31 Second, overall cost 
is only one possible outcome in analyses of EOLC. 35,38,39, so our ongoing analyses will aim at disaggregating 
costs and exploring alternative measures of intensity of care. Third, focusing on the last 12 months of life is 
an arbitrary choice and, as in any retrospective design for a study of EOLC, we might have included costs 
unrelated to EOLC. 40 However, it is also one of the most frequently used time frames and facilitates 
comparability with other studies. A retrospective design efficiently identifies the members of EOLC studies 
so we could construct large representative datasets. Our study doesn’t suffer from inaccurate 
prognostication of survival and incomplete enrolment of patients. Langton and colleagues 39 describe two 
retrospective and prospective cancer EOLC studies with comparable results. 41,42 Our own sensitivity 
analyses indicated that alternative, shorter time frames of six and one month provided similar results. 
Fourth, relying only on BHI claims could cause us to underestimate overall cost. Our estimates do not 
include costs covered by supplementary insurance, claims paid directly by patients or not delivered to 
insurers. 18,33 About 50% of inpatient cost are subsidized by cantons and BHI pays only about 18% of costs 
of nursing home stays (mainly for medical treatments). 24 However, our sensitivity analyses showed that 
while monetary cost understandably increases when we use cost corrected for cantonal subsidies of 
hospital care, the direction and strength of the associations remained unaffected.  
Relation to other studies 
Our reports of HCE during last 12 months of life is comparable with previous studies. Von Wyl et al. 24 
estimated median cost to be 30.3k CHF (individuals aged 65 and over, last 12 months of life) and Reich et 
al. 18 to be 17.7k CHF (general population, last six months of life). These are considerably higher than 
among the general population in Switzerland: mean annual HCE is about 3,5k CHF 43; for people aged 65 
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and over it is about 6.7k CHF per year. 33 Such a magnitude of difference with EOLC population was also 
reported in the U.S. 44, and points to importance of EOLC in delivery of care.  
Cancer is the costliest cause of death in both Switzerland and the U.S. 44, and the highest cost trajectory of 
Swiss decedents identified by von Wyl et al. 24 found a high share of cancer patients. The high cost of 
cancer been linked to expensive new drugs and therapies. Decreases in the intensity and cost of EOLC with 
age were reported in Switzerland 4,23,24 and elsewhere. 5,31,39,44 Even among the general, older Swiss 
population, age was associated with decrease of HCE. 33 Less use of inpatient care (including Intensive Care 
Units) and/or less “aggressive” treatments for the elderly lower costs in older people, and this study may 
support these findings. The elderly also tend to die closer to diagnosis of serious illness, which lower 
expenses because time since diagnosis is often associated with intensity and cost of treatments. 40 
Similarly, as in the U.S. 31 and the Netherlands 5, single and divorced individuals had slightly lower EOLC 
costs. Religious association seemed to play no role, which matches Kelley et al., 31 who found no 
association of EOLC cost with religiosity.  
We found evidence for large geographic variation in cost, yet were unable to completely explain its causes. 
The influence of language region suggests that regional differences in provision and consumption of care 
could be factors. In Switzerland, we knew the differences across cantons in overall cost of care 10,14,25, 
overall number of hospitalizations 34, and intensity of EOLC of cancer patients. 2 Language region also 
played a role in treatment intensity in ambulatory settings. 12 These findings overlap with ours: costs were 
higher in many regions of French- and Italian-speaking Switzerland. More people died in the hospital in 
French- and Italian-speaking cantons, and since hospital deaths tend to cost more, this may be a partial 
explanation. 18,45 Doctors’ EOL decisions also vary across cultural regions: Fisher, et al. demonstrated, for 
instance, that French-speaking physicians were more likely to manage pain and symptoms aggressively, but 
were less willing than their German-speaking colleagues to comply with patient wishes for non-
treatment. 46 We found no association of the cost of EOLC with urbanization, but after we adjusted for 
urbanicity, we found increased EOL costs around the biggest cities. Others reported a lack of association of 
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urbanicity with number of hospitalizations of cancer patients. 2. Deaths at home, which are associated with 
lower cost, are more common in rural areas, which might explain part of the pattern. 18 
We found no association with healthcare supply measures. Density of physicians, which was associated 
with intensity and cost of general healthcare in Switzerland in earlier studies 11,12,14, was not a factor 
associated with EOLC cost. Both earlier studies, however, used aggregated data which might have biased 
their results. Similarly, hospital bed density was not associated with cost of care, resembling previous 
results from Switzerland 10, but not from the U.S. 8,19,37 Our results suggest that, after other characteristics 
are adjusted for, a larger supply of inpatient care does not raise EOLC cost by increasing use of hospitals. 
Implications 
Previous efforts have been made to track variation in EOLC cost across place of death 18 and across time. 24 
This study adds regional analyses, which can be used to target interventions that will improve care. Policies 
that shape the cost of EOLC in Switzerland should focus more on individual-level characteristics of patients, 
but also account for regional differences in healthcare delivery and consumption. Supply of care does not 
seem to play a role in shaping EOLC costs. EOLC might not be the most efficient place for curbing the 
growing HCE 47, but we did identify significant variation that may indicate under- or overuse of services in 
EOLC. But if regions that spend more offer better quality of care and have higher patient satisfaction, the 
rest of the country should follow suit. If future research finds that this is not the case, then the areas 
highlighted by our findings should become the focus of regionally tailored interventions. Finally, regional 
findings may point to different patient preferences between regions. If serving these preferences, 
independent of medical needs, is considered a valid social goal 37, then substantial variation in cost of EOLC 
in Switzerland will persist.  
Conclusion 
BHI claims data show that in Switzerland EOLC cost depends on the cause of death and age of the 
decedents. Variation across language might indicate that care process for EOL seems to be organized 
differently between regions. However, supply of care does not seem to play a major role. In the light of the 
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2012 Swiss-wide changes to new inpatient reimbursement system, this study proves a benchmark for 
tracking the effects of these changes on EOLC.   
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Table 1. Characteristics of the study population. Frequencies and percentages across sex and age. 
Abbreviations: ‘CVD’ –cardiovascular deaths, ‘Mental & behav.’ – mental and behavioural disorders. Swiss-
SEP – Swiss neighbourhood index of socioeconomic position (see 28 for details). Causes of death are based 
on main groupings of the 10th revision of the International Statistical Classification of Diseases and Related 
Health Problems (ICD-10) classification: ‘cardiovascular diseases’ (CVD; I00-I99); ‘cancer’ (C00-C99); 
‘mental and behavioural disorders’ (F00-F99); ‘diseases of the nervous system’ (G00-G99); ‘respiratory 
diseases’ (J00-J99;, ‘diseases of the digestive system’ (K00-K99); ‘external causes of death’ (V00-V99, W00-
W99, X00-X99 and Y00-Y99); and, ‘other’ (all remaining codes).  
Characteristic Males, 19-65 Males, 66+ Females, 19-65 Females, 66+ Total 
 No. Col % No. Col % No. Col % No. Col % No. Col % 
Age group           
19 - 25 253 2%   105 2%   358 0% 
26 - 30 214 2%   126 2%   340 0% 
31 - 35 262 3%   153 2%   415 0% 
36 - 40 384 4%   252 4%   636 1% 
41 - 45 671 6%   391 6%   1,062 1% 
46 - 50 1,111 11%   702 11%   1,813 2% 
51 - 55 1,606 15%   1,048 16%   2,654 2% 
56 - 60 2,411 23%   1,468 23%   3,879 4% 
61 - 65 3,672 35%   2,191 34%   5,863 5% 
66 - 70   4,584 11%   2,801 5% 7,385 7% 
71 - 75   5,713 14%   4,153 8% 9,866 9% 
76 - 80   7,925 19%   6,607 13% 14,532 13% 
81 - 85   9,496 23%   11,268 21% 20,764 19% 
86 - 90   8,404 20%   13,527 26% 21,931 20% 
91+   5,411 13%   14,366 27% 19,777 18% 
Nationality           
Swiss 8,705 82% 38,063 92% 5,606 87% 50,065 95% 102,439 92% 
Foreigner/Unknown 1,879 18% 3,470 8% 830 13% 2,657 5% 8,836 8% 
Civil status           
Single 2,882 27% 3,365 8% 1,277 20% 5,701 11% 13,225 12% 
Married 5,643 53% 24,809 60% 3,393 53% 9,671 18% 43,516 39% 
Widowed 250 2% 10,546 25% 487 8% 33,388 63% 44,671 40% 
Divorced 1,809 17% 2,813 7% 1,279 20% 3,962 8% 9,863 9% 
Religion           
Protestant 3,731 35% 20,518 49% 2,422 38% 27,624 52% 54,295 49% 
Catholic 3,825 36% 14,312 35% 2,296 36% 18,136 34% 38,569 35% 
No affiliation 1,093 10% 2,137 5% 620 10% 1,661 3% 5,511 5% 
Other/Unknown 1,935 18% 4,566 11% 1,098 17% 5,301 10% 12,900 12% 
Cause of death           
CVD 2,178 21% 15,220 37% 786 12% 22,072 42% 40,256 36% 
102
Cancer 4,234 40% 11,873 29% 3,450 54% 9,800 19% 29,357 26% 
Mental & behav. 265 3% 2,048 5% 138 2% 4,532 9% 6,983 6% 
Nervous system 305 3% 1,873 5% 260 4% 2,996 6% 5,434 5% 
Respiratory 327 3% 3,310 8% 208 3% 3,152 6% 6,997 6% 
Digestive 585 6% 1,503 4% 291 5% 2,128 4% 4,507 4% 
External 1,628 15% 1,644 4% 663 10% 1,931 4% 5,866 5% 
Other 1,062 10% 4,062 10% 640 10% 6,111 12% 11,875 11% 
Urbanicity           
Urban 3,334 32% 12,752 31% 2,041 32% 18,462 35% 36,589 33% 
Peri-urban 4,611 44% 18,114 44% 2,967 46% 21,852 41% 47,544 43% 
Rural 2,639 25% 10,667 26% 1,428 22% 12,408 24% 27,142 24% 
Language region           
German 7,150 68% 29,466 71% 4,496 70% 37,538 71% 78,650 71% 
French 2,945 28% 9,912 24% 1,693 26% 12,212 23% 26,762 24% 
Italian 489 5% 2,155 5% 247 4% 2,972 6% 5,863 5% 
Swiss-SEP quintile           
1st (lowest) 787 7% 3,020 7% 403 6% 3,444 7% 7,654 7% 
2nd 2,313 22% 9,167 22% 1,281 20% 11,042 21% 23,803 21% 
3rd 3,027 29% 11,229 27% 1,751 27% 14,377 27% 30,384 27% 
4th 3,587 34% 13,868 33% 2,335 36% 18,861 36% 38,651 35% 
5th (highest) 870 8% 4,249 10% 666 10% 4,998 10% 10,783 10% 
Total 10,584 100% 41,533 100% 6,436 100% 52,722 100% 111,275 100% 
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Table 2. Variance on MedStat and Hospital Service Area levels across four models. ‘Change’ indicates 
%change in relation to model 1. Abbreviation: HSA – Hospital Service Area. 
 
Sex Age Level Model 
   1 2 3 4 
   Variance Variance Change Variance Change Variance Change 
Males 19-65 HSA 0.028 0.017 -39% 0.015 -46% 0.005 -82% 
MedStat 0.003 0.007 133% 0.005 67% 0.005 67% 
66+ HSA 0.025 0.022 -12% 0.015 -40% 0.006 -76% 
MedStat 0.007 0.000 -100% 0.001 -86% 0.001 -86% 
Females 19-65 HSA 0.034 0.031 -9% 0.024 -29% 0.008 -76% 
MedStat 0.008 0.004 -50% 0.004 -50% 0.004 -50% 
66+ HSA 0.040 0.039 -3% 0.033 -18% 0.014 -65% 
MedStat 0.006 0.005 -17% 0.005 -17% 0.006 0% 
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 Figure 1. Spatial distribution of deviation from national mean (random effects) of model 1 (unadjusted) 
across 564 modified MedStat regions.  
108
 Figure 2. Spatial distribution of deviation from national mean (random effects) of model 4 (fully adjusted) 
across 564 MedStat regions. Class breaks of the colour scheme are the same as with model 1  
109
Appendix 
Text 1. Geography and healthcare system of Switzerland. 
Switzerland has 8.2 million residents, of whom almost a quarter (23.8%) are foreigners. It has four official 
languages: German (declared as main language by 64% of residents), French (23%), Italian (8%) and 
Romansch (0.5%). 85% of population live in urban areas, with 39% concentrated in five largest cities. 
Despite a strong economy and high standard of living, there is substantial spatial variation in 
socioeconomic position and health outcomes across the country. 1,2 
The Swiss, consumer-driven healthcare system is chiefly financed by compulsory basic health insurance 
(BHI) and out-of-pocket payments. Citizens choose standardized BHI package offered to everyone on a 
private, highly regulated market of 60 (state as of 10.08.15) insurers, who deliver it on a non-profit basis. 
The package covers all essential benefits related to medical illness and pregnancy (including ambulatory 
and in-patient care, medications and medical aids) and deemed medically- and cost-appropriate. 
Approximately half of in-patient costs are co-financed and subsidised by the cantons. A separate insurance 
system covers accident-related costs. Residents choose a deductible in a range of 300 – 2,500 Swiss Francs 
(CHF: 1 CHF = 0.91 Euro = 0.98 U.S. Dollar, as of 27.01.16). Higher deductibles and managed care plans 
lower the cost of yearly premiums. Patients also make co-payments of 10% of their yearly healthcare costs, 
up to a limit of CHF 700. Social assistance subsidizes premium payments for low-income individuals. The 
basic insurance package can be supplemented with voluntary, private insurance to extend provider and 
treatment choices (e.g. complementary medicine, dental care) and providing additional benefits (e.g. 
private room during hospital stay). 3–5 
References: 
1.  Panczak R, Galobardes B, Voorpostel M, Spoerri A, Zwahlen M, Egger M. A Swiss neighbourhood index of socioeconomic 
position: development and association with mortality. J Epidemiol Community Health. 2012 Dec;66(12):1129–36.  
2.  Moser A, Panczak R, Zwahlen M, Clough-Gorr KM, Spoerri A, Stuck AE, et al. What does your neighbourhood say about 
you? A study of life expectancy in 1.3 million Swiss neighbourhoods. J Epidemiol Community Heal. 2014 Aug 
14;68(12):1125–32.  
3.  von Wyl V, Telser H, Weber A, Fischer B, Beck K. Cost trajectories from the final life year reveal intensity of end-of-life 
care and can help to guide palliative care interventions. BMJ Support Palliat Care. 2015;(Online First 16.10.15).  
4.  Reich O, Signorell A, Busato A. Place of death and health care utilization for people in the last 6 months of life in 
Switzerland: a retrospective analysis using administrative data. BMC Health Serv Res. 2013;13:116.  
5.  Biller-Andorno N, Zeltner T. Individual Responsibility and Community Solidarity — The Swiss Health Care System. N Engl J 
Med [Internet]. 2015;373(23):2193–7. Available from: 
http://scholar.google.com/scholar?hl=en&btnG=Search&q=intitle:New+engla+nd+journal#0 
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Table 1. Data sources of the study. Databases used in the analyses, together with their purpose, temporal coverage, 
resolutions and content. Causes of death in ‘Mortality records’ database are coded according to the International 
Classification of Diseases, Injuries, and Causes of Death, Tenth Revision (ICD-10). Abbreviations: SFSO - Swiss Federal 
Statistical Office; SMA- Swiss Medical Association (FMH). 
Data Source Years Purpose Data 
resolution 
Spatial 
resolution 
Variables used 
Health insurance 
claims 
Six 
insurance 
companies 
2008-
10 
Main dataset Individual 
patients, health 
insurance claim 
Postcode Date of birth, date of death, 
sex and postcode of place 
of residence, reimbursed 
claim 
Mortality records SFSO 2008-
10 
Assessing representativeness, 
record linkage to claims for 
cause of death and 
characteristics of decedents 
Individual 
patients 
Community date of birth, date of death, 
sex, community of 
residence, civil status, 
nationality, religion, main 
cause of death 
Hospital 
discharges 
SFSO 2010 Creating Hospital Service Areas Individual 
hospital 
discharges 
MedStat Age, major diagnostic 
category, type of entry, 
region of patient’s place of 
residence, region of 
hospitalization 
Physicians 
database 
SMA 2010 Supply of ambulatory care Individual 
physicians 
Postcode Sector of employment 
(ambulatory, stationary, 
other), specialization 
Characteristics of 
hospitals 
SFSO 2010 Supply of acute care Individual 
institutions 
MedStat Type of hospital, location of 
hospital, number of utilized 
beds, number of doctors 
and nurses (full time 
equivalent) 
Characteristics of 
socio-medical 
institutions 
SFSO 2010 Supply of non-acute care Individual 
institutions 
MedStat Type of institution, location 
of institution, number of 
beds, number of nurses 
Population SFSO 2010 Population denominator for 
healthcare supply indicators 
Individual 
patients 
Community Age, sex, community of 
residence 
Characteristics of 
communities 
SFSO 2008-
10 
Description of place of 
residence 
Community Community Urbanicity, language region 
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Panels B – D use 564 modified MedStat regions. All panels use overlay of 71 Hospital Service Areas.  
Language region and urbanicity of the modified Medstat was derived from SFSO’s classification of Swiss 
communities (Gemeinde). In cases when more than one community belonged to the region, and these 
differed in terms of urbanicity or language region we used majority (>50%) assignment as criterion. 
Communities where Romansh language was used were grouped together with German language. Swiss-
SEP (area based socioeconomic position) index 28 was derived as median value of all neighbourhoods that 
overlapped with modified MedStat.  
Boundaries of the 564 modified MedStat regions were adjusted to exclude the high altitude areas of Swiss 
Alps with very low density or no population. 
71 HSAs were build using SFSO’s individual-level discharges of all Swiss hospitals in 2010. We created 
matrix of counts derived from cross tabulation of regions of patient’s place of residence with region of 
hospitalization. We excluded records with missing geographical codes, records of individuals younger than 
19, records belonging to major diagnostic category ‘Births’ and records of individuals from prisons. 
Patients’ flows derived from the matrix were then used to aggregate modified MedStat regions to larger 
units where majority of residents were hospitalized.
113
 Figure 2. Flowchart of exclusion criteria for study population definition. 
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Table 2. Distribution of unlinked deaths across characteristics of the study population. Urbanicity, 
language region and Swiss-SEP index measured on the level of community (Gemeinde). Abbreviations: 
Swiss-SEP – Swiss neighbourhood index of socioeconomic position (see 28 for details). 
Characteristic Linked Unlinked Total 
 
No. Col % No. Col % No. Col % 
Sex 
      Male 53,316 47% 2,508 48% 55,824 47% 
Female 59,961 53% 2,672 52% 62,633 53% 
Age group 
      19 - 30 810 1% 114 2% 924 1% 
31 - 40 1,150 1% 119 2% 1,269 1% 
41 - 50 3,072 3% 234 5% 3,306 3% 
51 - 60 6,813 6% 380 7% 7,193 6% 
61 - 70 13,533 12% 715 14% 14,248 12% 
71 - 80 24,696 22% 1,048 20% 25,744 22% 
81 - 90 43,160 38% 1,753 34% 44,913 38% 
91+ 20,043 18% 817 16% 20,860 18% 
Urbanicity 
      Urban 35,987 32% 1,813 35% 37,800 32% 
Peri-urban 47,779 42% 2,117 41% 49,896 42% 
Rural 29,510 26% 1,250 24% 30,760 26% 
Language region 
      German 80,129 71% 2,966 57% 83,095 70% 
French 27,200 24% 1,909 37% 29,109 25% 
Italian 5,947 5% 305 6% 6,252 5% 
Swiss-SEP quintile 
      1st (lowest) 8,902 8% 417 8% 9,319 8% 
2nd 22,583 20% 1,038 20% 23,621 20% 
3rd 30,902 27% 1,462 28% 32,364 27% 
4th 38,126 34% 1,721 33% 39,847 34% 
5th (highest) 12,764 11% 542 11% 13,306 11% 
Total 113,277 100% 5,180 100% 118,457 100% 
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Table 3. Distribution of individuals without any reimbursed claims across characteristics of the study 
population. Abbreviations: ‘CVD’ –cardiovascular deaths, ‘Mental & behav.’ – mental and behavioural 
disorders (see text for ICD-10 codes). Swiss-SEP – Swiss neighbourhood index of socioeconomic position 
(see 28 for details). 
Characteristic Bills exist No bills Total 
 
No. Col % No. Col % No. Col % 
Sex 
      Male 52,117 47% 1,199 60% 53,316 47% 
Female 59,158 53% 803 40% 59,961 53% 
Age group 
      19 - 30 698 1% 112 6% 810 1% 
31 - 40 1,051 1% 99 5% 1,150 1% 
41 - 50 2,875 3% 197 10% 3,072 3% 
51 - 60 6,533 6% 280 14% 6,813 6% 
61 - 70 13,248 12% 285 14% 13,533 12% 
71 - 80 24,398 22% 298 15% 24,696 22% 
81 - 90 42,695 38% 465 23% 43,160 38% 
91+ 19,777 18% 266 13% 20,043 18% 
Nationality 
      Swiss 102,439 92% 1,761 88% 104,200 92% 
Foreigner 8,836 8% 241 12% 9,077 8% 
Civil status 
      Single 13,225 12% 514 26% 13,739 12% 
Married 43,516 39% 607 30% 44,123 39% 
Widowed 44,671 40% 563 28% 45,234 40% 
Divorced 9,863 9% 318 16% 10,181 9% 
Religion 
      Protestant 54,295 49% 868 43% 55,163 49% 
Catholic 38,569 35% 617 31% 39,186 35% 
No affil. 5,511 5% 153 8% 5,664 5% 
Other/Unknown 12,900 12% 364 18% 13,264 12% 
Cause of death 
      CVD 40,256 36% 674 34% 40,930 36% 
Cancer 29,357 26% 124 6% 29,481 26% 
Mental & 
behav. 6,983 6% 197 10% 7,180 6% 
Nervous system 5,434 5% 106 5% 5,540 5% 
Respiratory 6,997 6% 80 4% 7,077 6% 
Digestive 4,507 4% 69 3% 4,576 4% 
External 5,866 5% 429 21% 6,295 6% 
Other 11,875 11% 323 16% 12,198 11% 
Urbanicity 
      Urban 36,589 33% 741 37% 37,330 33% 
Peri-urban 47,544 43% 852 43% 48,396 43% 
Rural 27,142 24% 409 20% 27,551 24% 
116
Language 
region 
      German 78,650 71% 1,425 71% 80,075 71% 
French 26,762 24% 505 25% 27,267 24% 
Italian 5,863 5% 72 4% 5,935 5% 
Swiss-SEP 
quintile 
      1st (lowest) 7,654 7% 121 6% 7,775 7% 
2nd 23,803 21% 372 19% 24,175 21% 
3rd 30,384 27% 506 25% 30,890 27% 
4th 38,651 35% 785 39% 39,436 35% 
5th (highest) 10,783 10% 218 11% 11,001 10% 
Total 111,275 100% 2,002 100% 113,277 100% 
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 Table 4. Representativeness of the study population across characteristics of overall Swiss mortality 
2008-10.  
Characteristic Study population National mortality Representativeness 
 
No. Col % No. Col % % of national mortality (row %) 
Sex      
Male 52'117 47% 88'907 48% 60% 
Female 59'158 53% 95'910 52% 63% 
Age group 
     19 - 30 698 1% 1'389 1% 58% 
31 - 40 1'051 1% 2'026 1% 57% 
41 - 50 2'875 3% 5'535 3% 56% 
51 - 60 6'533 6% 11'658 6% 58% 
61 - 70 13'248 12% 22'300 12% 61% 
71 - 80 24'398 22% 40'165 22% 61% 
81 - 90 42'695 38% 69'849 38% 62% 
91+ 19'777 18% 31'895 17% 63% 
Nationality 
     Swiss 102,439 92% 170'420 92% 61% 
Foreigner 8,836 8% 14'397 8% 63% 
Civil status 
     Single 13,225 12% 22'839 12% 60% 
Married 43,516 39% 73'095 40% 60% 
Widowed 44,671 40% 72'432 39% 62% 
Divorced 9,863 9% 16'451 9% 62% 
Religion 
     Protestant 54,295 49% 82'221 44% 67% 
Catholic 38,569 35% 71'919 39% 54% 
No affil. 5,511 5% 9'977 5% 57% 
Other/Unknown 12,900 12% 20'700 11% 64% 
Cause of death 
     CVD 40,256 36% 66'472 36% 62% 
Cancer 29,357 26% 48'207 26% 61% 
Mental & behav. 6,983 6% 11'571 6% 62% 
Nervous system 5,434 5% 9'237 5% 60% 
Respiratory 6,997 6% 11'442 6% 62% 
Digestive 4,507 4% 7'431 4% 62% 
External 5,866 5% 10'597 6% 59% 
Other 11,875 11% 19'860 11% 61% 
Urbanicity 
     Urban 36,589 33% 61'288 33% 59% 
Peri-urban 47,544 43% 74'145 40% 64% 
Rural 27,142 24% 49'384 27% 60% 
Language region 
     German 78,650 71% 133'177 72% 60% 
118
French 26,762 24% 42'586 23% 64% 
Italian 5,863 5% 9'054 5% 66% 
Swiss-SEP quintile 
     1st (lowest) 7,654 7% 16'291 9% 55% 
2nd 23,803 21% 36'660 20% 62% 
3rd 30,384 27% 47'931 26% 64% 
4th 38,651 35% 63'707 34% 60% 
5th (highest) 10,783 10% 20'228 11% 63% 
Total 111,275 100% 184'817 100% 61% 
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Table 5. Mean cost and standard deviation [SD] of end of life care across study population 
characteristics. All costs given in thousands of Swiss Francs: 1 CHF = 0.91 Euro = 0.98 the U.S. Dollar, as of 
27.01.16. Abbreviations: ‘CVD’ –cardiovascular deaths, ‘Mental & behav.’ – mental and behavioural 
disorders (see text for ICD-10 codes). Swiss-SEP – Swiss neighbourhood index of socioeconomic position 
(see 28 for details).  
Characteristic Males 19-65 Males 66+ Females 19-65 Females 66+ Total 
 
Mean SD Mean SD Mean SD Mean SD Mean SD 
Age group 
          19 - 25 21.6 53.1 
  
39.7 58.4 
  
26.9 55.3 
26 - 30 25.4 46.4 
  
39.2 57.2 
  
30.5 51.0 
31 - 35 35.7 65.9 
  
42.1 58.7 
  
38.1 63.4 
36 - 40 32.5 50.7 
  
52.6 48.0 
  
40.5 50.6 
41 - 45 32.4 52.5 
  
53.7 53.2 
  
40.2 53.7 
46 - 50 38.6 47.5 
  
55.5 53.3 
  
45.1 50.5 
51 - 55 39.3 52.2 
  
50.3 46.8 
  
43.7 50.4 
56 - 60 43.5 54.2 
  
50.3 48.5 
  
46.1 52.2 
61 - 65 43.0 47.4 
  
49.4 45.4 
  
45.4 46.7 
66 - 70 
  
41.8 42.7 
  
46.8 47.1 43.7 44.5 
71 - 75 
  
39.1 38.9 
  
40.5 38.1 39.7 38.6 
76 - 80 
  
35.5 35.8 
  
34.5 30.5 35.0 33.5 
81 - 85 
  
30.1 27.9 
  
29.2 22.8 29.6 25.3 
86 - 90 
  
27.0 22.4 
  
26.9 18.9 26.9 20.3 
91+ 
  
25.0 19.2 
  
25.8 15.9 25.6 16.9 
Nationality 
          Swiss 39.5 51.6 31.9 31.5 50.1 49.1 29.9 25.1 32.6 32.6 
Foreigner 42.4 48.5 37.8 34.8 51.4 46.4 34.8 33.0 39.2 39.1 
Civil status 
          Single 29.9 44.3 28.7 26.4 43.3 47.5 28.9 23.3 30.5 32.8 
Married 46.6 54.8 34.3 34.3 55.1 51.5 35.8 34.0 37.8 39.6 
Widowed 40.1 52.1 28.7 25.5 46.5 45.0 28.3 21.9 28.7 23.5 
Divorced 35.6 45.4 34.0 35.4 45.7 42.0 33.7 30.4 35.7 36.8 
Religion 
          Protestant 39.7 47.9 31.1 31.3 50.1 48.8 29.1 24.7 31.5 31.1 
Catholic 41.5 53.1 32.9 30.6 50.8 48.0 31.1 25.2 34.0 33.0 
No affil. 37.6 52.8 36.1 38.5 52.2 49.2 32.1 31.5 37.0 41.6 
Other/Unknown 39.1 51.7 34.6 34.3 48.3 49.8 32.2 28.8 35.5 37.3 
Cause of death 
          CVD 21.2 40.2 25.7 28.3 26.3 42.5 25.7 21.3 25.5 26.0 
Cancer 63.4 50.7 42.2 36.4 66.4 47.9 40.4 34.6 47.5 41.0 
Mental & behav. 19.2 31.8 29.5 20.4 23.3 29.1 29.3 15.9 28.9 18.6 
Nervous system 40.6 43.0 35.3 27.5 41.5 32.7 32.7 18.4 34.5 24.7 
Respiratory 35.4 38.5 30.8 26.8 46.0 47.2 30.4 23.5 31.3 27.0 
Digestive 31.6 50.2 32.0 31.3 33.4 39.3 30.0 27.1 31.1 33.2 
External 13.5 26.2 24.8 28.2 19.9 24.7 25.5 23.9 21.3 26.4 
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Other 37.3 67.9 33.2 34.8 42.8 56.4 30.7 27.5 32.8 37.4 
Urbanicity 
          Urban 40.0 48.2 34.3 32.4 50.5 48.2 31.6 26.1 34.4 32.7 
Peri-urban 41.1 52.9 33.3 33.6 52.1 50.4 30.2 26.2 33.8 34.8 
Rural 38.2 51.3 28.5 27.5 46.2 45.7 27.9 23.3 30.1 30.6 
Language region 
          German 37.7 49.1 29.9 30.3 47.0 45.1 27.9 23.9 30.6 31.2 
French 45.3 56.1 38.7 35.1 59.1 56.8 36.6 29.3 39.8 37.8 
Italian 42.7 45.5 36.9 32.4 49.5 46.0 32.5 25.1 35.7 31.4 
Swiss-SEP quintile 
          1st (lowest) 37.0 44.1 29.8 26.7 43.6 43.1 29.6 21.7 31.2 28.4 
2nd 37.8 44.4 29.7 27.6 45.8 43.9 28.7 22.3 30.9 29.0 
3rd 39.9 54.2 31.7 30.5 49.9 46.2 29.4 25.7 32.5 33.1 
4th 41.2 52.2 33.7 33.4 52.8 52.5 31.1 27.0 34.3 34.7 
5th (highest) 44.2 56.7 37.3 40.4 55.0 52.4 32.2 28.7 36.6 38.5 
Physicians / 10'000 (FMH) 
         1st (lowest) 38.9 45.4 29.9 29.3 48.8 46.4 29.4 28.6 31.8 32.8 
2nd 37.9 46.2 29.8 29.8 50.9 49.8 28.7 23.1 31.5 31.5 
3rd quintile 38.9 55.3 29.1 28.7 45.1 44.6 27.4 23.0 30.2 31.6 
4th 41.1 53.1 33.1 32.8 51.4 49.6 30.7 25.0 33.8 33.7 
5th (highest) 40.9 51.4 34.7 33.5 51.8 49.9 31.4 26.3 34.6 33.9 
Nursing home beds / 10'000 
(65+) 
        1st (lowest) 42.1 57.3 36.9 35.9 58.5 58.0 34.2 29.1 37.6 38.4 
2nd 41.7 50.1 33.4 32.9 52.2 50.3 31.4 27.4 34.4 34.4 
3rd quintile 41.4 56.9 32.9 30.1 49.3 47.0 29.7 24.6 33.1 32.9 
4th 38.4 47.9 30.7 31.1 47.1 44.4 29.2 24.4 31.6 31.4 
5th (highest) 35.4 41.0 28.9 27.7 46.2 45.9 26.7 21.0 29.3 28.0 
Utilized beds (all) / 10'000 
         1st (lowest) 38.8 65.0 27.4 27.0 45.0 43.7 26.4 24.3 29.1 33.3 
2nd 37.5 45.2 29.4 29.0 47.0 45.6 27.8 21.9 30.4 29.6 
3rd quintile 39.7 52.3 31.3 30.5 49.2 48.1 29.3 24.3 32.4 32.9 
4th 41.2 50.0 35.6 35.2 53.5 51.4 32.7 28.3 35.8 35.4 
5th (highest) 40.5 49.7 31.6 29.8 49.9 47.9 29.3 23.9 32.2 31.2 
Total 40.0 51.1 32.4 31.9 50.3 48.7 30.2 25.6 33.1 33.2 
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Table 6.Significance of interaction parameters. P-values from test of interaction of sex (second column) 
and binary age indicator (19-65 vs. 66+; second and third columns) with the variables in rows. Multilevel 
models using individual patient data with log of overall cost as outcome with MedStat and Hospital Service 
Areas as extra levels, adjusted for all variables listed in the table. 
Characteristics Interaction with sex Interaction with age 
  
Males Females 
Age group    <0.0001 -- -- 
Nationality   0.784 0.584 0.066 
Civil status    <0.0001  <0.0001  <0.0001 
Religion   0.193 0.021  <0.0001 
Cause of death    <0.0001  <0.0001  <0.0001 
Urbanicity    <0.0001 0.806 0.001 
Language region   0.08 0.015 0.002 
Swiss-SEP quintile    <0.0001 0.141  <0.0001 
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2.4 Article 4: AMI and stroke mortality vary by distance to hospital? 
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Abstract: 
We examined the relationship between distance to different hospital types and mortality from acute 
myocardial infarction or stroke in the Swiss National Cohort. We performed Cox analyses using 
driving time and straight-line distance as distance measures, additionally adjusting for 
sociodemographic and economic variables. Compared to the lowest quintile of driving time to a 
university hospital, the acute myocardial infarction mortality was 27% and 14% higher in the highest 
quintile for the young and old population, whereas the stroke mortality was 15% higher in the third 
quintile and 7% higher in the fourth quintile in the fully adjusted model. Acute myocardial infarction 
mortality among those in the population 30 and older and stroke mortality in those 65 and above 
increase with distance to central and university hospitals.  
 
 
Keywords: distance to hospital, acute myocardial infarction, stroke, mortality 
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Introduction  
Life-threatening diseases such as acute myocardial infarction (AMI) or stroke need immediate 
medical intervention. Multiple factors can influence the time to treatment and thus survival. These 
include time from the event to the alert of emergency medical services (EMS), presence of a person 
to perform cardiopulmonary resuscitation, availability of an automated external defibrillator, and 
travel time to a hospital with necessary specialized treatment (e.g., thrombolysis or percutaneous 
coronary intervention (PCI)).  
The European guidelines on myocardial revascularization indicate the greatest benefit from 
reperfusion therapy occurs 2–3 hours after onset [1]. In a Danish study of ST-segment elevation 
myocardial infarction (STEMI), patients for whom the time from first contact with the health care 
system to initiation of reperfusion therapy is no longer than 60 minutes have a long-term mortality 
rate of 15.4%; this rate doubles to 30.8% with a delay of 181 to 360 minutes [2]. The 
recommendations for STEMI and non-ST-segment elevation acute coronary syndrome (NSTE-ACS) 
differ according to available treatment and patient risk profile. STEMI patients should be treated 
without delay, whereas NSTE-ACS patients should receive revascularization within 24 hours, but in 
any event no later than 72 hours after onset. However, high risk NSTE-ACS patients should undergo 
urgent coronary angiography within 2 hours of onset. In STEMI patients, primary PCI without 
previous fibrinolysis is now recommended over fibrinolysis as the preferred reperfusion therapy if it 
can be provided in a timely manner by experienced operators. But if PCI cannot be performed within 
120 minutes of contact with the health system patients should receive fibrinolysis followed by 
angiography [1].  
The 2008 European guidelines for stroke treatment recommend intravenous thrombolysis within 3 
hours of stroke onset [3]. The following year the treatment window was extended to 4.5 hours [4].  
These windows for reperfusion therapy indicate prompt notification of the EMS and rapid 
transportation to the hospital. Geographical inequalities in the provision of health care may 
therefore influence the likelihood of dying from acute myocardial infarction or stroke.  
In Switzerland, inhabitants of remote areas like peripheral valleys or mountainous regions often face 
long travel distances to the nearest hospital, which may not necessarily be a hospital specialized in 
AMI or stroke treatment with a catheter laboratory or a stroke unit). This will affect transport time, 
treatment, and survival. Switzerland has a high hospital density and efficient ambulance and air 
rescue services [5], which should reduce AMI and stroke mortality for people living farther from 
hospitals. However, no study has yet assessed the relation between AMI and stroke mortality, and 
distance to hospitals in Switzerland. We therefore used Swiss National Cohort (SNC) data to assess 
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how AMI and stroke mortality in Switzerland relate to distance as driving time from home to 
different types of hospitals. 
 
Data and methods  
Swiss National Cohort 
The Swiss National Cohort (SNC) is a longitudinal study that links census data for the entire 
population of Switzerland with mortality and emigration records. In addition to sociodemographic 
and economic variables, the SNC also includes the geographical coordinates of residences. But due to 
the lack of a unique person identifier and the anonymous death registry in Switzerland, we linked the 
records of the census of 1990 and 2000 to death and emigration records up to 2008 using 
deterministic and probabilistic linkage methods based on sex, date of birth, place of residence, 
nationality, and other variables. The SNC is explained in detail elsewhere [6,7]. 
Hospital information 
Yearly the Federal Office for Health (FOH) derives key figures for Swiss hospitals from hospital 
characteristics and discharge statistics available from the Swiss Federal Statistical Office (SFSO, 
http://www.bag.admin.ch/kzss). However, those data do not provide addresses and further 
information for all individual hospitals when a single corporate entity operates more than one 
hospital in one town or canton. We therefore used additional data from the Federal Office of 
Topography (swisstopo) and TomTom to locate individual hospitals.  
We derived the geographical coordinates of the FOH data set of 2008 using the STATA command 
geocode3, which retrieves coordinates via Google Geocoding API V3. To identify additional hospital 
locations we compared the coordinates of the FOH data set with the hospital coordinates that are 
provided by swisstopo, and the hospital coordinates provided by the TomTom MultiNet Shapefile 
2011. We deleted duplicates and checked for further information about the hospitals via the 
Internet. We merged the data sets to create one data set with the following information on hospitals 
operating in 2008: type of hospital (acute care, acute care with emergency room 24/7 (ER), central 
hospital, and university hospital), and geographical coordinates.  
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Distance calculation using geographical information system 
We calculated two related measures of the distance between residences and hospitals using ArcGIS 
10.3: straight-line distance and driving time. Driving times for the road network of Switzerland were 
calculated using the TomTom MultiNet Shapefile (2011) and ArcGIS Network Analyst. To model the 
road options for ambulances we excluded ferries, car-train tunnels, and walkways, but included 
pedestrian areas. Because not all buildings are immediately adjacent to streets, we measured the 
straight-line distance to the next traversable street segment, assumed 15 km/h speed for traveling 
this distance, and adjusted driving distance and time accordingly. These data were then added to the 
SNC data base.  
Selection of records 
We excluded people younger than 30 at the 2000 census because CVD deaths are quite rare in this 
age group. We also excluded records having no or imprecise building coordinates that is necessary 
for the calculation of exact distance to hospital. These buildings also had no Swiss neighborhood 
index of socioeconomic position (SSEP) values [8] necessary for calculation of exact location. Persons 
with institutional residences, who are older and have poorer health, were also excluded because 
they have higher stroke or AMI risk than the general population. Only records with deaths that were 
identified by stringent probabilistic linkage were included. Individuals were followed from 
5 December 2000 until death, emigration, or the end of the study period on 31 December 2008.  
Primary cause of death was coded using the International Classification of Disease, Injuries and 
Causes of Death, 10th revision (ICD-10). Outcomes were deaths by AMI (I21, I22) and stroke (I60, I61, 
I63, I64).  
We analyzed the association of driving time and straight-line distance with stroke and AMI mortality 
using three different Cox proportional hazard models. Each was age-adjusted via the time axis, which 
was individuals’ age, and includes this information:  
- Model 1: hospital distance (driving time or straight-line distance) 
- Model 2: hospital distance, sex, nationality, civil status, religion, education, household type, 
and language region  
- Model 3: hospital distance, sex, nationality, civil status, religion, education, household type, 
language region, SSEP, and urbanization 
Analyses were stratified for younger (30-64 years) and older (≥ 65 years) persons because other SNC 
studies have shown differences in younger and older SNC subjects [9,10]. For further information 
about the categories of the variables included in the analyses see table 1. Driving time and straight-
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line distance to each of the four different hospital types (nearest acute hospital, acute hospital with 
ER, central hospital, or nearest university hospital) was divided into quintiles, the other four of which 
were compared to the lowest quintile in the Cox analyses. Figure 1 is illustrating the driving distance 
quintiles to university hospitals for all included buildings in Switzerland. Statistical analyses were 
done in Stata version 13 (Stata Corporation, College Station, TX, USA).  
 
Overview of study population 
In 2008, 173 hospitals were operating in Switzerland. Of these, 138 had an ED, 12 were central 
hospitals, and 5 university hospitals. The distance calculation used 1,293,780 buildings. Originally, 
7,280,246 persons were included in the 2000 census. After excluding persons younger than 30, those 
living in nursing homes or institutions, and records without precise building coordinates, 4,490,439 
persons remained in the study. Of these 48% were male, 76.9% were 30 to 64 years old, 79.3% lived 
in households with two or more persons, 69.3% were married, 25.7% lived in rural regions, and 
72.2% resided in German-speaking Switzerland. 42.3% were Catholics, 17.9% did not have Swiss 
citizenship, and 22.2% had tertiary level education (see table 1).  
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Table 1 Characteristics of the study population 
Characteristics Study population Stroke deaths AMI deaths 
      Crude rate per 100,000   Crude rate per 100,000 
  Number % Number  % Rate 95% CI Number % Rate 95% CI 
All 4,490,439 100 21,931 100 63.8 63-64.7 19,301 100 56.2 55.4-57 
Gender                     
Male 2,156,749 48 9,361 42.7 57.1 55.9-58.3 11,446 59.3 69.8 68.5-71.1 
Female 2,333,690 52 12,570 57.3 70.0 68.8-71.2 7,855 40.7 43.7 42.8-44.7 
Age (years)                     
30 - 34 549,551 12.2 53 0.2 1.2 0.9-1.6 62 0.3 1.4 1.1-1.8 
35 - 39 603,925 13.4 88 0.4 1.8 1.5-2.3 174 0.9 3.6 3.1-4.2 
40 - 44 547,237 12.2 162 0.7 3.7 3.2-4.4 287 1.5 6.6 5.9-7.4 
45 - 49 491,143 10.9 240 1.1 6.2 5.4-7 479 2.5 12.3 11.3-13.5 
50 - 54 478,402 10.7 344 1.6 9.1 8.2-10.2 790 4.1 21.0 19.6-22.5 
55 - 59 438,264 9.8 466 2.1 13.6 12.4-14.9 1,065 5.5 31.1 29.3-33.1 
60 - 64 342,555 7.6 744 3.4 28.2 26.3-30.3 1,212 6.3 46.0 43.4-48.6 
65 - 69 306,346 6.8 1,440 6.6 61.9 58.8-65.2 1,780 9.2 76.5 73-80.2 
70 - 74 267,196 6 2,685 12.2 136.8 131.7-142 2,750 14.2 140.1 134.9-145.4 
75 - 79 219,519 4.9 4,596 21 303.6 295-312.5 3,662 19 241.9 234.2-249.9 
80 - 84 140,276 3.1 5,408 24.7 625.0 608.5-641.9 3,553 18.4 410.6 397.3-424.3 
85 - 89 76,053 1.7 3,941 18 999.5 968.8-1031.2 2,554 13.2 647.8 623.1-673.4 
90 - 94 25,576 0.6 1,516 6.9 1429.7 1359.5-1503.5 798 4.1 752.6 702.1-806.6 
95+ 4,396 0.1 248 1.1 1773.0 1565.5-2008 135 0.7 965.1 815.3-1142.5 
Neighbourhood index of SEP                     
Lowest quintile 898,100 20 4,511 20.6 66.2 64.3-68.1 4,240 22 62.2 60.3-64.1 
Second quintile 898,083 20 4,786 21.8 69.9 68-71.9 4,336 22.5 63.4 61.5-65.3 
Third quintile 898,089 20 4,577 20.9 66.6 64.7-68.6 4,119 21.3 59.9 58.1-61.8 
Fourth quintile 898,081 20 4,210 19.2 61.0 59.2-62.8 3,599 18.6 52.1 50.4-53.9 
Highest quintile 898,086 20 3,847 17.5 55.6 53.9-57.4 3,007 15.6 43.5 42-45.1 
Type of household                     
Single person household 927,282 20.7 9,048 41.3 132.5 129.8-135.2 6,846 35.5 100.2 97.9-102.6 
Household with 2 or more persons 3,563,157 79.3 12,883 58.7 46.8 46-47.6 12,455 64.5 45.3 44.5-46.1 
Marital status                     
Single 646,207 14.4 1,925 8.8 38.4 36.7-40.2 1,692 8.8 33.8 32.2-35.4 
Married 3,110,107 69.3 10,609 48.4 44.2 43.4-45 10,865 56.3 45.3 44.4-46.1 
Widowed 356,153 7.9 8,151 37.2 337.5 330.3-344.9 5,405 28 223.8 217.9-229.9 
Divorced 377,972 8.4 1,246 5.7 42.6 40.3-45.1 1,339 6.9 45.8 43.4-48.3 
Urbanization                     
urban 1,301,289 29 7,458 34 75.9 74.2-77.6 6,171 32 62.8 61.2-64.4 
peri-urban 2,034,574 45.3 8,602 39.2 54.9 53.8-56.1 7,652 39.6 48.9 47.8-50 
rural 1,154,576 25.7 5,871 26.8 66.2 64.6-67.9 5,478 28.4 61.8 60.2-63.5 
Language region                     
German 3,241,186 72.2 16,187 73.8 65.2 64.2-66.2 14,075 72.9 56.7 55.7-57.6 
French 1,034,224 23 4,726 21.5 60.1 58.4-61.8 4,223 21.9 53.7 52.1-55.3 
Italian 215,029 4.8 1,018 4.6 61.9 58.2-65.8 1,003 5.2 61.0 57.3-64.9 
Religious affiliation                     
Protestant Churches 1,664,535 37.1 10,755 49 84.6 83-86.2 8,841 45.8 69.5 68.1-71 
Roman Catholic Church 1,900,346 42.3 8,481 38.7 58.3 57.1-59.6 7,844 40.6 54.0 52.8-55.2 
No religious affiliation 521,035 11.6 1,140 5.2 28.3 26.7-30 1,274 6.6 31.6 29.9-33.4 
Other/ unknown 404,523 9 1,555 7.1 50.5 48.1-53.1 1,342 7 43.6 41.3-46 
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Results 
Over the eight years of the study period, 381,659 persons (8.5% of 4,490,439) died. 51.6% of the 
deceased were men. 142,926 died of CVD (48.9% male), 21,931 died of stroke (42.7% male), and 
19,301 (59.3% male) died of AMI. The crude mortality rate per 100,000 persons was 416 for CVD, 64 
for stroke, and 56 for AMI (see table 1).  
The average driving time to an acute hospital was 6.5 min (maximum 65 min.) and 80.8% of persons 
in the SNC data set could access an acute hospital in less than 10 minutes. Just 1.3% had to travel 20 
minutes or more. The average driving time to a university hospital was 29.7 min (maximum 178 min), 
while 58.2% had to travel 20 minutes or more (table 2, while the figures for straight-line distance are 
given in appendix 1).  
Table 2 Number of persons in the SNC by driving time for the four different hospital types and 
average driving time  
Driving time 
Average driving time SNC persons 
in min (max) Number in % 
Acute hospital 6.5 (65)     
   <5min   2,017,352 44.9 
   5 < 10min   1,610,354 35.9 
   10 < 15min   674,382 15.0 
   15 < 20min   132,161 2.9 
   20min+   56,190 1.3 
Acute hospital with ER 7 (65)     
   <5min   1,834,768 40.9 
   5 < 10min   1,672,327 37.2 
   10 < 15min   747,662 16.7 
   15 < 20min   162,452 3.6 
   20min+   73,230 1.6 
Central hospital 17.4 (119.6)     
   <5min   679,954 15.1 
   5 < 10min   795,805 17.7 
   10 < 15min   619,898 13.8 
   15 < 20min   755,915 16.8 
   20min+   1,638,867 36.5 
University hospital 29.7 (178.2)     
   <5min   502,197 11.2 
   5 < 10min   548,417 12.2 
   10 < 15min   372,887 8.3 
   15 < 20min   454,895 10.1 
   20min+   2,612,043 58.2 
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Cox analysis results 
We ran 96 Cox analyses; 48 for driving time and 48 for straight-line distance. Figures 2–5 present the 
results of these analyses of AMI and stroke deaths for the 30–64 and 65 and older age groups. On the 
top of each figure the results of 12 separate analyses for the three models and the driving time to the 
four different hospital types are displayed. At the bottom of the figures the results of the analyses for 
straight-line distance is shown (see appendix tables 2–5 for the exact numbers of the driving time 
analyses and appendix tables 6—9 for the results of the straight-line distance analyses).  
In younger persons, driving time to the nearest acute hospital and the nearest hospital with an ER 
was not associated with AMI mortality, but AMI mortality did increase with driving time to a central 
or university hospital (figure 2). In persons 65 and older, mortality increased with driving time to all 
four hospital types in model 1 (figure 3). After including sociodemographic variables (model 2) and 
additional SSEP and urbanization (model 3) the magnitude of the effects is weaker but still 
statistically significant for central and university hospitals (highest quintile of driving time to 
university hospital model 1: HR = 1.27, 95%CI: 1.21–1.34; model 2: HR = 1.19, 95%-CI: 1.13–1.26; 
model 3: HR = 1.15, 95%-CI: 1.08–1.21).  
The impact of driving time on stroke mortality is less pronounced than it is for AMI mortality, 
especially in younger persons (figure 4). We found no significant relationship between stroke 
mortality and driving time (figure 4) except for driving time to a university hospital in model 1. In 
older persons (figure 5), model 1 showed significant associations between driving time to all types of 
hospital and stroke mortality. No relationship between driving time to acute hospitals and those with 
an ER was seen in models 2 and 3. Stroke mortality generally increased with driving time to central 
and university hospitals in all 3 models, though results were greatest in the fourth quintile (central 
hospital) or third quintile (university hospital). Compared to the lowest quintile of driving time to a 
university hospital in the fully adjusted model 3, the stroke mortality was 15% higher in the third 
quintile and 7% higher in the fourth quintile.  
 
Discussion 
Main findings  
Risk of dying from AMI increased with distance (in driving time) from a central or university hospital 
for both those younger and older than 65 years in the Swiss National Cohort. For stroke mortality, 
though, a significant association with distance to the same hospitals was observed only in those 65 
and older. However, we did not observe a clear dose-response relationship, as the strongest 
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association was seen when comparing the third and fourth quantile to first quantile of distance. For 
those younger than 65, stroke mortality was not associated with distance from any type of hospital 
once the analyses adjusted for relevant individual and regional characteristics. Although we found 
statistically significant increased hazards for AMI and stroke mortality with increasing distance to 
central and university hospitals, the hazard ratios were relatively small and could be the result of 
residual confounding.  
Possible mechanisms  
Our study analyzed the outcome of death following AMI or stroke at any point along a rather 
complex chain of events and interventions: 1) experiencing the AMI/stroke, 2) someone noticing the 
AMI/stroke (the patient, if able, otherwise someone else), 3) alerting the EMS, 4) CPR and 
defibrillation if needed by AMI patients, 5) transport to a treatment facility, 6) treatment, 7) 
rehabilitation. Differences observed in AMI/stroke mortality by hospital distance could arise in any 
element of this chain. 
The positive association of stroke mortality with distance in those over 65 might be explained by 
differences in the awareness and interpretability of stroke symptoms by patients themselves, or 
persons in the same household or workplace. Certainly alarm time might be longer for older people 
living alone than younger people living in family households. Another possibility is that elderly 
people, who are known to be at higher risk for stroke [11], might also be more susceptible to time 
delays due to comorbidities or physical or biochemical disturbances that may accompany a stroke. It 
also might be possible that, similar to trauma patients who have been observed to have lower 
trauma unit admission rates with higher age [12], stroke patients—especially from rural areas where 
the awareness of stroke symptoms might be lower—have lower primary stroke unit admission rates, 
and increased mortality. In any event, treatment of patients who live far from a hospital with a stroke 
unit might more effectively rely upon air transport by helicopter. 
Early after occurrence, AMI (especially STEMI) can have poor survival, while mortality from stroke 
often occurs later due to secondary sequelae such as secondary cerebral bleeding in the infarct 
territory, haemodynamic instability, or pulmonary complications. Furthermore, stroke patients might 
suffer severe neurological impairment, increasing with increasing time to revascularization, but still 
survive. This might explain why the association between AMI and distance to hospital was more 
pronounced in all age groups compared to stroke patients.  
Most studies focus on in-hospital mortality because these data are easy to access. Data about 
persons dying at the scene of the event, on the way to the hospital, or after discharge from hospital 
are more difficult to obtain. 
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Referral to and enrollment in a chronic disease management program for cardiac rehabilitation was 
less likely in patients in Ontario, Canada who lived 60 or more minutes from a cardiac rehabilitation 
site [13]. Therefore, it is important to distinguish health care utilization from emergency treatment in 
the association of accessibility of health care facilities and outcomes.  
Investigating the association of distance to hospital and increased risk of death in patients with life-
threatening emergencies, Nicholl et al. justified the exclusion of out-of-hospital cardiac arrests from 
their study because survival depends upon time from call to treatment by ambulance staff rather 
than time or distance from scene to hospital [14]. In contrast, Evenson et al. emphasize that in acute 
stroke care prehospital delay—the time from onset of symptoms to hospital arrival—contributes the 
major proportion of delay time [15]. Because the SNC lacks detailed information about circumstances 
and place of death (e.g., death before being reached, death during transport, death in nursing home 
or hospital), we could not perform sensitivity analyses by excluding prehospital deaths. What we did 
do, however, was exclude persons who lived in institutions at the 2000 census from all analyses 
because treatment decisions for such persons, most of whom are elderly, might differ from those still 
living at home by, e.g., the existence of do not resuscitate orders. 
Study limitations 
As noted above, the SNC does not contain information on the exact location of a person when he or 
she had a stroke or heart attack. Because the average ages of all persons dying from stroke and AMI 
were respectively 82 and 78 we assumed the vast majority of stroke or AMI events occurred at or 
close to home and reasonably, we believe, we used home to hospital distance in our analyses. 
We located SNC participants at a place of residence in the 2000 census, which was also the basis for 
defining the neighborhood index of socioeconomic position [8]. However, over the years 2001 to 
2008 residents could have moved (some surely did) and that information is not available in the SNC 
data. For those who died, the SNC also has information about the community (but not exact 
geocode) of the residence at death. Of the 381,659 people who died in our study population 19,785 
(5.2%) did not die in the same community in which they lived at the census 2000 (1,089 in stroke 
cases, 908 in AMI cases). 
Information on whether a patient was admitted, to which hospital, was not available. We partially 
addressed this problem by including the distance to different types of hospitals as patients will be 
admitted to different specialized hospitals depending on their diagnosis/symptoms.  
Catheter laboratories and stroke units provide the best evidence-based treatments for AMI and 
stroke patients [1,3,16]. It would have been ideal to know the distance to hospitals that have 
catheter laboratories or stroke units. However, in Switzerland health care is mainly organized at the 
147
cantonal level with 26 cantons in charge of health care planning and organization. Information on 
which treatment services are available at each hospital does not exist in a national database, and this 
includes catheter labs and stroke units operating in the years 2000 to 2008. At the local level, rescue 
crews are supposed to know which hospitals on which day and hour can receive patients who are in 
need of specialized AMI or stroke treatments.  
Strengths 
This study benefits from data that form a true nationwide cohort with almost complete follow-up 
during the study period for persons 30 years or older at the 2000 census. All Swiss hospitals 
operating in 2008 were included and classified by type. Due to Swiss topography we decided to 
calculate driving time instead of only using straight-line distance because driving time is a more 
accurate measure of access in peripheral and rural areas [17]. However, in the mountains and other 
remote regions emergency medical transportation might be carried out by helicopter. Therefore, we 
also calculated straight-line distance to model helicopter flight times. We found results were 
comparable to driving time (see figures 2—5 or appendices 6–9). 
Comparison with other studies 
Several studies have found that AMI and stroke mortality increase with distance to hospital [18–22], 
whereas others have not found such an association [23–26].  
However, studies investigating how mortality from AMI or stroke varies by distance to hospital differ 
by study design (cohort study, ecological study), subjects included (patients, population), selection of 
hospitals (federal hospitals), type of mortality (in-hospital, prehospital, posthospital, all-cause 
mortality) or geographical setting (city, urban and rural, county, state, country). Moreover, one 
expects that the role of hospital distance differs by size and geographical structure of the region or 
country (e.g., Canada versus Monaco). This complicates any comparison of results obtained in other 
regions or countries with those of our study of Switzerland.  
 
Conclusions 
AMI mortality increased with distance to central and university hospitals in the Swiss population both 
under and over 65 years of age, while stroke mortality increased in those 65 and older, although the 
strength of the observed associations was rather small. Even though hospital density in Switzerland is 
high, complex geography in more remote Swiss areas might make it difficult for EMS to guarantee 
adequate time from onset to intervention for acute events such as AMI and stroke. 
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Fig. 1 Driving time quintiles to university hospitals displayed for each building 
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Fig. 2 Cox analyses of AMI mortality - driving time quintiles and straight-line distance quintiles for 
persons 30-64 years under models 1 to 3 for the four different hospital types 
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Fig. 3 Cox analyses of AMI mortality - driving time quintiles and straight-line distance quintiles for 
persons 65 and older under models 1 to 3 for the four different hospital types 
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Fig. 4 Cox analyses of stroke mortality - driving time quintiles and straight-line distance quintiles for 
persons 30-64 under models 1 to 3 for the four different hospital types 
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Fig. 5 Cox analyses of stroke mortality - driving time quintiles and straight-line distance quintiles for 
persons 65 and older under models 1 to 3 for the four different hospital types 
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Appendix 1 Number of SNC persons by straight-line distance groups to the 4 different hospital types 
and average driving time 
Straight-line distance 
Average straight-line distance  SNC persons 
in km (max) Number in % 
Acute hospital 4.1 (35.8)     
   <5km   3,066,120 68.3 
   5 < 10km   1,146,168 25.5 
   10 < 15km   231,432 5.2 
   15 < 20km   33,091 0.7 
   20km+   13,628 0.3 
Acute hospital with ER 4.5 (35.8)     
   <5km   2,909,789 64.8 
   5 < 10km   1,222,016 27.2 
   10 < 15km   290,970 6.5 
   15 < 20km   52,108 1.2 
   20km+   15,556 0.3 
Central hospital 16.1 (84.4)     
   <5km   1,122,167 25.0 
   5 < 10km   623,079 13.9 
   10 < 15km   556,787 12.4 
   15 < 20km   630,307 14.0 
   20km+   1,558,099 34.7 
University hospital 33.4 (176.3)     
   <5km   794,125 17.7 
   5 < 10km   411,948 9.2 
   10 < 15km   283,952 6.3 
   15 < 20km   349,764 7.8 
   20km+   2,650,650 59.0 
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Appendix 2 Cox analyses of AMI mortality and driving time quintiles for persons 30-64 under models 
1 to 3 for the four different hospital types 
 
 Model 1 Model 2 Model 3 
Driving time Hazard ratio 95% CI Hazard ratio 95% CI Hazard ratio 95% CI 
Acute hospital  p<0.001  p=0.011  p=0.134 
Lowest quintile 1  1  1  
Second quintile 0.970 0.878 - 1.071 0.952 0.862 - 1.052 0.959 0.867 - 1.060 
Third quintile 0.885 0.800 - 0.978 0.870 0.786 - 0.963 0.897 0.806 - 0.997 
Fourth quintile 1.017 0.923 - 1.120 0.984 0.892 - 1.086 1.012 0.909 - 1.127 
Highest quintile 1.104 1.004 - 1.216 1.029 0.933 - 1.134 0.987 0.882 - 1.104 
Acute hospital with ER  p<0.001  p=0.011  p=0.052 
Lowest quintile 1  1  1  
Second quintile 0.928 0.839 - 1.025 0.914 0.826 - 1.010 0.918 0.830 - 1.015 
Third quintile 0.889 0.805 - 0.983 0.885 0.801 - 0.979 0.917 0.825 - 1.018 
Fourth quintile 1.035 0.940 - 1.139 1.010 0.917 - 1.114 1.039 0.935 - 1.154 
Highest quintile 1.077 0.979 - 1.186 1.015 0.921 - 1.119 0.968 0.868 - 1.081 
Central hospital  p<0.001  p<0.001  p=0.001 
Lowest quintile 1  1  1  
Second quintile 0.981 0.884 - 1.089 0.998 0.898 - 1.109 1.093 0.973 - 1.227 
Third quintile 1.182 1.069 - 1.306 1.164 1.051 - 1.290 1.231 1.097 - 1.380 
Fourth quintile 1.223 1.107 - 1.352 1.203 1.086 - 1.333 1.204 1.076 - 1.348 
Highest quintile 1.224 1.107 - 1.353 1.169 1.055 - 1.296 1.111 0.987 - 1.251 
University hospital  p<0.001  p<0.001  p<0.001 
Lowest quintile 1  1  1  
Second quintile 1.056 0.950 - 1.174 1.066 0.957 - 1.188 1.143 1.018 - 1.284 
Third quintile 1.298 1.172 - 1.438 1.252 1.127 - 1.391 1.231 1.102 - 1.375 
Fourth quintile 1.366 1.233 - 1.512 1.291 1.162 - 1.433 1.233 1.100 - 1.382 
Highest quintile 1.398 1.264 - 1.547 1.373 1.231 - 1.532 1.269 1.126 - 1.431 
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Appendix 3 Cox analyses of AMI mortality and driving time quintiles for persons 65 and older under 
models 1 to 3 for the four different hospital types 
 
 Model 1 Model 2 Model 3 
Driving time Hazard ratio 95% CI Hazard ratio 95% CI Hazard ratio 95% CI 
Acute hospital  p<0.001  p=0.004  p=0.012 
Lowest quintile 1  1  1  
Second quintile 1.089 1.038 - 1.144 1.059 1.009 - 1.112 1.058 1.008 - 1.111 
Third quintile 1.119 1.065 - 1.177 1.060 1.008 - 1.115 1.063 1.008 - 1.121 
Fourth quintile 1.195 1.136 - 1.257 1.102 1.047 - 1.160 1.102 1.042 - 1.166 
Highest quintile 1.189 1.132 - 1.249 1.071 1.019 - 1.126 1.046 0.987 - 1.109 
Acute hospital with ER  p<0.001  p=0.031  p=0.272 
Lowest quintile 1  1  1  
Second quintile 1.072 1.021 - 1.125 1.045 0.996 - 1.097 1.039 0.990 - 1.091 
Third quintile 1.081 1.028 - 1.137 1.032 0.981 - 1.085 1.029 0.976 - 1.085 
Fourth quintile 1.154 1.097 - 1.214 1.071 1.017 - 1.127 1.063 1.006 - 1.123 
Highest quintile 1.183 1.127 - 1.243 1.075 1.023 - 1.130 1.042 0.985 - 1.103 
Central hospital  p<0.001  p<0.001  p=0.036 
Lowest quintile 1  1  1  
Second quintile 1.044 0.992 - 1.098 0.994 0.944 - 1.046 0.995 0.940 - 1.053 
Third quintile 1.111 1.056 - 1.170 1.031 0.979 - 1.087 1.017 0.960 - 1.078 
Fourth quintile 1.152 1.097 - 1.210 1.070 1.017 - 1.125 1.045 0.989 - 1.105 
Highest quintile 1.218 1.162 - 1.277 1.119 1.066 - 1.175 1.079 1.019 - 1.143 
University hospital  p<0.001  p<0.001  p<0.001 
Lowest quintile 1  1  1  
Second quintile 1.120 1.062 - 1.180 1.067 1.011 - 1.125 1.077 1.017 - 1.141 
Third quintile 1.189 1.130 - 1.252 1.097 1.042 - 1.156 1.073 1.016 - 1.134 
Fourth quintile 1.256 1.196 - 1.319 1.157 1.100 - 1.216 1.122 1.062 - 1.186 
Highest quintile 1.273 1.213 - 1.335 1.193 1.131 - 1.257 1.145 1.079 - 1.214 
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Appendix 4 Cox analyses of stroke mortality and driving time quintiles for persons 30-64 under 
models 1 to 3 for the four different hospital types 
 
 Model 1 Model 2 Model 3 
Driving time Hazard ratio 95% CI Hazard ratio 95% CI Hazard ratio 95% CI 
Acute hospital  p=0.767  p=0.923  p=0.897 
Lowest quintile 1  1  1  
Second quintile 1.002 0.875 - 1.149 1.013 0.883 - 1.161 1.017 0.886 - 1.167 
Third quintile 0.927 0.808 - 1.064 0.958 0.834 - 1.101 0.982 0.848 - 1.136 
Fourth quintile 0.976 0.852 - 1.117 1.016 0.885 - 1.167 1.053 0.906 - 1.224 
Highest quintile 1.001 0.874 - 1.146 1.003 0.873 - 1.152 1.012 0.864 - 1.186 
Acute hospital with ER  p=0.439  p=0.353  p=0.187 
Lowest quintile 1  1  1  
Second quintile 0.992 0.865 - 1.139 0.998 0.869 - 1.145 1.001 0.872 - 1.150 
Third quintile 0.928 0.808 - 1.066 0.962 0.837 - 1.106 0.993 0.859 - 1.150 
Fourth quintile 1.059 0.926 - 1.211 1.101 0.962 - 1.262 1.148 0.991 - 1.330 
Highest quintile 1.006 0.878 - 1.153 1.006 0.875 - 1.156 1.016 0.869 - 1.189 
Central hospital  p=0.081  p=0.353  p=0.495 
Lowest quintile 1  1  1  
Second quintile 0.896 0.779 - 1.029 0.945 0.821 - 1.088 0.982 0.840 - 1.147 
Third quintile 0.958 0.835 - 1.100 0.997 0.866 - 1.148 1.025 0.876 - 1.199 
Fourth quintile 1.072 0.937 - 1.227 1.091 0.950 - 1.253 1.095 0.941 - 1.274 
Highest quintile 1.037 0.905 - 1.188 1.012 0.879 - 1.164 0.986 0.839 - 1.159 
University hospital  p=0.010  p=0.074  p=0.224 
Lowest quintile 1  1  1  
Second quintile 0.989 0.858 - 1.140 1.045 0.904 - 1.208 1.099 0.940 - 1.285 
Third quintile 1.138 0.990 - 1.308 1.163 1.008 - 1.342 1.166 1.004 - 1.355 
Fourth quintile 1.196 1.042 - 1.373 1.197 1.038 - 1.380 1.183 1.013 - 1.380 
Highest quintile 1.171 1.020 - 1.345 1.135 0.973 - 1.323 1.096 0.927 - 1.296 
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Appendix 5 Cox analyses of stroke mortality and driving time quintiles for persons 65 and older under 
models 1 to 3 for the four different hospital types 
 
 Model 1 Model 2 Model 3 
Driving time Hazard ratio 95% CI Hazard ratio 95% CI Hazard ratio 95% CI 
Acute hospital  p<0.001  p=0.059  p=0.063 
Lowest quintile 1  1  1  
Second quintile 1.017 0.975 - 1.061 0.992 0.951 - 1.034 0.990 0.949 - 1.033 
Third quintile 1.104 1.058 - 1.153 1.055 1.010 - 1.101 1.053 1.006 - 1.102 
Fourth quintile 1.096 1.049 - 1.146 1.025 0.980 - 1.072 1.021 0.972 - 1.073 
Highest quintile 1.091 1.045 - 1.139 1.015 0.971 - 1.060 0.998 0.948 - 1.051 
Acute hospital with ER  p<0.001  p=0.110  p=0.090 
Lowest quintile 1  1  1  
Second quintile 1.009 0.968 - 1.053 0.995 0.954 - 1.037 0.991 0.950 - 1.034 
Third quintile 1.077 1.032 - 1.125 1.041 0.996 - 1.087 1.039 0.992 - 1.087 
Fourth quintile 1.102 1.055 - 1.152 1.042 0.997 - 1.090 1.036 0.987 - 1.087 
Highest quintile 1.070 1.025 - 1.117 1.009 0.966 - 1.054 0.988 0.940 - 1.039 
Central hospital  p<0.001  p<0.001  p<0.001 
Lowest quintile 1  1  1  
Second quintile 1.059 1.014 - 1.107 1.019 0.974 - 1.065 1.026 0.977 - 1.078 
Third quintile 1.120 1.071 - 1.171 1.061 1.014 - 1.110 1.070 1.018 - 1.126 
Fourth quintile 1.170 1.121 - 1.221 1.129 1.081 - 1.180 1.137 1.084 - 1.193 
Highest quintile 1.135 1.089 - 1.183 1.103 1.057 - 1.152 1.111 1.056 - 1.169 
University hospital  p<0.001  p<0.001  p<0.001 
Lowest quintile 1  1  1  
Second quintile 1.128 1.078 - 1.180 1.081 1.032 - 1.131 1.091 1.039 - 1.146 
Third quintile 1.231 1.179 - 1.286 1.154 1.105 - 1.206 1.145 1.093 - 1.200 
Fourth quintile 1.149 1.100 - 1.199 1.081 1.035 - 1.129 1.068 1.017 - 1.120 
Highest quintile 1.101 1.055 - 1.149 1.088 1.039 - 1.140 1.066 1.012 - 1.124 
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Appendix 6 Cox analyses of AMI mortality and straight-line distance quintiles for persons 30-64 under 
models 1 to 3 for the four different hospital types 
 
  Model 1 Model 2 Model 3 
Straight-line distance Hazard ratio 95% CI Hazard ratio 95% CI Hazard ratio 95% CI 
Acute hospital   p=0.001   p=0.094   p=0.413 
Lowest quintile 1   1   1   
Second quintile 0.989 0.894 - 1.094 0.968 0.875 - 1.071 0.975 0.881 - 1.079 
Third quintile 0.964 0.873 - 1.066 0.941 0.851 - 1.041 0.975 0.877 - 1.084 
Fourth quintile 1.083 0.983 - 1.194 1.038 0.941 - 1.146 1.065 0.955 - 1.187 
Highest quintile 1.147 1.041 - 1.264 1.062 0.962 - 1.172 1.018 0.909 - 1.140 
Acute hospital with ER   p<0.001   p=0.071   p=0.651 
Lowest quintile 1   1   1   
Second quintile 0.974 0.881 - 1.077 0.960 0.868 - 1.062 0.971 0.877 - 1.074 
Third quintile 0.968 0.876 - 1.069 0.958 0.867 - 1.059 0.995 0.896 - 1.106 
Fourth quintile 1.060 0.961 - 1.168 1.024 0.928 - 1.131 1.049 0.942 - 1.168 
Highest quintile 1.155 1.049 - 1.272 1.084 0.983 - 1.195 1.034 0.925 - 1.154 
Central hospital   p<0.001   p<0.001   p<0.001 
Lowest quintile 1   1   1   
Second quintile 1.002 0.903 - 1.112 1.016 0.914 - 1.129 1.117 0.995 - 1.254 
Third quintile 1.228 1.111 - 1.358 1.203 1.086 - 1.333 1.262 1.125 - 1.415 
Fourth quintile 1.279 1.158 - 1.413 1.244 1.123 - 1.378 1.251 1.118 - 1.400 
Highest quintile 1.213 1.096 - 1.342 1.169 1.054 - 1.297 1.118 0.996 - 1.255 
University hospital   p<0.001   p<0.001   p=0.001 
Lowest quintile 1   1   1   
Second quintile 1.028 0.924 - 1.142 1.027 0.921 - 1.144 1.092 0.971 - 1.228 
Third quintile 1.271 1.148 - 1.408 1.224 1.103 - 1.359 1.195 1.070 - 1.333 
Fourth quintile 1.391 1.258 - 1.539 1.304 1.175 - 1.446 1.243 1.110 - 1.391 
Highest quintile 1.356 1.225 - 1.500 1.325 1.187 - 1.479 1.224 1.087 - 1.378 
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Appendix 7 Cox analyses of AMI mortality and straight-line distance quintiles for persons 65 and 
older under models 1 to 3 for the four different hospital types 
 
  Model 1 Model 2 Model 3 
Straight-line distance Hazard ratio 95% CI Hazard ratio 95% CI Hazard ratio 95% CI 
Acute hospital   p<0.001   p<0.001   p<0.001 
Lowest quintile 1   1   1   
Second quintile 1.086 1.034 - 1.141 1.061 1.011 - 1.115 1.060 1.009 - 1.113 
Third quintile 1.160 1.103 - 1.220 1.097 1.043 - 1.153 1.102 1.045 - 1.162 
Fourth quintile 1.244 1.183 - 1.308 1.148 1.091 - 1.208 1.150 1.087 - 1.217 
Highest quintile 1.194 1.136 - 1.255 1.082 1.029 - 1.139 1.060 0.999 - 1.125 
Acute hospital with ER   p<0.001   p=0.001   p=0.036 
Lowest quintile 1   1   1   
Second quintile 1.075 1.024 - 1.129 1.054 1.003 - 1.106 1.051 1.000 - 1.103 
Third quintile 1.114 1.060 - 1.172 1.065 1.012 - 1.120 1.064 1.009 - 1.122 
Fourth quintile 1.184 1.125 - 1.246 1.100 1.044 - 1.158 1.092 1.032 - 1.156 
Highest quintile 1.196 1.138 - 1.256 1.095 1.042 - 1.151 1.064 1.005 - 1.127 
Central hospital   p<0.001   p<0.001   p=0.001 
Lowest quintile 1   1   1   
Second quintile 1.037 0.986 - 1.091 0.983 0.934 - 1.035 0.980 0.927 - 1.037 
Third quintile 1.086 1.032 - 1.144 0.997 0.946 - 1.051 0.973 0.918 - 1.032 
Fourth quintile 1.145 1.090 - 1.203 1.057 1.005 - 1.112 1.027 0.971 - 1.085 
Highest quintile 1.213 1.157 - 1.272 1.129 1.076 - 1.185 1.080 1.022 - 1.142 
University hospital   p<0.001   p<0.001   p<0.001 
Lowest quintile 1   1   1   
Second quintile 1.121 1.063 - 1.182 1.058 1.002 - 1.116 1.069 1.009 - 1.134 
Third quintile 1.183 1.125 - 1.244 1.099 1.044 - 1.157 1.075 1.019 - 1.135 
Fourth quintile 1.298 1.237 - 1.363 1.194 1.136 - 1.255 1.160 1.098 - 1.225 
Highest quintile 1.247 1.188 - 1.309 1.165 1.104 - 1.230 1.116 1.053 - 1.184 
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Appendix 8 Cox analyses of stroke mortality and straight-line distance quintiles for persons 30-64 
under models 1 to 3 for the four different hospital types 
 
  Model 1 Model 2 Model 3 
Straight-line distance Hazard ratio 95% CI Hazard ratio 95% CI Hazard ratio 95% CI 
Acute hospital   p=0.366   p=0.510   p=0.449 
Lowest quintile 1   1   1   
Second quintile 1.061 0.925 - 1.217 1.060 0.924 - 1.216 1.062 0.925 - 1.219 
Third quintile 0.950 0.827 - 1.092 0.974 0.847 - 1.121 1.004 0.866 - 1.163 
Fourth quintile 1.059 0.924 - 1.213 1.084 0.945 - 1.244 1.127 0.968 - 1.311 
Highest quintile 1.072 0.935 - 1.228 1.058 0.921 - 1.216 1.079 0.920 - 1.265 
Acute hospital with ER   p=0.032   p=0.049   p=0.027 
Lowest quintile 1   1   1   
Second quintile 0.978 0.851 - 1.123 0.983 0.856 - 1.129 0.989 0.861 - 1.137 
Third quintile 0.897 0.780 - 1.031 0.924 0.803 - 1.064 0.959 0.827 - 1.111 
Fourth quintile 1.100 0.963 - 1.257 1.129 0.986 - 1.291 1.185 1.022 - 1.373 
Highest quintile 1.063 0.929 - 1.217 1.051 0.916 - 1.206 1.079 0.924 - 1.261 
Central hospital   p=0.034   p=0.185   p=0.311 
Lowest quintile 1   1   1   
Second quintile 0.853 0.741 - 0.981 0.896 0.777 - 1.033 0.933 0.798 - 1.090 
Third quintile 1.022 0.893 - 1.169 1.055 0.918 - 1.212 1.079 0.925 - 1.260 
Fourth quintile 1.024 0.895 - 1.173 1.032 0.897 - 1.186 1.037 0.890 - 1.208 
Highest quintile 1.037 0.906 - 1.188 1.010 0.878 - 1.160 0.982 0.841 - 1.147 
University hospital   p=0.028   p=0.132   p=0.238 
Lowest quintile 1   1   1   
Second quintile 1.047 0.909 - 1.205 1.106 0.957 - 1.278 1.172 1.002 - 1.371 
Third quintile 1.156 1.006 - 1.329 1.176 1.019 - 1.357 1.176 1.012 - 1.366 
Fourth quintile 1.150 0.999 - 1.323 1.141 0.988 - 1.318 1.127 0.963 - 1.319 
Highest quintile 1.223 1.065 - 1.404 1.204 1.034 - 1.404 1.156 0.981 - 1.362 
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Appendix 9 Cox analyses of stroke mortality and straight-line distance quintiles for persons 65 and 
older under models 1 to 3 for the four different hospital types 
 
  Model 1 Model 2 Model 3 
Straight-line distance Hazard ratio 95% CI Hazard ratio 95% CI Hazard ratio 95% CI 
Acute hospital   p<0.001   p=0.103   p=0.206 
Lowest quintile 1   1   1   
Second quintile 1.032 0.989 - 1.076 1.012 0.970 - 1.055 1.009 0.967 - 1.053 
Third quintile 1.100 1.054 - 1.149 1.050 1.006 - 1.097 1.049 1.001 - 1.098 
Fourth quintile 1.118 1.070 - 1.169 1.050 1.004 - 1.099 1.047 0.996 - 1.100 
Highest quintile 1.106 1.060 - 1.155 1.033 0.989 - 1.080 1.020 0.969 - 1.074 
Acute hospital with ER   p<0.001   p=0.035   p=0.071 
Lowest quintile 1   1   1   
Second quintile 1.013 0.972 - 1.057 1.000 0.959 - 1.043 0.998 0.957 - 1.041 
Third quintile 1.067 1.021 - 1.114 1.033 0.988 - 1.079 1.032 0.985 - 1.080 
Fourth quintile 1.126 1.077 - 1.177 1.066 1.019 - 1.114 1.062 1.011 - 1.115 
Highest quintile 1.080 1.035 - 1.127 1.025 0.981 - 1.070 1.010 0.961 - 1.062 
Central hospital   p<0.001   p<0.001   p<0.001 
Lowest quintile 1   1   1   
Second quintile 1.090 1.043 - 1.139 1.042 0.996 - 1.089 1.054 1.004 - 1.106 
Third quintile 1.128 1.078 - 1.179 1.062 1.014 - 1.111 1.074 1.020 - 1.130 
Fourth quintile 1.156 1.108 - 1.207 1.107 1.060 - 1.157 1.117 1.064 - 1.172 
Highest quintile 1.162 1.114 - 1.211 1.139 1.091 - 1.188 1.144 1.089 - 1.201 
University hospital   p<0.001   p<0.001   p<0.001 
Lowest quintile 1   1   1   
Second quintile 1.121 1.071 - 1.173 1.063 1.015 - 1.113 1.071 1.019 - 1.127 
Third quintile 1.190 1.140 - 1.242 1.123 1.075 - 1.173 1.114 1.063 - 1.167 
Fourth quintile 1.160 1.111 - 1.210 1.094 1.048 - 1.143 1.082 1.031 - 1.135 
Highest quintile 1.097 1.051 - 1.145 1.081 1.032 - 1.133 1.060 1.007 - 1.116 
 
 
 
167
  
168
3    Discussion 
3.1 Main findings 
Regional variation of avoidable hospitalizations in Switzerland (Article 1) 
In 2010, 3.1% of all hospital stays were AH. Patient’s characteristics differed between low and high 
volume hospitals. The study results showed 3.6-fold variation between the 59 HSAs from 2008 to 
2010 and up to 12-fold variation within one year. Lower rates of all AH were found in areas with very 
high supply of primary care physicians, increased AH rates in areas with more specialists (irrespective 
of the disease group) and in areas with higher proportion of rural residents. No association was 
found with reimbursement system and hospital capacity.  
Adequate treatment of emergency STEMI patients? (Article 2)   
Using the hospital discharge and hospital statistics of 2010 and 2011 we identified 9,696 STEMI cases, 
71.6% of them received a PCI or CABG. Older and female patients were less likely to receive 
revascularization which suggests that the treatment guidelines may not be uniformly applied in 
Switzerland. Other variables as the insurance status, the infrastructure of the hospital, or the 
language region of the hospital didn’t affect the receipt of revascularization. A sensitivity analysis 
showed that being admitted to a small hospital first, limits the chance of receiving a 
revascularization.  
The geography of cost of end of life care in Switzerland (Article 3) 
The data of six large Swiss health insurances were utilized to examine the cost at the end of life of all 
deceased customers who died between 2008 and 2010. Cardiovascular disease and cancer were the 
main causes of death. Cancer deaths accumulated the largest costs, followed by diseases of the 
nervous system, respiratory diseases and CVD. Cause of death and age were the major drivers of high 
cost of end of life care. The language region also played a role: In the French speaking part of 
Switzerland the EOLC costs were 28% to 35% higher. No effect was found for health care supply 
measures. Still, large geographical variation in cost were observed, which couldn’t be explained with 
the variables included in the analyses.  
Distance to hospital and AMI and stroke mortality (Article 4) 
The Swiss National Cohort was used to examine the relationship between distance from the place of 
residence to different hospital types and the risk of dying from acute myocardial infarction or stroke. 
The AMI mortality risk for the young (below 65 years) and old (65+ years) Swiss population increases 
with the distance to a central or university hospital. An elevated risk of stroke mortality was also 
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found for the older Swiss population. For both, AMI and stroke mortality, the observed associations 
were rather small. 
3.2 Strengths and limitations 
Study-specific strengths and limitations are discussed in detail in each of the articles comprising this 
thesis. In general, all studies aimed to cover the whole country and followed a population-based 
approach which was sometimes limited by data quality and accessibility. To my knowledge, the 
consideration of the referral pattern in the hospital discharge statistics is unique. In contrast, 
previous studies incorporated the variables “whereabouts before entry” and “stay after exit” to 
distinguish whether the patient was referred from or to a hospital, another health care provider, 
home or elsewhere. None considered the exact referral pathway between different hospitals of each 
patient.  
This thesis provides an overview of a great part of the data available for health services research in 
Switzerland. The data can be used to monitor trends of identified deficits although I discovered 
several limitations that need to be addressed in the future.  
Given the extent of the data and the numerous different institutions involved in the data collection, 
missing records or values are an issue. For example, 300 hospitals are deriving data for the hospital 
discharge statistics from their hospital information system. Delayed software updates can lead to 
incorrect data values as seen with the assignment of patients’ MedStat in some hospitals (Berlin et 
al., 2014). Furthermore, the coding quality between hospitals can differ in terms of the completeness 
and accuracy of diagnoses and treatments and this can affect the results of studies using data from 
multiple hospitals. Since cantons utilize the hospital discharge data statistics for their health care 
planning, correct data about places of residence and the number of treatments performed are 
essential.  
Census, mortality registry, and health insurance data are routinely collected, as are hospital 
discharge and hospital statistics. Such data are not designed specifically for research purposes which 
can present challenges for those trying to do so. Performing observational studies with such data can 
introduce bias by mechanisms such as missing information. Having no exact place of death limits the 
interpretation of the relationship of distance to hospital and AMI and stroke mortality (Article 4). No 
information was available in the hospital discharge statistics about medication given to patients 
during their hospital stay. Again, this restricts the analysis of the adequate treatment of STEMI 
patients as information about fibrinolysis is not available in the data set (Article 2).  
Another issue in the presented studies is the absence of data about disease prevalence in 
geographical units in Switzerland. Differences in the disease prevalence can have an impact on the 
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observed regional variation in health care. Measuring such disease prevalence data would require a 
very cost- and time-intensive data collection process. The hospital discharge statistics provides an 
important part in the estimation of disease prevalence in Switzerland. Conducting diagnostic and 
treatment information also in the ambulatory setting could have been a major contribution to the 
estimation of disease prevalence. 
Another challenge in conducting observational studies with these data is that information about 
health care utilization behaviour is not available. For example, it is difficult to distinguish whether it is  
lower access to care or the influence of the lower propensity of rural residents to seek care 
(Longman et al., 2011), or indeed both, that determines the higher rate of avoidable hospitalisations 
in rural areas.  
Due to the lack of a unique identifier for every person living in Switzerland, deterministic and 
probabilistic linkage techniques were used to connect data sets of different sources (Articles 3 and 
4). These techniques do not provide 100% congruency as unlinked or incorrect linked records will 
occur and the linkage proportions can vary among subgroups, which may affect the results of studies 
including those here.  
In the hospital discharge statistics a so-called anonymous unique person identifier is used. 
Unfortunately, this person identifier does not identify persons uniquely. The patients first and last 
name, date of birth and gender is used to generate a unique Hash-code. However, an individual may 
be assigned more than one Hash-code if, for example, their family name changes. Additionally, I 
found disparities in age and gender for patients with the same person identifier indicating that the 
person identifier has been assigned to two or more different persons. The SFSO is aware of these 
weaknesses since the introduction of the hospital discharge statistics, but they rate it as a negligible 
problem.  
3.3 Implications for policy and future research 
3.3.1 Application of treatment guidelines 
Similar to studies in other countries, I found differences in revascularization by age and gender. For 
health care professionals these results indicate that the treatment for older persons and women isn’t 
optimal and treatment guidelines, providing the best evidence-based knowledge so far, might not be 
applied properly in Switzerland. Unfortunately, due to major limitations of the data (Article 2) it is 
not possible to distinguish the reasons for these discovered differences in the treatment of STEMI 
patients.  
It is known that female ACS patients present more frequently with atypical symptoms and with more 
pre-hospital delay than men (de-Miguel-Balsa et al., 2015; Steg et al., 2012). Also, elderly patients 
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often present with atypical or mild symptoms, which can result in delayed or missed diagnosis of 
AMI. Both female and elderly patients have a higher risk of bleeding. Although they require special 
attention in acute diagnostic and in their treatment, the recommended treatment doesn’t differ for 
men and women, and younger and older patients (Steg et al., 2012).  
A high degree of awareness for AMI in women and elderly patients is of great importance and 
medical personnel in Switzerland need to be appropriately trained, with skills reinforced in refresher 
courses. Although the study presented in this thesis has limitations it still provides an opportunity to 
monitor the development of the application of treatment guidelines. Additional variables e.g. 
medical information would be desirable but might blow up and hamper the data collection process.  
3.3.2 Missing factors influencing the costs at the end of life  
Health care supply measures seem to not play a role in the variation of EOLC costs, whereas the 
linguistic region does seem to influence the costs of EOLC. The different linguistic regions in 
Switzerland offer a great opportunity to examine the influences of diverse cultures in one country. 
However, such huge variations in the cost of health care across Switzerland indicates large 
inequalities in provision and consumption of health care.  
Although a large proportion of the factors influencing the regional variation of EOLC costs throughout 
Switzerland couldn’t be explained in the study (Article 3), it was possible to map the variation and 
pinpoint the regions of low or high costs and hence potential under- or overuse of services in EOLC. 
Therefore, future research needs to address the quality of care and patient satisfaction because low 
costs do not necessarily indicate under-use and vice versa. If higher spending leads to better quality 
of care and patient satisfaction then this should be the benchmark for the other regions, and 
conversely.   
3.3.3 Distance to hospital matters 
The results of the analyses in article 4 show increasing risk of dying from AMI or stroke with distance 
from a central or university hospital. Unfortunately, major information on the circumstances of the 
death are missing in the study (e.g. admission to hospital, died on the way to hospital, died at place 
of onset), which limits the explanatory power of the study. This induces questions for further 
research e.g. to evaluate effectiveness and quality of the Swiss EMS by illustrating the emergency 
pathways of AMI or stroke patients, where the patient will be brought to (the nearest hospital or 
immediately to a stroke unit or catheter laboratory) to perform specialized treatment and how this 
affects patient outcomes (e.g. mortality).  
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Between 2002 and 2012, 65 acute hospitals have been closed down or merged, mainly due to 
economic reasons (O’Dea, 2014). Therefore, another interesting topic to examine would be the 
influence of hospital closures on medical emergencies such as life-threatening diseases or childbirth.  
3.3.4 Supporting ambulatory care to reduce potentially avoidable hospitalisations 
In the past decade, it has frequently been reported that Switzerland will face a lack of primary care 
physicians, mainly in rural and peripheral areas, in the near future (Forster, 2012; Kunz, 2015; Meier, 
2014; Sbr, 2014). This thesis showed that a very high density of primary care physicians keeps the AH 
rates at a low level, whereas a low density of primary care physicians leads to increasing AH rates 
(Article 1). This would indicate that health policy should promote primary care physicians in deprived 
areas.  
Interestingly, since 2002, Switzerland has established and enforced regulations that prevent 
physicians from opening an office based practice stating that there are currently too many physicians 
in Switzerland. Right now, just specialists are not allowed to open a practice, indicating that primary 
care physicians are needed. Although the government can limit the blockage regulation to certain 
regions they cannot force physicians to open or take over a practice in a specific deprived region 
(Brotschi, 2015).  
In a report from the Swiss Federal Council regarding strategies to address the lack of physicians and 
to support primary care in Switzerland, the key recommendation was to train more physicians by 
increasing the number of university places for medicine, and to improve efficiency by introducing 
managed care models (Bundesrat, 2011). The core of managed care models is a consortium of 
primary care and specialized physicians that collaborates to take care of patients. The goals are: 
being a gatekeeper of the health care system, better coordination, and improvement of quality. The 
initiative to implement the managed care model was rejected by Swiss voters in the 2012 
referendum. A survey showed that most people feared that this would result in the loss of their free 
choice of physicians (Ses/sda, 2012).  
3.4 The data issue – opportunities and challenges in the future 
3.4.1 New Research Program “Smarter Health Care” 
With regard to the future challenges of the Swiss health care system, the Swiss National Science 
Foundation (SNSF) recently launched the National Research Program “Smarter Health Care”, which 
aims to support innovative health services research that addresses concrete challenges of chronic 
disease care in Switzerland. Additionally, the program aims to outline  the current weaknesses of 
Swiss health care data and to recommend targets to improve these data (SNSF, 2015). This thesis 
provides substantial information about a major component of the Swiss health care data (e.g. 
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hospital discharge statistics, hospital statistics, mortality registry, SNC, insurance data), its 
weaknesses and limitations as well as the future challenges and possible improvements for these 
data. 
3.4.2 Available and missing data 
The data presented in this thesis mainly contains information about hospital location or 
infrastructure, the density of primary care and specialized practices, and information on individual 
level from census, mortality registry and hospital discharge statistics. Nonetheless, inferring policy 
recommendations is limited because a major drawback of all analyses is the lack of a comprehensive 
ambulatory care data set that includes diagnoses and treatments on an individual level for all 
ambulant practices for the whole country. In the end of life care study, the attempt to include 
information on the patient’s ambulatory utilization using insurance data was mostly limited to 
information about the generated costs before death (Article 3).  
The lack of comprehensive ambulatory data is known (OECD/WHO, 2011) and also referred to it by 
the Swiss legislation (Huguenin, 2015). To fulfil the requirements of this legislation the SFSO is 
preparing the implementation of the statistics of ambulatory health care in Switzerland. Besides the 
characteristics of the ambulatory practices (e.g. number and profession of staff, infrastructure, range 
of services), information about the diagnoses or treatments on an individual level for patients being 
treated with ambulatory care in hospitals will be collected. An expansion of the data collection of 
individual patient records to all ambulatory primary and specialized care practices is planned for 
2017 (SFSO, 2016).  
The SFSO states that the private, economical characteristic of the ambulatory sector and the large 
number of institutions involved will influence the response rate of the ambulatory care data 
collection. Of note, the Swiss Medical Association, representing physicians, is concerned that the 
data collection will affect the confidentiality of patients’ information and does not apply the data 
protection regulations properly (Mw/sda, 2012). Thus, similar to the hospital discharge statistics, it 
might take several years until all ambulatory health care providers will contribute their data.  
The SFSO is about to set the variables for collection for the ambulatory health care database using 
variables from the hospital discharge dataset, such as the person identifier and MedStat, which 
indicate the place of residence of the patient and the location of the practice. The use of the same 
method to create the personal identifier across the two databases will enable the linkage of the 
ambulatory and inpatient data. In this thesis it was shown that these two variables (personal 
identifier and MedStat) are prone to mistakes. Before the implementation of the new statistics, the 
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SFSO should consider ways to improve the construction of the personal identifier and the assignment 
of MedStat regions.  
The introduction of the ambulatory care statistics will be the key element to connect ambulatory and 
inpatient data. For the first time it will be possible to map the pathways of each patient between the 
ambulatory and inpatient sectors and the pathways between Swiss health care providers.   
These linked data sets will enable researchers to study whether avoidable hospitalisations received 
appropriate care by primary care or specialized care physicians prior to their hospitalisation. This 
then can be used to validate the application of the OECD avoidable hospitalisation criteria in 
Switzerland.  
3.4.3 Implementation of SwissDRG 
Three of the four articles in this thesis utilized routinely collected data on hospital discharges, which 
were derived from hospital information systems before the implementation of Swiss Diagnosis 
Related Groups (SwissDRG) in Switzerland at 1st January, 2012. SwissDRG is a tariff system which is 
used for the reimbursement of inpatient hospital services on the basis of case-based lump sum 
payments. Prior to 2012, only a few of the 26 cantons were using APDRG, a precursor to the 
SwissDRG. From 2012 onwards, all hospitals have been obligated to use Swiss-DRG for 
reimbursement. Several factors contribute to the assignment of a SwissDRG. Namely, the main 
diagnosis, secondary diagnoses, CHOP codes, severity of the condition, age, gender, length of stay, 
etc. The aim of the implementation of the SwissDRG is to support transparency and comparability 
between the hospitals in order to increase efficiency (SwissDRG AG, 2016).  
It is expected that hospitals now apply the coding guidelines more carefully than before the 
implementation of the SwissDRG, since the completeness of the records determine the SwissDRG 
and consequently the reimbursement. This process should also improve the data quality of the 
hospital discharge statistics. However, critics are concerned that the introduction of the SwissDRG 
will cause conflicts between commitment to the patient’s well-being and the economic interests of 
the hospital (Fässler et al., 2015). Furthermore, the new reimbursement system might lead to misuse 
by the hospitals by modifying the patients’ condition and treatment codes in order to declare a 
SwissDRG that results in a higher reimbursement. On the other hand, there is criticism that certain 
procedures are not appropriately reimbursed by the SwissDRG system (Mehra et al., 2015).  
There are some studies investigating possible differences in the length of stay, patient care, outcome 
and satisfaction both before and after the introduction of SwissDRG (Fässler et al., 2015; Stauber et 
al., 2014; Thommen et al., 2014). This is an interesting field that needs further investigation. The 
Swiss Public Health Department has initiated the evaluation of the introduction of the SwissDRG. This 
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involves the examination of changes in quality of inpatient services and the definition of indicators to 
evaluate the quality. But first of all it has to be proven that the hospital discharge statistics can be 
used to examine the quality of inpatient services as this data set is the basis of these planned 
examinations (Swiss Public Health Department, 2016). 
This thesis shows that a major limitation of the pre-SwissDRG hospital discharge data is the poor 
quality of the comorbidities and treatment codes. A comparison of hospital discharge data before 
and after the introduction should be performed with caution.  
Insurance claims for inpatient care didn’t include detailed diagnostic or treatment information before 
the introduction of the SwissDRG. Now, the invoices include the SwissDRG, which can be used to 
derive the main ICD-10 codes and CHOP codes that lead to this specific SwissDRG. In contrast to the 
hospital discharge data, the invoice includes the effective costs.  
3.4.4 Future research with the available data 
The linkage of the hospital discharge and the hospital statistics data sets will be more difficult in the 
future. While I received two separate data sets and then merged these using the hospital-ID, this 
won’t be possible in the future. Furthermore, not all variables will be available with the same level of 
detail in the future, since the SFSO is tightening up their data protection. This will hinder the 
performance of small area analysis and the continuation or replication of the 3 studies from this 
thesis that based their analysis on these data sets. Several projects of the new National Research 
Program “Smarter Health Care” will be faced with these difficulties, which will hopefully have an 
impact on health policy stakeholders to improve data availability.   
3.5 Conclusion 
The aim of this thesis was to provide a contribution to CVD epidemiology and HSR in Switzerland. The 
four articles presented addressed different research questions and utilized a wide range of methods 
and data, reflecting the multidisciplinary field of health services research.  
I showed that lower rates of all AH were found in areas with a very high supply of primary care 
physicians, and increased AH rates in areas with more specialists and in areas with a higher 
proportion of rural residents. 
The study looking into the adequacy of STEMI treatment found that females and older patients were 
less likely to receive revascularization. This suggests treatment guidelines may not be uniformly 
applied across Switzerland. 
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Cause of death and age are strongly associated with cost of end of life care. Place of residence and, in 
particular, the linguistic region had a significant influence on costs. No effect was found for health 
care supply measures. 
Risk of dying from AMI increased with distance from a central or university hospital for both younger 
persons and older persons over the age of 65 years in the Swiss National Cohort. For stroke mortality, 
though, a significant association with distance to the same hospitals was observed only in those 65 
years of age and older. 
The major data sources of all studies were administrative data, which was not collected for these 
research purposes. This thesis described the challenges and limitations of the data sources used.  
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